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ABSTRACT

Ejaculatory dysfunction impacts large numbers of men of all ages and around the world. In
addition, a great majority of men with chronic spinal cord injury (SCI) experience ejaculatory
dysfunction, which negatively impacts the quality of life of these individuals and their partners.
SCI men emphasize the significance of regaining sexual function as their main goal. Currently,
there is a marked absence of literature reporting the alterations to sexual function and ejaculation
in particular in animal models of chronic SCI. In addition, there are many unanswered questions
pertaining to the spinal cord control of ejaculation in healthy, intact men. It is known that
ejaculation is controlled by a population of lumbar spinothalamic (LSt) cells in the lumbar spinal
cord through their direct projections to preganglionic autonomic and motor neurons in the
lumbosacral spinal cord. It is hypothesized that LSt cells control ejaculatory reflexes through the
release of their neuropeptides galanin, cholecystokinin (CCK), gastrin-releasing peptide (GRP),
and enkephalin onto receptors in autonomic and motor areas of the lumbosacral spinal cord. This
hypothesis was tested in this thesis utilizing a paradigm in anesthetized and spinalized male rats,
with stimulation of the sensory inputs via the dorsal penile nerve. Consistent with the hypothesis,
mu and delta opioid receptor, galanin, CCK, and GRP receptor activation in LSt target areas in
the lumbosacral spinal cord was demonstrated to be critical for ejaculatory reflexes. Next, the
hypothesis that intrathecal infusions of the LSt neuropeptides can improve ejaculatory reflexes in
male rats with chronic SCI was tested. Results indicated that intrathecal infusions of GRP and
the mu opioid receptor agonist DAMGO improved ejaculatory reflexes in male rats with chronic
contusion SCI. Finally, the hypothesis that the D3 receptor agonist 7-OH-DPAT will recover
ii

ejaculatory function in male rats with chronic spinal cord injury was tested. Indeed, systemic
infusions of 7-OH-DPAT greatly improved ejaculatory reflexes in SCI males. Together, the
studies in this thesis further clarified the mechanisms involved in the spinal cord control of
ejaculation in male rats and represent an initial but pivotal first step towards the recovery of
ejaculatory function after chronic spinal cord injury.

Key Words: ejaculation, spinal ejaculation generator, chronic spinal cord injury, lumbosacral
spinal cord, spinal cord contusion, galanin, cholecystokinin, enkephalin, gastrin-releasing
peptide, dopamine D3 receptor.
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Chapter 1: Introduction

Spinal cord control of ejaculatory reflexes in male rats: Effects of
spinal cord injury

2

1.1 Introduction

Male sexual dysfunction, including erectile and ejaculatory dysfunction, commonly occurs in
adult men of all ages and around the world. While the mechanisms of erectile dysfunction are
well-known and various effective treatment options are currently available, the mechanisms
underlying the control of ejaculation remain largely unknown. Premature ejaculation is one of
the most frequently reported ejaculatory dysfunctions and at present there are no effective
treatment options available (Vale, 1999). Ejaculation is also severely altered in men with chronic
spinal cord injury (SCI) (Brackett et al., 1998). However, among paraplegic men, the recovery of
normal sexual function is the highest priority and is even ranked above recovery of locomotor
function (Anderson, 2004). The current review will summarize literature describing the central
control of ejaculation in humans and animal models. In addition, the effects of chronic SCI on
ejaculation are reviewed. Finally, potential treatments geared toward the recovery of normal
sexual function in men suffering from premature ejaculation and in men with chronic SCI will be
reviewed.

1.2 Ejaculation

Male sexual behavior is highly complex and consists of several components including the pursuit
and investigation of the female, mounts and intromissions finally culminating in ejaculation, a
process that is closely associated with orgasm in men (Meisel R, 1994) and reward in male rats
(Hull et al., 2002). Ejaculation is physiological process that refers to the expulsion of seminal
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contents from the urethral meatus (Marberger, 1974; McKenna, 1999) and is composed of two
separate components, emission and expulsion. Emission refers to the secretion of seminal
contents from the accessory sex glands, including the vas deferens, seminal vesicles and prostate
(Wang et al., 1991) and the closure of the bladder neck and external uretheral sphincter to avert
retrograde ejaculation (Newman et al., 1982). Expulsion refers to the coordinated, rhythmic
contractions of the striated perineal muscles and the bulbocavernosus muscle (BCM) in
particular, as well as the smooth muscles of the urethra, which forcefully expel semen from the
urethral meatus (Breedlove and Arnold, 1980, 1981; Breedlove et al., 1983).

1.3 The Spinal Ejaculation Generator

It has been known for some time from studies of chronic SCI patients and animal models that
ejaculation is a reflex and the central mechanisms that regulate this reflex are localized to the
lumbosacral spinal cord (Comarr, 1970; Comarr and Gunderson, 1975; McKenna, 1997;
McKenna, 1999). Previous studies have shown that vibratory penile stimulation is sufficient to
trigger ejaculatory reflexes in men with complete spinal cord injuries above the 10th thoracic
spinal segment (Brackett et al., 1998; Brackett, 1999; Sonksen and Ohl, 2002). Similarly,
stimulation of the dorsal penile nerve (DPN), the sensory branch of the pudendal nerve, triggers
ejaculatory reflexes in male rats with complete spinal cord transection (Staudt et al., 2010;
Staudt, 2011; Kozyrev et al., 2012). The fact that ejaculatory reflexes persist in spinalized men
and male rats (Comarr, 1970; Comarr and Gunderson, 1975; Pescatori et al., 1993; Brackett et
al., 1998; McKenna, 1999) despite the complete absence of functional reciprocal connections
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with supraspinal regions suggests that ejaculation is regulated by a control center in the
lumbosacral spinal cord. This control center is known as the spinal pattern generator (McKenna
et al., 1991; Carro-Juarez and Rodriguez-Manzo, 2007), spinal pacemaker (Sachs and Garinello,
1979), or spinal ejaculation generator (Marberger, 1974; Marson and McKenna, 1994) and it
controls ejaculation in two main ways. First, it coordinates sympathetic, parasympathetic and
motor outflow to trigger the two components of ejaculation: emission and expulsion. Secondly,
the spinal ejaculation generator integrates this autonomic and motor outflow with sensory inputs
necessary to induce ejaculation which are conveyed during sexual activity (Coolen et al., 2004;
Allard et al., 2005; Coolen, 2005; Young et al., 2009).

1.3.1

LSt Cells Form an Integral Component of the Spinal Ejaculation Generator

About a decade ago, substantial progress was made in identifying a population of interneurons in
the lumbosacral spinal cord that form a critical component of the spinal ejaculation generator
(Truitt and Coolen, 2002). These interneurons are located in lamina 10 around the central canal
and the medial portion of lamina 7 in lumbar levels (L3 – L4) of the spinal cord and have direct
projections to the parvocellular subparafascicular thalamic nucleus (SPFp) (Ju et al., 1987;
Coolen et al., 2003; Truitt et al., 2003). Moreover, these lumbar spinothalamic (LSt) cells, named
according to their anatomical position in the spinal cord and thalamic projections, are sexuallydimorphic and show neural activation, visualized with Fos, specifically following ejaculation in
male but not in female rats (Truitt and Coolen, 2002; Coolen et al., 2003; Truitt et al., 2003). In
addition, LSt cells co-express several neuropeptides including galanin, cholecystokinin (CCK),
enkephalin and gastrin-releasing peptide (GRP) (Newton, 1993; Nicholas et al., 1999; Phan and
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Newton, 1999; Newton and Phan, 2006; Sakamoto et al., 2008; Kozyrev et al., 2012) and project
their axons to autonomic preganglionic neurons (Xu et al., 2006) and pudendal motoneurons
(Newton, 1993; Newton and Phan, 2006) in the thoracolumbar and lumbosacral spinal cord.
Galanin, a marker of LSt cells, is expressed in axons projecting to preganglionic sympathetic and
parasympathetic neurons as well as pudendal motor neurons (Newton, 1993; Truitt and Coolen,
2002). Neural activation of LSt cells, based on Fos and galanin co-expression, is specifically
related to the onset of ejaculation (Truitt et al., 2003; Coolen et al., 2004). Targeted lesions of the
LSt cells with intraspinal injections of a neurotoxin SSP-Saporin abolished ejaculation in
copulating male rats but spared all other components of male rat sexual behavior including
pursuit and investigation of the female, mounts and intromissions (Truitt and Coolen, 2002).
Furthermore, targeted lesions of the LSt cells with the same neurotoxin prevented rhythmic
contractions of the BCM following DPN, urethral or pharmacological stimulation with the
dopamine D3 receptor agonist 7-OH-DPAT, in anesthetized and spinalized male rats (Staudt,
2011). In addition, in male rats with LSt lesions, galanin-immunoreactive fibers normally
projecting to autonomic nuclei in the lumbosacral spinal cord were absent, confirming that LSt
cells are required for these functional projections (Truitt and Coolen, 2002). Together these
studies demonstrated that LSt cells are essential for ejaculation in male rats and that LSt cells
regulate ejaculation through intraspinal connections to preganglionic autonomic and motor
neurons in the lumbosacral spinal cord (Truitt and Coolen, 2002; Truitt et al., 2003; Staudt,
2011). Thus, LSt cells are a population of interneurons in the lumbar spinal cord which comprise
a pivotal component of the spinal ejaculation generator and transform sensory inputs during
sexual activity into motor and secretory outputs (McKenna, 1999).
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1.3.2

Spinal Inputs to the Ejaculation Generator

During sexual activity, the DPN, the sensory branch of the pudendal nerve, plays a central role in
the transmission of sensory inputs to the spinal ejaculation generator required to trigger
ejaculation (Marberger, 1974; Hull et al., 2002). Indeed, electrical stimulation of the DPN
triggers rhythmic contractions of the BCM similar to those observed in copulating male rats
(Pescatori et al., 1993). Furthermore, both DPN stimulation in anesthetized and spinalized male
rats and ejaculation in mating males triggers phosphorylated ERK (pERK) and phosphorylated
NMDA receptor subunit 1 (pNR1) in LSt cells (Staudt et al., 2010, 2011). Moreover, injections
of antagonists for ERK and NMDA receptors blocked DPN stimulation-induced BCM bursting
in male rats (Staudt et al., 2010, 2011). Pudendal nerve terminals are found in close proximity to
the LSt cells in the lumbosacral spinal cord and are mainly localized to medial dorsal horn and
dorsal gray commissure (DGC) (McKenna and Nadelhaft, 1986; Ueyama et al., 1987).
Presumably, these sensory signals are relayed to the LSt cells through intraspinal connections
between the LSt cells and the dorsal horn and DGC. However, precisely how this transfer occurs
is currently unknown as there are no known direct projections from the dorsal horn and DGC to
the LSt cells. These sensory inputs are conveyed by the DPN during sexual activity prior to
ejaculation and activate the LSt cells to induce ejaculation and may include visceral sensory,
somatosensory, proprioceptive or noxious inputs (Carro-Juarez and Rodriguez-Manzo, 2005).
Some sensory inputs related to the summation of sexual activity may also be conveyed by the
hypogastric and pelvic nerves (McKenna, 2001; Coolen et al., 2004; Coolen, 2005). Pelvic nerve
afferents terminate in the vicinity of pudendal nerve afferent terminals in the lumbosacral spinal
cord, at around segments L6 – S1 (Nadelhaft and Booth, 1984). Furthermore, the pelvic nerve
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conveys sensory stimuli associated with mating to supraspinal regions including the central
tegmental field and lesions of the pelvic nerve dramatically reduce neural activation of the
central tegmental field induced by mating (Wersinger et al., 1993). Unlike the pudendal and
pelvic nerves, the hypogastric nerve terminates in the dorsal horn of the thoracolumbar spinal
cord, in segments T13 – L2 in male rats (De Groat W, 1990). Nevertheless, electrical stimulation
of the intermesenteric nerve which contains fibers of the hypogastric nerve triggered seminal
plug expulsion in anesthetized rats (Bernabe et al., 2007). In men, the penis is innervated by a
large number of sensory fibers which include mainly small, unmyelinated Aδ and C fibers
terminating in free nerve endings (Halata and Munger, 1986). These sensory fibers of the penis
can detect temperature, pain and mechanical stimuli including touch, pressure and stretch
(Kitchell et al., 1982). In addition, the penis exclusively contains a genital end bulb which is a
type of encapsulated nerve ending that may regulate sensory responses to stimulation of the glans
(Coolen et al., 2004). Furthermore, the sensitivity of penile receptors is greatly enhanced by
penile erection (Johnson, 1988). In summary, penile receptors convey sensory information
regarding temperature, touch, stretch, pressure and pain via the DPN as well as the pelvic and
hypogastric nerves to the lower thoracic, lumbar and sacral spinal cord. These sensory inputs
ultimately converge in the spinal ejaculation generator and trigger the activation of LSt cells,
which in turn triggers ejaculation.

1.3.3

Outputs of the Spinal Ejaculation Generator

During the emission phase of ejaculation, autonomic nuclei in the thoracolumbar and
lumbosacral spinal cord supply sympathetic and parasympathetic innervation to the pelvic
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viscera including the seminal vesicles, ductus deferens and prostate(Giuliano and Clement,
2005). The intermediolateral cell column (IML) and dorsal central autonomic nucleus (DCN)
located in the thoracolumbar spinal cord in spinal segments (T13 – L2) contain sympathetic
preganglionic neurons that send sympathetic ouflow mainly through the hypogastric and pelvic
nerves to the visceral organs (Hancock and Peveto, 1979a; Nadelhaft and McKenna, 1987; Baron
and Janig, 1991; Giuliano et al., 1997). Among the two populations of sympathetic preganglionic
neurons, it is those of the DCN which send projections to the prevertebral ganglia and are
implicated in the control of the visceral organs while IML neurons are thought to be involved
mainly in the control of cardiovascular function (Janig and McLachlan, 1987). Parasympathetic
preganglionic neurons are located in the sacral parasympathetic nucleus (SPN) in spinal
segments (S2-S5) which innervate the pelvic organs including the prostate (Orr and Marson,
1998), urethra (Vizzard et al., 1995) and penis (Marson and Carson 3rd, 1999). In summary, the
emission phase of ejaculation is under the control of both the sympathetic and parasympathetic
preganglionic cell populations as are many of the physiological events leading up to emission,
including contractions of the ductus deferens (Kolbeck and Steers, 1992; Kihara and de Groat,
1997) and the discharge of prostatic contents into the urethra (Wang et al., 1991). The expulsion
phase of ejaculation is under the control of pudendal motoneurons in the lumbosacral spinal cord
(Coolen et al., 2004). These pudendal motoneurons are localized to the spinal nucleus of the
bulbocavernosus (SNB) as well as the dorsolateral (DL) nucleus in male rats (Schroder, 1980;
McKenna and Nadelhaft, 1986; Ueyama et al., 1987), and to Onuf’s nucleus in men (Schroder,
1985; Thor et al., 1989). Motoneurons in these nuclei innervate the bulbospongiosus and
ischiocavernosus striated perineal muscles and the external urethral and anal sphincters.
Coordinated contractions of these muscles and sphincters trigger the ejection of semen from the
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urethral meatus (Bohlen et al., 1980; Gerstenberg et al., 1990; Holmes et al., 1991; Holmes and
Sachs, 1991). Notably, the striated perineal muscle contractions occur concurrently with the
pleasurable orgasmic sensations experienced at ejaculation (Gerstenberg et al., 1990).

1.4 Supraspinal Sites Regulating Ejaculation

Several supraspinal regions in the brain and brainstem provide descending modulation of the
spinal ejaculation generator. These supraspinal regions exert excitatory and inhibitory influences
over the spinal ejaculation generator to regulate ejaculation.

1.4.1

The Medial Preoptic Area (MPOA)

One such region is the medial preoptic area (MPOA) of the hypothalamus (Pehek et al., 1989;
Markowski et al., 1994; Hull et al., 1997; Hull et al., 2004), a central area in regulating male
sexual behavior (Hull et al., 2004). The MPOA exerts its excitatory effects on ejaculation
through dopamine D2 (Hull et al., 1989; Hull et al., 1992) and D3 receptors (Kitrey et al., 2007)
and electrical stimulation of the MPOA triggers contractions of the striated penile muscles in
anesthetized male rats (Sato and Christ, 2000). Moreover, the activation of D3 receptors has been
recently shown to be critical for ejaculation in male rats (Clement et al., 2007; Kitrey et al.,
2007; Clement et al., 2009b). Since there are no known direct projections from the MPOA to the
lumbosacral spinal cord, it is likely that the MPOA exerts its effects on ejaculation through
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connections with other brain regions involved in the control of ejaculation, including the nucleus
paragigantocellularis (NPGi)(Marson et al., 1992; Marson and McKenna, 1992; Yells et al.,
1992; Murphy et al., 1999) and the paraventricular nucleus of the hypothalamus (PVN) (Marson
and McKenna, 1994).

1.4.2

Nucleus of the paragigantocellularis (NPGi)

Neurons of the NPGi in the ventral medulla are well-known for their inhibitory effects of
ejaculation in male rats (Marson et al., 1992; Marson and McKenna, 1992; Yells et al., 1992). It
is currently suggested that this descending inhibition is serotonergic in nature and is mediated by
5-hydroxytryptamine (5-HT)(Marson and McKenna, 1992). Bilateral lesions of the NPGi
enhanced sexual performance in sexually-naïve male rats, by reducing the frequency of mounts,
intromission and latency to ejaculation. In addition, males with such lesions demonstrated
increased latency to copulate to exhaustion and dramatically augmented numbers of ejaculations
prior to the onset of sexual exhaustion (Yells et al., 1992). Furthermore, bilateral lesions of the
NPGi markedly reduced the latency to the onset of ex copula reflexes (Marson et al., 1992).
In addition, 50% of anesthetized male rats with intact spinal cords displayed the urethrogenital
reflex which can normally be elicited only in animals with completely transected spinal cords,
following the removal of descending inhibition (Marson et al., 1992). NPGi neurons have direct
projections to the ventral horn in the vicinity of pudendal motor neurons in the lumbosacral
spinal cord (Marson and McKenna, 1992). Moreover, intrathecal infusions of 5-HT prevented
the rhythmic contractions of the striated perineal muscles and ejaculation induced by stimulation
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of the urethra while infusions of the 5-HT antagonist abolished this inhibitory effect (Marson and
McKenna, 1992). This finding supports the notion that 5-HT exerts descending inhibitory
influences on ejaculation. However, conflicting evidence exists for the inhibitory effects of
serotonin on ejaculation. It has been demonstrated that the serotonin 1A receptor agonist 8-OHDPAT inhibits emissions elicited in the ex copula paradigm (Lee et al., 1990). In contrast, other
studies demonstrated enhanced effects of 8-OH-DPAT on ejaculation in copulating animals
(Haensel et al., 1991; Fernandez-Guasti et al., 1992; Coolen et al., 1996; Coolen et al., 1997b). In
addition, another study found a facilitative effect of 8-OH-DPAT on urethral stimulation-induced
rhythmic bursting patterns of the BCM, indicative of the expulsion phase of ejaculation (CarroJuarez and Rodriguez-Manzo, 2001). One proposed explanation for the discrepancies is that the
two components of ejaculation: emission and expulsion can occur independently of one another
(Staudt, 2011). Indeed, the seminal vesicles are not required for the contractions of striated
perineal muscles in copulating male rats (Cukierski et al., 1991). Similarly, the emission of
seminal fluids into the urethra or urethral stimulation is not required for the expulsion reflex in
male rats (Holmes and Sachs, 1991). Therefore, the inhibitory effects of 8-OH-DPAT on
emission can exist alongside enhanced effects of expulsion in mating animals. In summary,
descending projections of the NPGi exert inhibitory influences on ejaculatory reflexes in the ex
copula paradigm and on ejaculatory behavior in copulating male rats by acting on motor neurons
in the ventral horn of the lumbosacral spinal cord. Moreover, bilateral lesions of the NPGi
facilitated ejaculatory behavior in mating animals and ejaculatory reflexes in anesthetized rats,
providing further evidence of the inhibitory effects of NPGi on ejaculation. However, due to
conflicting results, it is currently unclear whether this inhibition of ejaculation is mediated by
serotoninergic mechanisms or whether other neurotransmitters may be involved.
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1.4.3

The paraventricular nucleus of the hypothalamus (PVN)

The PVN is another brain region which provides descending excitatory modulation of
ejaculation. Axons of PVN neurons terminate in the lumbosacral spinal cord and release the
neurotransmitter oxytocin (Wagner and Clemens, 1991, 1993). Specifically, PVN neurons
project to the pudendal motor neurons in the lumbar spinal cord around segments L5 – L6 in the
region of the SNB (Wagner and Clemens, 1991). Moreover, neurophysin (the product of
oxytocin and vasopressin) containing fibers and putative terminals were observed in close
contact to SNB motor neurons(Wagner and Clemens, 1993). Lesions of the PVN resulted in an
absence of neurophysin-containing fibers in the pudendal motor neurons, indicating that these
fibers originated in the PVN (Wagner and Clemens, 1993). Additional support for the role of the
PVN comes from a recent report that oxytocin receptors in the brain regulate ejaculation
triggered by infusions of the D3 agonist 7-OH-DPAT (Clement et al., 2008). Specifically, i.c.v.
infusions of an oxytocin antagonist resulted in a dose-dependent blockade of sexual responses
elicited by 7-OH-DPAT, including changes in seminal vesicle pressure (SVP), intracavernosal
pressure (ICP) and rhythmic bursting of the BCM (Clement et al., 2008). In addition, intrathecal
administration of the oxytocin antagonist to the L6 lumbar segment significantly diminished
ejaculation and the duration of BCM bursting but had no effect on ICP responses (Clement et al.,
2008). From these results, the authors concluded that while brain oxytocin receptors mediate
ejaculatory responses triggered by infusions of 7-OH-DPAT, spinal oxytocin receptors only
control the occurrence of ejaculation. These findings provide further support to the idea that
oxytocin is released from axon terminals of the PVN onto oxytocin receptors expressed on
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pudendal motor neurons in the lumbosacral spinal cord to modulate ejaculation in male rats
(Clement et al., 2008). Furthermore, the levels of oxytocin in blood plasma are substantially
enhanced in male rats (Stoneham et al., 1985), rabbits (Todd and Lightman, 1986) and men
(Murphy et al., 1987) following ejaculation. PVN lesions do not prevent ejaculation but reduce
the amount of seminal contents ejected in copulating male rats suggesting that the PVN is critical
for the emission component of ejaculation (Ackerman et al., 1997).

1.5 Supraspinal network displaying neural activation specifically with ejaculation

It has been demonstrated that certain regions of the posterior thalamus, MPOA, bed nucleus of
the stria terminals (BNST) and medial amygdala (MEA) express Fos, a marker of neural
activation, following various components of sexual behavior in male rats (Coolen et al., 2004). In
addition, certain subdivisions of these regions express Fos specifically following ejaculation and
not following other components of male rat sexual behavior including intromissions and mounts
(Coolen et al., 2004). These regions include subdivisions of the posterior thalamus, BNST and
MEA. In particular, these include the medial subregion of the parvocellular subparafascicular
thalamic nucleus (SPFp), the lateral zone of the posterior medial MEA, the posterior medial
BNST and the posterodorsal preoptic nucleus (PDPn) (Baum and Everitt, 1992; Coolen et al.,
1996, 1997a). Although all of these regions show neural activation with ejaculation, most of
these, in particular the posterior medial MEA and PDPn, are not critical for the display of
ejaculatory behavior (Coolen et al., 2004). In contrast, lesions of the SPFp, including the zona
incerta abolished ejaculation in male rats (Maillard and Edwards, 1991). However, when lesions
were restricted to the SPFp, ejaculatory behavior was not affected (Heeb and Yahr, 2000). These
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results indicate that the SPFp is involved in the relay of sensory signals associated with
ejaculation but is not involved in inducing ejaculation in male rats (Coolen et al., 2004).

1.6 LSt-SPFp pathway

It has long been unknown precisely how sensory signals associated with ejaculation are
conveyed to supraspinal regions. Several years ago, a candidate pathway was identified which
transmits sensory information associated with ejaculation from the sexual organs to the thalamus.
Specifically, the DPN transmits sensory signals from the periphery to the LSt cells and from
there these signals are relayed to the medial SPFp in the thalamus by way of the spinothalamic
pathway (Ju et al., 1987; Coolen et al., 2003). The LSt – medial SPFp pathway is involved in the
transmission and processing of sensory information associated with ejaculation (Truitt et al.,
2003). In support of this hypothesis, the SPFp and the LSt cells demonstrate neural activation
specifically following ejaculation (Truitt et al., 2003). Neural activation, visualized with Fos
expression, is not observed following other aspects of male sexual behavior including mounts
and intromissions. Moreover, several neuropeptides are expressed in the LSt – medial SPFp
pathway including galanin, CCK and enkephalin (Ju et al., 1987; Nicholas et al., 1999; Coolen et
al., 2003). Of these neuropeptides, galanin infusions in the medial SFPp have been shown to
suppress sexual behavior in male rats, indicating that endogenous galanin is released in the
medial SFPp following ejaculation and acts to suppress subsequent mating for a short duration
during the post-ejaculatory interval or for a longer duration once sexual satiety is reached
(Coolen et al., 2004).
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1.7 Summary: Spinal cord control of ejaculation

In summary, ejaculation is controlled by the LSt cells in the lumbosacral spinal cord
which form a critical component of the spinal ejaculation generator. Sensory signals from the
periphery are conveyed by the DPN to activate the LSt cells and trigger ejaculation. In turn, the
LSt cells convert these sensory signals into secretory or motor outputs to induce the emission and
expulsion components of ejaculation. Outputs of the LSt cells include sympathetic and
parasympathetic preganglionic neurons in the IML, CAN and SPN respectively as well as motor
neurons in the SNB. Both sympathetic and parasympathetic preganglionic neurons are involved
in initiating the emission component of ejaculation by triggering the secretion of seminal fluids
into the prostatic urethra, closure of the bladder neck and contractions of the seminal vesicles,
prostate and vas deferens. Expulsion is controlled by motor neurons which induce contractions of
the striated perineal muscle thereby eliciting the ejection of seminal contents from the urethral
meatus. In addition, supraspinal regions in the brain and brainstem provide excitatory and
inhibitory descending modulation of ejaculation. Excitatory input is provided by the MPOA and
PVN while inhibitory modulation originates in the NPGi in the ventral medulla. Finally, sensory
signals associated with ejaculation are conveyed from the LSt cells to the medial SPFp in the
posterior thalamus through the spinothalamic pathway. Neural activation of the SPFp specifically
following ejaculation or infusions of galanin inhibit sexual behavior in male rats. In addition, the
medial SPFp has a number of connections with other brain regions including the BNST, MPOA
and MEA that are involved in male rat sexual behavior and that demonstrate neural activation
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specifically with ejaculation. Therefore, the medial SPFp likely exerts inhibition of mating
through its connections with these brain regions.

1.8 Ejaculation is severely impaired following chronic spinal cord injury

Traumatic spinal cord injury (SCI) radically alters erectile and ejaculatory function in men. In
particular, SCI is associated with severely disrupted ejaculation. Of men with SCI, 0% to 55%
(with a median of 15%) can achieve ejaculation with a partner during sexual intercourse or
during masturbation (Biering-Sorensen and Sonksen, 2001). Moreover, the majority of SCI men
can only ejaculate with the aid of intense penile vibratory stimulation or electroejaculation and
both of these procedures are effective first-line treatment of ejaculatory disorders in SCI men
(Soler and Previnaire, 2011). Complete transection of the spinal cord results in a loss of
sensation and voluntary muscle control below the level of the lesion in the spinal cord. Even
though SCI men can ejaculate through intense vibratory stimulation and electroejaculation, the
ejaculation is sometimes retrograde, suggesting that ejaculatory dysfunction in SCI men may be
due to the lack of coordination between sympathetic, parasympathetic and motor neurons (Soler
and Previnaire, 2011).
It is known that fewer than 10% of men with complete SCI are able to ejaculate with
sexual intercourse or genital stimulation (Bors, 1960; Comarr, 1970). Preliminary studies of men
with SCI determined that vibratory penile stimulation is an effective means to trigger ejaculation
in patients with spinal cord lesions above the 12th thoracic segment (Brindley, 1984). More
recently, similar studies of men with SCI found that an intact spinal cord between the 10th
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thoracic and 2nd lumbar segments (T10 – L2) as well as an intact sacral spinal cord is necessary
to elicit ejaculation (Soler et al., 2008). Therefore, the preservation of intact preganglionic
autonomic and motor neurons is necessary in order to integrate the autonomic and somatic
outflow required to trigger ejaculation with sensory inputs conveyed by the DPN during sexual
intercourse or genital stimulation. In addition, these regions of the spinal cord must be intact to
coordinate the autonomic and motor outflow to trigger the two phases of ejaculation: emission
and expulsion.
Among available treatments for ejaculatory dysfunction following SCI, midodrine
appears to have promising results. Midodrine, an alpha1-adrenergic agonist, is predominantly
used as a remedy for neurogenic orthostatic hypotension (Soler et al., 2008), is a vasoconstrictor
of venous capacitance vessels as well as arterial resistance and has been shown to be effective in
the treatment of anejaculation in men with SCI (Staerman et al., 2001; Soler et al., 2007;
Courtois et al., 2008). In addition to enhancing ejaculation and orgasmic sensations in men after
SCI, midodrine use also has a low reported incidence of autonomic dysreflexia, a dangerous
condition which frequently accompanies ejaculation and orgasm in SCI patients (Sheel et al.,
2005; Courtois et al., 2008). The dramatic increase in blood pressure and heart rate immediately
prior to ejaculation typically return to normal within minutes following ejaculation in healthy
able-bodied men (Littler et al., 1974; Nemec et al., 1976; Kruger et al., 1998). However, in men
with SCI, these considerable increases in blood pressure and heart rate do not return to baseline
levels for several hours, and sometimes for days following ejaculation (Sheel et al., 2005).
Autonomic dysreflexia is a cardiovascular deficit associated with SCI and occurs due to a
dysregulation of the sympathetic nervous system following SCI (Sheel et al., 2005). Autonomic
dysreflexia is particularly common in SCI patients with lesions of the cervical or upper thoracic
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spinal cord, at or above T6 and involves a sudden, extreme rise in blood pressure, headache,
perspiration, bradycardia and anxiety (Karlsson, 1999; Teasell et al., 2000).
Intense penile vibratory stimulation is considerably more effective than sexual
intercourse in eliciting ejaculation in SCI with 65% of SCI men reaching ejaculation by these
means compared to 5 – 15 % achieving ejaculation through sexual intercourse (Soler et al., 2007,
2008). During penile vibratory stimulation, there is a strong activation of the autonomic nervous
system in response to intense stimulation of the DPN (Soler et al., 2007, 2008). Moreover,
vibratory stimulation can be used as a home treatment to enhance bladder capacity and alleviate
spasticity in SCI men (Biering-Sorensen et al., 2005). In addition, penile vibratory stimulation
can be utilized to facilitate ejaculatory reflexes in SCI men and with repeated use can improve
ejaculatory function and responsiveness during sexual intercourse (Elliott, 2002; Soler et al.,
2008). Patients with upper motor neuron lesions (above T10) are often able to ejaculate and
orgasm when penile vibratory stimulation is combined with midodrine (Soler et al., 2007, 2008).
Indeed, penile vibratory stimulation in conjunction with midodrine elicited ejaculation in 84% of
men with complete SCI and of these, 59% were able to reach orgasm as well (Soler et al., 2008).
However, vibratory stimulation is ineffective in SCI men with injuries to the T11-S4 spinal
segments, since this method depends on intact preganglionic autonomic neurons in the
lumbosacral spinal cord (Brackett et al., 2010). Penile vibratory stimulation triggers ejaculation
through intense stimulation of the DPN and subsequent powerful activation of the autonomic
nervous system. Because the spinal cord must be intact between segments T11-S4 for vibratory
stimulation to be effective, this suggests the presence of a spinal ejaculation generator in humans,
which is localized to the lumbosacral spinal cord. While the existence of the spinal ejaculation
generator is well-established in male rats, it is not known whether this generator also exists in
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men and whether it is located in the lumbosacral spinal cord. However, studies in SCI men
indicate that if a spinal ejaculation generator indeed exists in men, it is localized to the
lumbosacral spinal cord, to coordinate the autonomic and motor outflow required for ejaculation
and to integrate this outflow with sensory signals from the sexual organs during sexual activity.
Electroejaculation is utilized as a treatment for ejaculatory dysfunction in SCI men in
whom penile vibratory stimulation is ineffective in eliciting ejaculation or who have spinal cord
lesions caudal to T11 which disrupt the ejaculatory reflex arc (Brackett et al., 2010). The
electroejaculation protocol involves inserting an electrical probe into the rectum such that the
probe is adjacent to the rectal wall in close proximity to the seminal vesicles and prostate gland
(Soler and Previnaire, 2011). Next, electrical stimulation of the prostate and seminal vesicles is
administered in waves, with increasing voltage as the procedure progresses until ejaculation
ensues. One disadvantage of electroejaculation is the considerable discomfort experienced by
patients undergoing the procedure. These patients tend to have some residual sensation following
the SCI and an invasive procedure like electroejaculation can produce painful sensations
requiring the administration of spinal anesthetics (Halstead et al., 1987; Bennett et al., 1988;
Biering-Sorensen and Sonksen, 2001). Because electroejaculation is a procedure which is
invasive, requires the use of medical equipment and may require the use of spinal anesthesia, it
cannot be used as a home treatment for anejaculation in men with SCI. Another disadvantage of
electroejaculation is that it often results in retrograde ejaculation with very low antegrade sperm
motility and motile sperm counts compared to a procedure such as penile vibratory stimulation
(Halstead et al., 1987; Bennett et al., 1988; Ohl et al., 1996; Ohl et al., 1997). Therefore, penile
vibratory stimulation is a more suitable procedure for sperm retrieval for reproductive purposes
compared to electroejaculation in SCI men (Halstead et al., 1987; Bennett et al., 1988; Ohl et al.,
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1996; Ohl et al., 1997). One significant advantage of electroejaculation is that it has a success
rate of nearly 100% in triggering ejaculation in men with SCI that do not respond to genital
stimulation or penile vibratory stimulation. Moreover, the effectiveness of electroejaculation
does not depend on the level of spinal cord lesion or on an intact ejaculatory reflex arc (T11-S4)
(Halstead et al., 1987; Bennett et al., 1988).

1.9 Summary: Effects of spinal cord injury on ejaculation

In summary, ejaculation is severely impaired and a greater amount and intensity of
stimulation may be necessary to trigger ejaculation in men with SCI (Elliott, 2002). One
possibility is that ejaculatory function is dramatically diminished following chronic SCI due to
the loss of supraspinal influences on the ejaculatory reflex arc in the lower thoracic, lumbar and
sacral spinal cord (Soler and Previnaire, 2011). Intense penile vibratory stimulation is a
promising treatment of ejaculatory dysfunction in SCI men (Sonksen et al., 1994; Ohl et al.,
1997; Brackett et al., 1998) which induces intense vibratory stimulation of the DPN and as a
result triggers powerful activation of autonomic nuclei in the lumbosacral spinal cord (Soler et
al., 2007). It is not clear whether penile vibratory stimulation also triggers activation of motor
neurons in Onuf’s nucleus, in the sacral spinal cord. In male rats, stimulation of the DPN triggers
rhythmic bursting of the perineal muscles, including the BCM, which are under the control of
motor neurons in the SNB in the lumbosacral spinal cord (Pescatori et al., 1993; McKenna, 1999;
Staudt et al., 2010; Kozyrev et al., 2012; Kozyrev, 2013c, 2013b). Moreover, rhythmic bursting
of the BCM is required for the expulsion phase of ejaculation indicating that vibratory
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stimulation likely triggers the activation of autonomic as well as motor neurons in the
lumbosacral spinal cord, to induce the emission and expulsion components of ejaculation in SCI
men. The DPN is required for ejaculation induced by penile vibratory stimulaiton since local
anesthesia of the DPN prevents ejaculation in SCI men (Wieder et al., 2000). Penile vibratory
stimulation in combination with midodrine is even more effective and can restore ejaculation and
orgasmic sensations in up to 80% of SCI men (Soler et al., 2007, 2008). In addition, SCI men
who do not respond to vibratory stimulation alone are more likely to ejaculate and experience
orgasmic sensations when this type of stimulation is supplemented with midodrine (Soler et al.,
2007, 2008). Interestingly, repeated sessions of penile vibratory stimulation can reduce the
threshold necessary to trigger ejaculation in SCI men (Elliott, 2002) suggesting that recurrent
DPN stimulation can improve the conductance of sensory signals required to activate autonomic
and motor nuclei in the lumbosacral spinal cord and induce ejaculation. Therefore, repeated
sessions of penile vibratory stimulation can be useful in treating ejaculatory dysfunction and may
be easily administered at home (Elliott, 2002).
1.10

Animal models of chronic spinal cord injury

Animal models, by imitating the human experience, can be used to study the effects of SCI on
ejaculation. Currently, there are three validated models of human SCI that are frequently utilized
in animal studies. The first model, complete spinal transection, results in the complete
denervation of the spinal cord from supraspinal regions and is a model of complete spinal cord
injury (Wrathall, 1992; Jacob et al., 2001; Young, 2002; Gris et al., 2003; Jacob et al., 2003;
Onifer et al., 2007). The second model is the clip compression model in which an aneurysm clip
is positioned around the spinal cord but the dura is left undisturbed. Next, the clip is tightly
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clasped around the cord for one minute to induce trauma to the spinal cord. The last method,
contusion injury of the spinal cord, is performed using a spinal cord impactor, such as the Infinite
Horizon IH0400 Impactor (200 kdyne, Precision Systems and Instrumentation). The clip
compression model and the contusion injury models are considered to be models of partial SCI
and are validated models of SCI in humans (Wrathall, 1992; Young, 2002; Onifer et al., 2007).

1.11

Thesis rationale and objectives

Given that men with SCI emphasize the importance of regaining sexual function as their primary
goal (Anderson, 2004), it is astounding to observe the absence of literature describing the
changes to sexual function and ejaculation in particular in animal models of chronic SCI. In
addition, many more questions remain regarding the spinal cord control of ejaculation in intact,
healthy men. Although some progress has been made in the spinal cord research of ejaculatory
reflexes, the literature is still lacking and treatment options for ejaculatory dysfunction are
unsatisfactory. However, recent advances in science have generated insight into the spinal cord
control of ejaculation. It is currently known that ejaculation is under the control of LSt cells in
the lumbosacral spinal cord (Truitt and Coolen, 2002; Truitt et al., 2003; Staudt, 2011). Targeted
lesions of the LSt cells abolish ejaculation and ejaculatory reflexes via their direct projections to
preganglionic sympathetic neurons in the IML and CAN and to preganglioninc parasympathetic
neurons in the SPN as well as motor neurons in the SNB (Truitt and Coolen, 2002; Staudt, 2011).
My overall hypothesis is that LSt cells control ejaculatory reflexes via release of their
neuropeptides galanin, CCK, GRP, and enkephalin in the IML, CAN, SPN, and pudendal
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motorneurons. In these LSt target areas, neuropeptide receptor activation is therefore critical in
triggering ejaculation. This hypothesis is tested in Chapters 2, 3, and 4 utilizing the DPN
stimulation model described above in anesthetized, spinalized male rats. In Chapter 5, I will
determine the effects of chronic spinal injury using a contusion paradigm on ejaculatory reflexes.
Moreover, I will next test the hypothesis that administration of the LSt neuropeptides can
alleviate the detrimental effects of chronic spinal cord injury in male rats. Finally, in Chapter 6, I
will test the hypothesis that D3 receptor agonist will improve ejaculatory function in male rats
with chronic spinal cord injury. The D3 receptor agonist 7-OH-DPAT has been demonstrated to
facilitate ejaculation in spinal intact and acutely spinalized rats (Ahlenius and Larsson, 1995;
Clement et al., 2007), but the effect of this agonist on impaired ejaculatory function in rats with
spinal cord injury has not been determined.
Together, the studies in this thesis further elucidate the mechanisms by which the spinal
ejaculation generator controls ejaculatory function in male rats. Moreover, these studies will
form a first, but critical step towards an improvement of ejaculatory dysfunction following
chronic spinal cord injury.
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Chapter 2: Activation of gastrin-releasing peptide
receptors in the lumbosacral spinal cord is required for
ejaculation in male rats1

1

Research article published in J Sex Med: 9(5) 1303 – 1318
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2.1

Introduction

Male sexual behavior is a complex and rewarding behavior that ultimately results in
ejaculation (Hull et al., 2002). Ejaculation is defined as the expulsion of seminal fluid from the
urethral meatus (Marberger, 1974; McKenna, 1999) and comprises two phases: emission and
expulsion. Emission refers to the secretion of seminal fluids from the accessory sex glands,
contraction of the ductus deferens, and closure of the bladder neck and external urethral
sphincter. Expulsion refers to the forceful ejection of semen which is produced by the rhythmic
contractions of the striated perineal and smooth muscles of the urethra, and the bulbocavernosus
muscle (BCM) in particular (Bohlen et al., 1980; Gerstenberg et al., 1990; Holmes et al., 1991;
Holmes and Sachs, 1991; Pescatori et al., 1993).
It is well known that ejaculation is a reflex and that the central components that regulate
the ejaculatory reflex are located in the lumbosacral spinal cord (Griffith et al., 1973; Pescatori et
al., 1993; McKenna, 1999) (Figure 1). Indeed, ejaculatory reflexes remain intact in animals and
men with complete spinal cord transection (Griffith et al., 1973; Pescatori et al., 1993; McKenna,
1999). Thus, ejaculation is mediated by a spinal control center, referred to as a spinal ejaculation
generator (Marberger, 1974; McKenna, 1999; Carro-Juarez and Rodriguez-Manzo, 2007), spinal
pattern generator (McKenna et al., 1991), or spinal pacemaker (Sachs and Garinello, 1979). This
spinal ejaculation generator is suggested to coordinate sympathetic, parasympathetic, and motor
outflow to induce the emission and expulsion phases of ejaculation. In addition, the spinal
ejaculation generator is hypothesized to integrate this autonomic and motor outflow with sensory
inputs associated with the summation of sexual activity, thereby triggering ejaculation.
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Figure 1 Schematic diagram of the spinal ejaculation generator
Lumbar spinothalamic (LSt) cell
cellss receive sensory inputs related to the summation of sexual
activity via the dorsal nerve of the penis (DPN), triggering activation of the LSt cells. LSt cells
send axonal projections to preganglionic sympathetic neurons in the central autonomic nucleus
(CAN)
AN) and intermediolateral cell column (IML), to preganglionic parasympathetic neurons in the
sacral parasympathetic nucleus (SPN), and to pudendal motorneurons in the sacral nucleus of the
bulbocavernosus (SNB). It is hypothesized that the neuropeptides ex
expressed
pressed in the axon
termimals of the LSt cells trigger ejaculatory reflexes by acting in the LSt target areas.

The spinal ejaculation generator is composed of a population of interneurons in the
central gray of lumbar levels L3
L3-4 that play a pivotal role in the control of ejaculation, and are
hypothesized to convert sensory signals into motor or secretory outputs (Truitt et al., 2003).
2003) This
population of interneurons is located in lamina 10 and the medial portion of lamina 7 of lumbar
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segments 3 and 4 (L3-4), contain the neuropeptides galanin, cholecystokinin, gastrin releasing
peptide, and enkephalin (Ju et al., 1987; Nicholas et al., 1999; Coolen et al., 2003; Truitt et al.,
2003; Sakamoto et al., 2008), and have projections to a nucleus in the thalamus: the parvocellular
subparafascicular thalamic nucleus (Ju et al., 1987; Coolen et al., 2003; Truitt et al., 2003).
Based on their anatomical location in the spinal cord and thalamic projections, these particular
cells are referred to as lumbar spinothalamic (LSt) cells (Truitt and Coolen, 2002).
Moreover, LSt cells have additional characteristics that are consistent with their role as a
critical component of the spinal ejaculation generator. Mating-related sensory inputs induce
activation of LSt cells, thereby triggering ejaculation (Sachs and Garinello, 1979; Pescatori et al.,
1993; McKenna, 2001; Coolen et al., 2004). These sensory inputs are relayed via the sensory
branch of the pudendal nerve, or dorsal penile nerve (DPN) (Staudt et al., 2010, 2011). Mating or
stimulation of the DPN, which reliably triggers ejaculatory reflexes in anesthetized and
spinalized male rats, induces expression of markers of neural activation cFos (Truitt et al., 2003)
and phosphorylated MAP kinase (pERK) (Staudt et al., 2010) in LSt cells. Moreover, inhibition
of MAP kinase kinase (MEK) completely abolished ejaculation induced by DPN stimulation
(Staudt et al., 2010) . Therefore, DPN fibers transmit sensory inputs to LSt cells and in turn
trigger ejaculation via activation of the MAP kinase pathway.
LSt cells are ideally located to coordinate outflow necessary for ejaculation. LSt cells
have axonal projections to target regions of the spinal cord implicated in ejaculatory control
(Newton, 1993; Allard et al., 2005; Xu et al., 2006). Specifically, LSt cells project to
preganglionic sympathetic neurons in the intermediolateral cell column (IML) and central
autonomic nucleus (CAN) of the thoracolumbar spinal cord and to the preganglionic
parasympathetic neurons in the sacral parasympathetic nucleus (SPN) of the lumbosacral spinal
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cord (McKenna, 1997; Allard et al., 2005) and motor neurons in the spinal nucleus of the
bulbocavernosus (SNB) (Newton, 1993; Sakamoto et al., 2008). LSt cells and their axonal
projections contain several neuropeptides, including galanin, cholecystokinin, enkephalin and
gastrin releasing peptide (GRP) (Ju et al., 1987; Nicholas et al., 1999; Coolen et al., 2003; Truitt
et al., 2003; Sakamoto et al., 2008). Thus, we hypothesize that these neuropeptides act in the LSt
target areas to mediate ejaculatory reflexes. In support of this hypothesis, GRP, a member of the
family of bombesin-like peptides (McDonald et al., 1979; Battey and Wada, 1991), has been
implicated in male erectile and ejaculatory function in spinally-intact males utilizing the excopula reflex paradigm (Sakamoto et al., 2008). However, in order to study the role of GRP in
ejaculatory reflexes, it is necessary to eliminate supraspinal influences on the spinal ejaculation
generator.
Therefore, the purpose of the present study was to test the role of GRP in the control of
ejaculation using a physiologically-relevant model of ejaculation involving electrical stimulation
of the DPN in anesthetized, spinalized male rats. Stimulation of the DPN reliably triggers
ejaculation in all mammals, including rats (Pescatori et al., 1993), monkeys (Herbert, 1973) and
humans (Wieder et al., 2000). Moreover, in anesthetized and spinalized male rats, DPN
stimulation elicits rhythmic contractions of the BCM similar to those observed in a mating
animal during ejaculation (Coolen et al., 2004; Staudt et al., 2010), and reflexive penile erections
are evident (Pescatori et al., 1993; Rampin et al., 1997b). The aim of the present study was
twofold. First, it was confirmed that GRP is expressed in LSt cells and their axon terminals in
autonomic and motor areas in the lumbosacral spinal cord. Next, it was tested whether GRP
receptor activation is required to trigger the emission and expulsion phases of ejaculation and
whether GRP is sufficient to trigger ejaculatory reflexes in the absence of DPN stimulation.
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2.2 Materials and Methods

2.2.1

Animals

Adult male Sprague Dawley rats (4-5 months) were obtained from Charles River
(Sherbrook, Quebec, Canada and Wilmington, MA, USA) and were housed in pairs in standard
housing cages on a 12-hour light/dark cycle with lights off at 10 a.m. Food and water were
available ad libitum. All procedures were approved by the University Committee on Use and
Care of Animals at Western University and the University of Michigan and conform to the
guidelines outlined by the National Institutes of Health.

2.2.2

Experimental designs

2.2.2.1 Intrathecal infusion of GRP receptor antagonist RC-3095
Male rats were anesthetized with urethane (1.5 g/kg, i.p.), a laminectomy was performed
between the 6th and the 8th thoracic spinal segments and the spinal cord was completely
transected. Next, the dorsal penile nerve (DPN) and the muscle of the bulbocavernosus (BCM)
were exposed and the surrounding connective tissue was removed. In preparation for
electromyographic (EMG) recordings, silver recording electrodes, connected to the
PowerLab/7SP Data Acquisition System (ADInstruments, Inc., Colorado Springs, CO) were
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inserted bilaterally into the BCM and a ground electrode was placed into the muscle of the right
thigh. A bipolar stimulating electrode connected to the SD9 Square Pulse Stimulator (Grass
Technologies, West Warwick, RI) was positioned directly on top of the DPN. Initial stimulation
of the DPN was performed in order to verify the completeness of the spinal cord transection,
indicated by a rhythmic bursting pattern of the BCM (Figure 2). Electrical stimulation of the
DPN comprised square wave pulses of 1 ms duration, 4 V at 60 Hz for 10 seconds. These
stimulation parameters have previously been demonstrated to trigger rhythmic bursting of the
BCM indicative of the expulsion phase of ejaculation in 100% of control animals (Staudt et al.,
2010, 2011). Experiments started 2 hours following transection of the spinal cord to allow for
potential acute effects of spinal cord transection to subside. A second laminectomy was
performed at spinal level T10 in preparation for intrathecal administration of neuropeptides. A
small incision was made in the dura mater at the site of the second laminectomy and a
polyethylene catheter (Caly-Adams PE-10, Parsippany, NJ, USA) was inserted into the
subarachnoid space at lumbar levels, to deliver drugs presumably to the entire lumbosacral spinal
cord. First, 10 µl/min of saline was infused and BCM EMG activity was recorded for 25 minutes.
Following these 25 minutes, the DPN was stimulated twice with 5 minute intervals between
stimulation, at 30Hz and 60Hz in a counter balanced manner (testing trial 1; control trial). BCM
activity was recorded for 90 seconds, the time period for a typical BCM bursting activity (Lodder
and Zeilmaker, 1976). One hour later, the procedure was repeated in the same animals, which
now received a 10 µl infusion (over 1 minute) of either 0.9% saline (N = 10) or one of two doses
of the GRP receptor antagonist RC-3095, 20 nmol (N = 9) and 10 nmol (N = 6) (Sigma-Aldrich
Canada Ltd. (Oakville, Ontario)). BCM activity was recorded for 25 minutes, after which the
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DPN was stimulated at 30Hz and 60 Hz as described above in a counterbalanced manner, and the
BCM EMG activity was recorded (testing trial 22; drug trial).

Figure 2 Example of characteristic BCM EMG induced by DPN stimulation.
Dashed lines in the EMG trace in ((A)) represent the period of DPN stimulation followed
f
by 90
seconds of EMG recording showing BCM events (activity above baseline) and clusters of events,
i.e. BCM bursts. Time is presented on horizontal scale (Scale bar in A represents 20 seconds)
and activity amplitude (in µV) on vertical scale. The four bursts indicated by the box (16 seconds
of recording) are shown on an enlarged time scale in ((B)) to clearly show the clusters of BCM
events within bursts and the return to baseline activity between bursts.
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2.2.2.2 Intrathecal infusion of GRP20-29 agonist
A separate group of male rats was anesthetized, spinalized, and prepared as described above.
Males received intrathecal 10 µl infusions of 0.9 % saline (N=11) and BCM EMG was recorded
for 10 minutes following infusion. Then, the DPN was stimulated at 5 HZ, 10 HZ, 30 HZ and 60
HZ in a randomized and counterbalanced manner and BCM EMG was recorded for a period of
90s following stimulation (testing trial 1; control trial). One hour after the last DPN stimulation,
the procedure was repeated in the same group of animals, which now received 10 µl intrathecal
infusions of either 0.9% saline (N=11) or one of two doses of GRP agonist (GRP20-29 0.2 nmol,
n=7; 0.5 nmol, n=7 (Phoenix Pharmaceuticals Inc. USA, Burlingame, CA)) and BCM EMG was
recorded for 10 minutes after infusion of vehicle or drug. Next, the DPN was stimulated at 5, 10,
30 and 60 HZ in a counterbalanced order as described above (testing trial 2; drug trial).

2.2.3

BCM EMG analysis

BCM EMG recordings were analyzed for the 25 or 10 minutes following the infusion of the
antagonist or agonist respectively, and for 90 seconds following each DPN stimulation. The
numbers of events and bursts, as well as latencies to first event were analyzed. The analysis of
numbers of events was performed using LabChart 7 (AD Instruments), and all events that were
above baseline activity were recorded (Staudt et al., 2011). In addition, numbers of bursts were
analyzed by two independent observers blinded to experimental treatment groups. Bursts were
defined as a group of 10 or more events, without return to baseline activity between events.
These criteria were based on a detailed analysis of the BCM bursting activity in a subgroup of
control animals (n = 15). The average number of events per burst, number of bursts and time
intervals between successive bursts during a period of 90 seconds following a 30 or 60 Hz DPN
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stimulation were calculated, There was an average of 48.56 (ranging from 10 – 253) or 62.57
(ranging from 10 – 315) BCM events per burst after 30 and 60 Hz DPN stimulation respectively.
Furthermore, there was a mean of 7.4 bursts (ranging between 3 – 12 bursts) or 8.07 bursts
(ranging between 4 – 12 bursts) following 30 or 60 Hz resp. Analysis of time (s) between bursts
revealed that there was an average of 2.54 seconds between successive bursts (ranging from 0.2 7 seconds).
Effects of antagonist treatments on numbers of events or bursts were compared both
within animals (between the two testing trials (control and drug trials) and within the same drug
treatment group) and between groups (within each of the two testing trials, and between drug
treatment groups), separately for the 30 or 60 Hz stimulations, using two-way repeated ANOVA
(factors: Drug treatment and Testing trial) and Holm-Sidak post hoc tests, Effects of agonist
treatments on numbers of events or bursts were compared within animals (between the five
stimulations (following infusion without stimulation, 5, 10, 30, 60 Hz)) and between treatment
groups (within each stimulation setting), separately for each of the two testing trials, using a twoway repeated ANOVA (factors: Drug treatment and Stimulation) and Holm-Sidak post hoc tests,
A 95% confidence level was used for all tests.

2.2.4

Immunohistochemistry experiments:

2.2.4.1 GRP expression in LSt cells
In order to verify that LSt cells and their axon terminals in autonomic and motor areas express
GRP, 8 male rats were perfused transcardially with 10 mL 0.9 % saline followed by 500 mL of
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4% paraformaldehyde in phosphate buffer (0.1 PB). Spinal cords were removed and postfixed
for 1 hour in the same fixative and subsequently placed in cryoprotective solution (20 % sucrose
in 0.1 PB with 0.01 % sodium azide) until further processing for immunohistochemistical
detection of GRP and galanin, a marker for LSt cells (Truitt and Coolen, 2002; Truitt et al.,
2003; Coolen et al., 2004; Staudt et al., 2010, 2011).

2.2.4.2 DPN stimulation-induced pERK after RC-3095
To verify that GRP antagonist did not prevent activation of LSt cells, expression of
phosphorylation of ERK (pERK) in LSt cells was examined following stimulation of the DPN
(Staudt et al., 2010). Male rats (n = 6) were anesthetized and spinalized as described above. Two
hours after spinalization, the DPN and BCM were exposed and vehicle (saline, n = 3) or drug
(RC-3095; Sigma-Alderich Inc.; 20 nmol; n = 3) were infused in a volume of 10 µl intrathecally
as described above. 25 Minutes later, the DPN was stimulated at 30 Hz and BCM EMG activity
was recorded for 90 seconds. Five minutes following DPN stimulation, animals were perfused
transcardially with 5 mL 0.9 % saline solution and 500 mL of 4% paraformaldehyde in 0.1M PB.
Spinal cords were removed and postfixed for 1 hour in the same fixative and subsequently placed
in cryoprotective solution (20 % sucrose in 0.1 PB with 0.01 % sodium azide) until further
processing for immunohistochemical detection of pERK and galanin. The stimulation parameters
and time of perfusion were previously shown to be optimal for visualization of pERK expression
in LSt cells (Staudt et al., 2010). Moreover, it was previously shown that spinalization and
exposure of DPN and BCM without electrical stimulation of the DPN did not induce pERK
expression in LSt cells (Staudt et al., 2010), hence negative control groups were not included in
this experiment.
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2.2.5

Immunohistochemistry

Spinal cords were sectioned using a freezing microtome (Thermo Fisher Scientific, Walldorf,
Germany) into 12 parallel series of 35 um coronal sections in cryoprotectant solution (30 %
sucrose, 30 % ethylene glycol in 0.1 M PB with 0.01 % sodium azide) and stored at -20 C until
further processing. Free floating sections containing lower thoracic, lumbar, and sacral spinal
levels were thoroughly rinsed in 0.1 M saline buffered sodium phosphate (PBS) between
incubations and blocked with 1% H2O2 for 10 minutes prior to incubation. All antibody
incubations were performed in incubation solution containing 0.1% bovine serum albumin and
0.4% Triton X-100 (BP151-500, Thermo Fisher Scientific, Ottawa, Ontario) in PBS at room
temperature with gentle agitation.

Galanin/GRP Dual Fluorescence: One series of sections for four animals (2 spinal intact and 2
spinalized) were dual stained for galanin and GRP. Sections were incubated overnight with
rabbit anti-galanin (1:60,000; T-4334; Bachem, Torrance, CA) and with biotinylated goat antirabbit for one hour (1:500; Vector Laboratories, Burlingame, CA, USA), avidin horseradish
peroxidase complex (ABC-elite, 1:1000 in PBS; 1 hour; Vector Laboratories), biotinylated
tyramine (BT; 1:250 in PBS containing 1uL/ml of 3% H2O2 for 10; NEL700 /700A; PerkinElmer
Life Sciences, Boston, MA), and Alexa 488-conjugated streptavidin (1:100 in PBS, 30 minutes
(Jackson ImmunoResearch Laboratories, West Grove, PA). Next, sections were incubated with
rabbit anti-GRP (1:2,000; Phoenix (H-027-13)) and Alexa 555-conjugated goat anti-rabbit for 30
minutes in PBS (1:100; Jackoson ImmunoResearch Laboratories, West Grove, PA) and mounted

36

on plus charged slides, coverslipped with gelvatol and stored in the dark at 4°C. One series of
sections of 4 animals (2 spinal intact and 2 spinalized) was stained using this same procedure,
but were first processed for GRP immunoreactivity (-ir; using rabbit-anti-GRP; 1:40,000) and
subsequently for galanin (rabbit anti-galanin; 1:3,000).

Galanin/pERK Dual Fluorescence: One series of sections were processed using the same
protocol as described above using rabbit anti-pERK (1:1,000; overnight; Cell Signalling # 26L)
and rabbit anti-galanin (1:3,000).
For all procedures, the omission of primary antibodies resulted in a complete loss of signal at
specific wavelengths and served as a control manipulation. Moreover, all primary antibodies
have been previously characterized (Truitt et al., 2003; Staudt et al., 2010, 2011) .

2.2.6

Data Analysis:

2.2.6.1 Analysis for Galanin/GRP co-localization
Sections of the lumbosacral spinal cord containing LSt cells were analyzed for expression of
GRP using a Leica DM5000B (Leica Microsystems, Wetzlar, Germany). In all 8 animals
included in the analysis, all galanin-ir and CGRP-ir cells were analyzed for co-expression of
GRP-ir or galanin-ir respectively. The percentages of galanin-ir co-expressing GRP and vice
versa were determined for each animal and a group mean was calculated. In addition, the colocalization of galanin and GRP was analyzed in LSt axons in the intermediolateral cell column
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(IML), central autonomic nucleus (CAN), sacral parasympathetic nucleus (SPN), and spinal
nucleus of the bulbocavernosus (SNB) using a Zeiss laser-scanning confocal microscope system
(Zeiss LSM510; Carl Zeiss MicroImaging, Inc., Thornwood, NY). Alexa 555-fluorescence was
imaged using a 567 nm emission filter and a HeNe laser and Alexa 488 was imaged using a 505
nm filter and Argon laser. Images were generated by projecting several 1 µm optical sections
collected at 1 µm intervals through areas of interest in the z-axis using a 63x water-immersion
objective.

2.2.6.2 pERK Expression in LSt cells
pERK expression in LSt cells was analyzed on a DM5000B Leica fluorescent microscope (Leica
Microsystems, Wetzlar, Germany). Specifically, all lumbar cells expressing galanin-ir were
analyzed for expression of pERK. Data are expressed as the mean percentages of LSt cells that
express pERK for each animal. The group means were calculated and compared between animals
that received an infusion of RC-3095 (20nmol) and saline-treated controls, using Student t tests
with 95% confidence levels.

2.2.6.3 Pressure recording in seminal vesicles
Based on findings from the above described experiments, an additional experiment was
conducted to analyze pressure in the seminal vesicles (SV), which is considered an indicator of
the emission phase (Clement et al., 2008). Spinal cords were transected, and BCM and DPN
were exposed as described above. In addition, the right SV was exposed by coeliotomy. SV
pressure (SVP) was measured using a pressure catheter (ADInstruments, model number: SPR-

38

671(1.4F, Single, Straight, 15cm, Ny) attached to a catheter interface cable (ADInst, model
number: AEC-IOD) and connected to a Bridge AMP (ADInst). The pressure catheter was
inserted into the lumen of the SV and secured prior to recording. SVP and BCM EMG (as
described above) were simultaneously recorded and analyzed using LabChart 7 (ADInst). There
were three groups of animals (N=3 per group). The first group of control animals received DPN
stimulation at 5, 10, 30 and 60 Hz 10 minutes after intrathecal saline infusion (control Trial 1)
and identical treatment in trial 2 (control Trial 2). The second group of animals received
intrathecal saline and DPN stimulation at 30 and 60 Hz 25 minutes later (control Trial 1), and
subsequent intrathecal RC-3095 (20 nmol; Trial 2; drug trial) again followed by DPN stimulation
at 30 and 60 Hz 25 minutes after each infusion. The third group of animals received intrathecal
saline and DPN stimulation at 5,10, 30, and 60 Hz 10 minutes later (Trial 1; control trial) and
subsequent GRP agonist (GRP20-29; Trial 2; drug trial) followed by DPN stimulation at 5, 10, 30,
and 60 Hz 10 minutes after each infusion.

Analysis: BCM EMG was analyzed as described above and numbers of bursts were compared
within animals and between trails 1 and 2 using t-tests or the Mann-Whitney –Wilcoxon test.
SVP was analyzed using LabChart7 (ADInst). SVP increased simultaneously with BCM EMG
bursts and the numbers of times that increased SVP occurred were counted and compared within
animals between trials 1 and 2 using t-tests with confidence levels of 95%.

2.3 Results
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2.3.1

GRP expression in LSt cells and axons

GRP was co-expressed by all LSt cells analyzed, based on analysis of 119 galanin-IR cells in
eight animals (Figure 3). Moreover, 100% GRP-IR neurons in the lumbosacral spinal cord coexpressed galanin-IR, suggesting that GRP is exclusively expressed by LSt cells. There was no
effect of spinal transection on co-expression of galanin and GRP-ir. In addition, qualitative
analysis showed that virtually all galanin-IR axons in IML, CAN, SPN, and SNB co-expressed
GRP (Figure 3). Hence, GRP may be released in autonomic and motor areas to mediate
ejaculation However, a few GRP-IR fibers that did not co-express galanin-IR were detected
dorsal to the SPN (Figure 3J-L), raising the possibility that the SPN also receives a minor GRP
input from cells other than LSt neurons and outside the lumbosacral spinal cord.
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Figure 3 The co-expression of galanin-ir and GRP-ir in LSt cells, IML, CAN and SPN of
the male rat
Confocal images (1 µm optical sections) illustrating the co-expression of galanin-ir (A) and
GRP-ir (B) in LSt cells (A-C), IML (D-F), CAN (G-I), and SPN (J-L) in a spinal intact male rat.
Galanin-ir was immunoprocessed using TSA amplification, while GRP was immunoprocessed
using a conjugated secondary antibody. Arrows in (C) indicate putative close contacts of
galanin/GRP-ir axon terminals with LSt cells. Arrows in L indicate GRP-ir fibers dorsal to the
SPN that do not co-express galanin-ir. Scale bars indicate 20 µm.
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2.3.2

GRP receptor antagonist blocked ejaculatory reflexes

GRP receptor antagonist RC-3095 significantly reduced DPN stimulation-induced ejaculatory
reflexes at both 30 and 60 Hz stimulation frequencies as evidenced by the reduced numbers of
BCM events and bursts (Figure 4C-F). There were main effects of testing trial on the numbers of
BCM events for both 30 (F(1, 43) 13.760; p=0.002; Figure 4C) and 60 Hz stimulation
frequencies (F(1, 41) 12.727; p=0.003; Figure 4D). Post hoc analyses revealed that animals
treated with either dose of RC-3095 during the second, drug trial (trial 2; Figure 4B) had
significantly decreased BCM events in response to 30 and 60 Hz DPN stimulation compared to
their DPN stimulation-induced BCM events following saline treatment in their first control trial
(trial 1; 60 Hz: p=0.008 (10nmol); p=0.040 (20nmol); 30 Hz: p=0.022 (10nmol); p=0.029
(20nmol); Figure 4C-D and Figure 5C-D). There were no significant differences between the two
groups treated with the lower and higher doses of RC-3095. Saline treated animals did not differ
in their BCM events during trial 2 compared to trial 1 (30 Hz: p=0.130; 60 Hz: p=0.280, Figure
4C-D and Figure 5A-B), demonstrating that the reduction in BCM events was not an effect of
repeated testing, but rather of RC-3095 treatment. Similarly, there were main effects of testing
trial on the numbers of BCM bursts for both 30 Hz (F(1,48) = 56.209; p < 0.001; Figure 4E) and
60 Hz (F(1,48) = 41.878; p < 0.001; Figure 4F) stimulation frequencies. Males treated with either
dose of RC-3095 during trial 2 (drug trial) had significantly lower numbers of BCM bursts
compared to trial 1 (control trial) with saline treatment (30Hz: p < 0.001 (10 nmol), 60 Hz: p <
0.001 (20nmol). Once again, there was no effect of the dosage of the antagonist and of repeated
testing, as saline-treated animals did not differ in the numbers of BCM bursts during the second
compared to the first testing trial (Figure 4E-F).
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RC-3095
3095 infusion on the numbers of BCM
Figure 4 Effects of GRP receptor antagonist RC
events and bursts in male rats
Quantitative analysis of BCM events and bursts following infusions with GRP receptor
antagonist RC-3095
3095 During Trial 1 (A; control trial), all groups received saline infusions (arrow)
and 30 and 60 Hz DPN stimulation (bolt arrows; in counterbalanced manner
manner).
). During Trial 2 (B;
drug trial), the same groups received saline or RC
RC-3095
3095 (10 or 20 nmol) infusions (arrow)
followed by 30 and 60 Hz DPN stimulation (bolt arrows; in counterbalanced manner). Numbers
of BCM events are shown in (C) (30 Hz) and (D) (60 Hz);
); while numbers of BCM bursts are
shown in (E) (30 Hz) and (F) (60 Hz). # denotes significant differences from Trial 1 within the
same treatment group. * indicates significant differences from controls within the same testing
trial.
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Figure 5 Infusions of RC-3095 prevent DPN stimulation-induced bursting of the BCM in
male rats.
Representative EMG recording traces depicting BCM activity induced by 60Hz DPN stimulation
(indicated by arrow) following intrathecal infusions of saline or GRP antagonist RC-3095. DPN
stimulation induced characteristic BCM bursting following infusion of saline in trial 1 (A, C)
and again following saline in trial 2 (B; same animal as A). In contrast, infusion of the GRP
antagonist RC-3095 (20nmol) in trail 2 completely prevented BCM activity (D; same animal as
C). Each trace represents 90 seconds of BCM activity.

A significant interaction between drug treatment and testing trial was detected for
numbers of BCM events at the 60 Hz stimulation (F(2,48) = 6.941; P = 0.005). Post hoc analyses
demonstrated that during trial 2 (drug trial), animals treated with 10 nmol RC-3095 had
significantly fewer numbers of BCM events induced by 60 Hz stimulation compared to saline
controls (p=0.004; Figure 4D). A trend towards significance was observed in animals treated
with the higher dose of RC-3095 (20nmol) and received 60 Hz DPN stimulation (P = 0.06;
Figure 4D). Interactions between drug treatment and testing trial were also detected for numbers
of BCM bursts at 30 Hz (F(2,48) = 5.250; P = 0.014) and 60 Hz (F(2,48) = 6.941; P = 0.005)
stimulations. Specifically, during trial 2 (drug trial), animals treated with the lower dose of RC3095 had significantly lower numbers of BCM bursts compared to saline controls for both 30 Hz
(P = 0.01; Figure 4E) and 60 Hz (P < 0.001; Figure 4F) stimulations and animals treated with
the higher dose had fewer BCM bursts compared to saline controls following 60 Hz stimulation
(P = 0.003; Figure 4F). There were no significant differences between the two groups treated
with the lower and higher doses of RC-3095. Finally, there were no differences in numbers of
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BCM events nor bursts between groups during the first control trial, when all groups were treated
with saline (Figure 4C-F), demonstrating that group differences during the second testing trial
were caused by drug treatments, rather than differences in BCM bursting responses.

2.3.3

RC-3095 did not affect DPN stimulation-Induced pERK in LSt cells

In order to verify that GRP antagonist RC-3095 blocks BCM bursting via actions in LSt target
areas rather than acting directly on LSt cells, DPN stimulation-induced neural activation of LSt
cells was examined. In both antagonist treated and control males, DPN stimulation induced
pERK in 97 ± 0.03% of LSt cells, similar to the activation reported previously in control males
(Staudt et al., 2010). Thus, GRP receptor antagonist treatment did not affect the activation of LSt
cells in response to DPN stimulation (Figure 6).

Figure 6 Expression of pERK in LSt cells induced by DPN stimulation
Confocal images (1 µm optical sections) demonstrating pERK expression (B) in LSt cells (A)
induced by DPN-stimulation. The pattern of pERK labeling is representative of all antagonistand control-treated animals. Scale bar indicates 20 µm.
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2.3.4

GRP20-29 agonist facilitated BCM activity

During the first testing trial (control trial), there was an overall effect of DPN stimulation
parameters on the number of BCM events (F(4, 121)= 28.878; P < 0.001) and bursts (F(4,121) =
54.775; P < 0.001). Post hoc tests showed that following 30Hz DPN stimulation, all treatment
groups had significantly increased numbers of BCM events (compared to infusion, 5Hz, or 10Hz,
P < 0.001; Figure 7C), and bursts (compared to infusion, 5Hz, or 10Hz, P < 0.001; Figure 7E).
DPN stimulation at 60 Hz also increased numbers of BCM events and bursts (compared to
infusion, 5Hz, or 10Hz, P < 0.001; Figure 7C, 7E). These data confirm that 30 and 60 Hz
stimulations reliably trigger BCM bursting while 5 and 10 Hz represent sub-threshold levels of
stimulation. Moreover, saline infusions alone (without DPN stimulation) did not trigger any
BCM activity (Figure 7C, 7E, 8A). Finally, during control trial 1, there were no differences
between treatment groups in the numbers of BCM events nor bursts (Figure 7C,7E),
demonstrating that there were no initial group differences in BCM bursting responses and that
repeated DPN stimulations in the randomized order did not affect BCM responses to subsequent
stimulations.
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Figure 7 Effects of GRP infusions on the numbers of BCM events and bursts in male rats.
Quantitative analysis of BCM events and bursts following infusions with GRP20-29. During Trial
1 (A; control trial) all groups received intrathecal saline (arrow) followed by four DPN
stimulations (bolt arrows) at 5-60 Hz (in counterbalanced manner). During Trial 2 (B; drug trial),
all groups received intrathecal GRP20-29 (10 or 20 nmol; arrow) again followed by four DPN
stimulations at 5-60 Hz (bolt arrows; in counterbalanced manner). Numbers of events are shown
in (C) (Trial 1) and (D) (Trial 2), while numbers of bursts are shown in (E) (Trial 1) and (F)
(Trial 2). # denotes significant differences from BCM activity following infusion, 5 Hz, and 10
Hz within the same treatment group and trial, * indicates significant differences from the saline
control group within the same DPN stimulation and trial.

During the second testing trial (drug trial), there were overall effects of DPN stimulations
on BCM bursts (F(4,120) = 2.795, P = 0.031)) and there were significant interactions between
stimulations and drug treatments for events ((F(8, 119) = 5.048; P < 0.001) and bursts (F(8,120)
= 8.053; P < 0.001). First, the GRP20-29 receptor agonist significantly triggered BCM activity in
the absence of DPN stimulation in a subset of animals, (43% of 0.2 nmol and 43% of 0.5 nmol;
Figure 7D, 7F and Figure 8F). Latencies to BCM activity were 149 ± 13.66 (0.2 nmol) and 148 ±
5.69 (0.5 nmol) seconds post-infusion. Comparisons of numbers of BCM events and bursts
showed a significant increase in BCM activity in animals treated with the low dose of GRP20-29
(0.2 nmol) compared to saline controls (events: P = 0.015; bursts: P = 0.008) and a trend toward
significance compared to animals treated with the high dose of GRP20-29 (0.5 nmol; events:
P=0.07; Figures 7D, 7F). These results indicate that in a portion of the animals, the low dose of
GRP20-29 was sufficient for triggering ejaculatory reflexes in the absence of sensory stimulation.
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Furthermore, intrathecal infusions of GRP20-29 facilitated ejaculatory reflexes in response to
subthreshold levels of DPN stimulation (5-10 Hz) as evidenced by the increased numbers of
events and bursts (Figures 7D, 7F, 8D). Post hoc analyses revealed significantly increased BCM
events in response to DPN stimulation in animals treated with low dose of GRP20-29 (0.2 nmol) at
5 Hz (P = 0.022) and 10 Hz (P = 0.042) compared to saline-treated control animals (Figure 7D).
Similarly, animals treated with the high dose of GRP20-29 (0.5 nmol) demonstrated significantly
increased BCM events in response to 5 Hz DPN stimulation (P = 0.012; Figure 7D). Animals
treated with the low dose of GRP20-29 (0.2 nmol) also had significantly more BCM bursts in
response to 5 Hz DPN stimulation (P = 0.016) and a trend to significance at 10 Hz (P = 0.041)
compared to saline-treated animals (Figure 7F). Similarly, animals treated with the high dose of
GRP20-29 (0.5 nmol) demonstrated significantly increased BCM bursts after 5Hz (P = 0.001) and
10 Hz (P = 0.012) DPN stimulation compared to saline controls (Figure 7F).
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Figure 8 Effects of GRP infusions on BCM activity in male rats.
Representative EMG recording traces showing BCM activity induced by subthreshold
stimulation of the DPN (5Hz; indicated by bolt arrows) following intrathecal infusion of saline
(A-C) or GRP20-29 (D).. Subthreshold DPN stimulation did not induce BCM activity following
intrathecal infusions of saline in trial 1 (A, C), or following saline in trail 2 (B; same animal as
A).. In contrast, subthreshold DPN stimulation following intrathecal infusion of GRP20-29 (0.2
nmol) did induce BCM activity (D; same animal as C
C). Infusion of GRP20-29 (0.2 nmol) (F) but
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not saline (E; same animal as F) also induced BCM activity without DPN stimulation. Each
trace represents 90 seconds of BCM activity.

GRP20-29 treatment did not affect BCM activity at 30 Hz stimulation. But, unexpectedly, GRP
agonist treatment significantly decreased BCM activity in response to high levels of DPN
stimulation (60 Hz) at both the lower dose (events: p= 0.016; bursts: P < 0.001) and the higher
dose (events: P < 0.001; bursts: P < 0.001) of GRP20-29 compared to saline-treated control
animals (Figure 7D-F). Finally, saline treatment did not affect increased BCM events and bursts
following 30 Hz (Events; infusion: P = 0.007, 5Hz: p=0.017, 10Hz: P = 0.037; Bursts; infusion:
P < 0.001, 5Hz: P < 0.001, 10Hz: P = 0.001) or 60 Hz (Events; infusion, 5Hz, 10Hz: P < 0.001,
30Hz: P = 0.006; Bursts; infusion, 5Hz, 10Hz: P < 0.001) DPN stimulation, confirming that
there was no effect of repeated DPN stimulations (Figure 7D-F).

2.3.5

GRP mediates SVP Increases following DPN stimulation

The findings described above confirm a role for GRP in the expulsion phase of ejaculatory
reflex. Next, we determined the role of GRP for increases in SVP, indicative of the emission
phase. Since effects of DPN stimulation on SVP have not yet been documented, saline-treated
controls were analyzed. DPN stimulation triggered SVP increases that were concurrent with
BCM EMG bursts in saline treated animals (Figure 9). There were no significant differences in
the numbers of SVP increases following DPN stimulation between trial 1 and trial 2 in animals
treated with saline (at 5, 10, 30, or 60 Hz; Table 1), showing lack of effect of repeated DPN
stimulation. Similarly, and in concordance to the results described above, there were no
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significant differences in the numbers of BCM bursts induced by DPN stimulation between trial
1 and trial 2 in saline treated animals (Table 1). The frequency of SVP increases was closely
close
coupled to the numbers of BCM bursts. Each SVP increase was accompanied by a BCM burst,
although a number of DPN-stimulation
stimulation induced BCM bursts occurred in the absence of SVP
increases, in animals that received 30 or 60 Hz DPN stimulation. In the absenc
absencee of BCM activity
following subthreshold levels of DPN stimulation (Trial 1: control trial; saline infusion, 5 Hz,
and 10 Hz) there was a similar absence of SVP increases (Table 1).

Figure 9 SVP and concurrent BCM activity induc
induced by DPN stimulation
A representative example of a simultaneous recording of BCM activity and SVP (90 seconds
duration) after 60 Hz DPN stimulation 10 minutes following intrathecal saline infusion. The
dotted lines in A and B indicate the end of DPN stim
stimulation.
ulation. Stars in (B) indicate SVP increases.
A fragment of the trace indicated in the box area in A and B is enlarged in C and D to clearly
show a BCM burst (C) coupled with a single increase in SVP (D) over 4 seconds of recording
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Table 1 Numbers of SVP increases and BCM bursts following infusions of saline, RC-3095
and GRP in male rats.
Numbers of seminal vesicle pressure (SVP) increases and BCM bursts in animals treated with
saline-saline (n=3), saline-RC3095 (20nmol; n =3) or saline-GRP (0.2nmol; n = 3) in trial 1-trial
2 respectively, and with DPN stimulation at 0, 5, 30, or 60 Hz frequencies. # indicates significant
difference from trial 1 within the same treatment group and stimulation parameter.

Saline-saline
(n = 3)

Trial 1: Numbers of Trial 2: Numbers of Trial 1: Numbers of Trial 2: Numbers
of
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SVP
SVP
BCM bursts
BCM bursts

Infusion

0

0

0

0

5 Hz

0

0

0

0

10 Hz

0

0

0

0

30 Hz

3.33 ± 1.43

2.33 ± 0.94

8 ± 1.08

8.33 ± 0.62

60 Hz

4 ± 0.71

2.33 ± 1.03

8.33 ± 0.24

9.33 ± 0.62

Saline-RC3095
20nmol (n = 3)

Trial 1: Numbers of Trial 2: Numbers of Trial 1: Numbers of Trial 2: Numbers of
SVP
SVP
BCM bursts
BCM bursts

30 Hz

4.66 ± 1.86

0#

6.66 ± 0.47

0#

60 Hz

3.66 ± 2.03

0 (P =0.052)

8 ± 0.71

0#

Saline-GRP
0.2nmol (n = 3)

Trial 1: Numbers of Trial 2: Numbers of Trial 1: Numbers of Trial 2: Numbers of
SVP
SVP
BCM bursts
BCM bursts

Infusion

0

3.66 ± 1.89

0

5 ± 2.86

5 Hz

0

1.33 ± 0.24 #

0

4.33 ± 0.62 #

10 Hz

0

2 ± 0.41 #

0

4 ± 0.71 #

30 Hz

1 ± 0.41

3.33 ± 0.47 #

7.33 ± 0.62

6.66 ± 0.62

60 Hz

4.33 ± 2.09

2 ± 0.41

8 ± 0.41

6.33 ± 0.62
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GRP appears to be critically involved in the regulation of both BCM EMG activity and
SVP increases (Table 1, Figure 10). Indeed, RC
RC-3095
3095 (20 nmol) treatment completely blocked
both BCM EMG bursts (confirming results described above) and SVP increases in response
re
to
30 Hz (BCM: P < 0.001; SVP: p = 0.03) and 60 Hz (BCM: p = 0.001; SVP: P = 0.052) DPN
stimulation (Table 1).. Moreover, in 2/3 animals, GRP20-29 triggered BCM bursts and SVP
increases in the absence of DPN stimulation (Table 1, Figure 10). In addition, GRP20-29 facilitated
BCM bursts and SVP increases in response to subthreshold levels: 5 Hz (BCM: p = 0.004; SVP:
P = 0.005) and 10 Hz (BCM: P = 0.005; SVP: P = 0.013) of DPN stimulation (Table 1).

Figure 10 BCM activity and concurrent increases in SVP triggered by infusions of GRP in
a male rat
Simultaneous recording of BCM activity (A) and SVP (B) in one animal (45 seconds of EMG
recording) 145 seconds after an intrathecal infusion of GRP20-29 (0.2nmol). The traces in A and B
are magnified to show one BCM burst (C) occurring simultaneously with an increase in SVP
(D).
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2.4 Discussion

The findings of this set of studies support the hypothesis that GRP plays a critical role in the
control of ejaculation by acting in autonomic and motor areas targeted by LSt axons. GRP was
found to be present in all LSt cells and LSt axon projections within the lumbosacral spinal cord.
As predicted, intrathecal administration of GRP receptor antagonist RC-3095 severely disrupted
both the emission and expulsion phases of ejaculation in response to sensory stimulation,
reflected in the reduced numbers of SVP increases and BCM activity in response to DPN
stimulation in RC-3095-treated male rats. In contrast, intrathecal infusion of GRP20-29 facilitated
both the emission and expulsion phases of ejaculation, as evidenced by the surge in the numbers
of SVP increases and BCM bursts respectively in male rats treated with GRP20-29. In particular,
GRP20-29 was most effective in facilitating ejaculation after sub-threshold sensory stimulation (510 Hz), signifying the presence of a cumulative effect of GRP receptor activation by intrathecal
infusion of GRP and the release of endogenous GRP or other neuropeptides in response to
stimulation of the DPN.
GRP is a bombesin-like peptide that is widely distributed in the central nervous system of
mammals (Marberger, 1974; Roth et al., 1982; McKenna, 1999) and is involved in many
physiological processes including the suppression of feeding behavior (Merali et al., 1993)
circadian rhythms (Drouyer et al., 2010; Francl et al., 2010; Gamble et al., 2011) and itching
behavior (Sun and Chen, 2007). In the lumbosacral spinal cord, GRP was shown here to be
exclusively expressed by LSt cells, as 100% of LSt neurons, identified by immunoreactivity for
galanin, co-expressed GRP and vice versa. Moreover, virtually all galanin-IR LSt axons in the
autonomic and motor areas co-expressed GRP. This finding is in slight contrast with a previous
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report of a sub-population of GRP-IR neurons that do not co-express galanin dorsal to the central
canal in the lumbar spinal cord (Sakamoto et al., 2008). The discrepancy is possible due to
differences in the sensitivity of immunohistochemical detections: in the present study, two
different immunohistochemistry protocols were performed in which either one of the
neuropeptide signals were amplified for optimal sensitivity of peptide detection. Results from
both protocols were identical and complete co-localization of galanin- and GRP-ir was found in
soma and axon terminals. Moreover, the present study utilized spinal cord tissues from both
spinal intact and spinal transected male rats, thereby correcting for the possibility of supraspinal
influences on galanin or GRP expression. A few GRP-IR fibers that did not co-express galaninIR were observed in the region of and dorsal to the SPN, suggesting that the SPN receives inputs
from GRP neurons outside of the spinal ejaculation generator and the lumbosacral spinal cord.
Sources of GRP indeed exist outside of the spinal ejaculatory network (Roth et al., 1982). The
SPN is known for its role in erectile function (Rampin et al., 1997a; Tang et al., 1998; Giuliano
and Rampin, 2004) and emission (Allard et al., 2005; Johnson, 2006) and destruction of sacral
autonomic centers abolishes reflex erections (Everaert et al., 2010) but a specific role for SPN in
the expulsion phase of ejaculation has not been documented. Therefore, it is likely that GRP
axons located dorsally to the SPN are predominantly involved in erectile function and emission,
but not expulsion (Morgan et al., 1981; Rampin et al., 1997b; Tang et al., 1998). Indeed, one of
the sources of GRP outside of the spinal ejaculation generator is the paraventricular nucleus of
the hypothalamus (Roth et al., 1982), an area well known to be involved in erectile function
(Chen et al., 1997; Argiolas and Melis, 2005) and to project to the lumbosacral spinal cord (Shen
et al., 1990; Tang et al., 1998). It is currently unknown if GRP in the PVN or its projections
mediate erection, and this possibility can be tested in future studies.
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The expression of GRP in LST cells and projections is consistent with the proposed role of GRP
in control of ejaculation via action in autonomic and motor areas in the lumbosacral spinal cord
(see Figure 3), Moreover, intrathecal injections of GRP receptor antagonist RC-3095 blocked
BCM bursting in response to DPN stimulation. It is assumed that RC-3095 acted primarily in the
areas of the spinal cord that are located adjacent to the pia-arachnoid space, including all LSt
target areas. Indeed, GRP receptor expression has been reported in the SPN and SNB of the
lumbosacral spinal cord (Ju et al., 1987; Nicholas et al., 1999; Coolen et al., 2003; Truitt et al.,
2003; Sakamoto et al., 2008), however its expression in other LSt target regions, including the
CAN and IML requires further investigation. Another possibility is that GRP or GRP antagonist
treatment acts directly on the LSt cells. Galanin- and GRP-ir axon terminals arising from LSt
cells that make putative contacts with LSt cells have previously been observed (see Figure 5;
(Truitt et al., 2003)) and thus GRP may be released directly onto LSt cells to control ejaculation.
However, RC-3095 treatment did not decrease neural activity of LSt cells, indicated by pERK
expression, substantiating that RC-3095 likely blocks the ejaculatory reflex by acting on GRP
receptors downstream of the LSt cells, rather than directly disrupting activity of LSt cells.
In a portion of the animals [33-43%], GRP20-29 was sufficient in triggering ejaculatory reflexes in
the absence of DPN stimulation. It is possible that the differences in the ability of GRP to induce
ejaculatory reflexes between groups of rats are due to differences in receptor densities for
neuropeptides or receptors expressed in the spinal ejaculation generator, including GRP. In
addition, GRP20-29 was not sufficient to trigger ejaculatory reflexes in all the animals indicating
that a higher dose of GRP agonist may have been necessary to trigger BCM bursting and SVP
increases in some animals. Alternatively, the lack of responses to GRP20-29 in all animals
suggests that other neuropeptides expressed in LSt cells and potentially released in LSt target
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areas may act in concert with GRP to control ejaculation. These neuropeptides include galanin
(Newton, 1993; Kozyrev, 2013b), cholecystokinin (Ju et al., 1987; Kozyrev, 2013b) and
enkephalin (Nicholas et al., 1999; Kozyrev, 2013c). An unexpected finding was that the higher
dosages of GRP20-29 caused significant suppression of BCM activity induced by the highest
stimulation parameters. A similar finding is that stimulation of the DPN at higher frequencies
(such as 120 Hz) does not trigger ejaculatory reflexes (unpublished personal observations).
Hence, such stimulation by agonists and high frequency may represent a super physiological
manipulation that leads to dysfunction or possible muscle fatigue.
An advantage of the current study of the role of GRP in ejaculation is the use of the DPN
stimulation paradigm which utilizes anesthetized and spinalized male rats and elicits rhythmic
contractions of the BCM and concurrent SVP increases, akin to those observed in freely-moving
animals during mating (Beyer et al., 1982; Holmes and Sachs, 1991; Staudt et al., 2010;
Normandin and Murphy, 2011; Staudt et al., 2011). Thus, complete transection of the spinal cord
permits the study of ejaculation as a reflex response in the absence of supraspinal influences
(Sachs and Garinello, 1980; Chung et al., 1988; Monaghan and Breedlove, 1992). The DPN is
the primary afferent that transmits sensory information related to the summation of mating to the
spinal ejaculation generator and triggers ejaculation (Hart, 1968; McKenna and Nadelhaft, 1986).
Indeed, bilateral transection of the DPN blocks ejaculation in mating rats (Lodder and Zeilmaker,
1976). Although the pathways whereby sensory information is transmitted from the DPN to the
LSt cells are currently unknown, it has been shown that DPN nerve fibers terminate in the lower
lumbar and upper sacral levels of the spinal cord in the general vicinity of the LSt cells, dorsal
horn and dorsal grey commissure (DCG) (McKenna and Nadelhaft, 1986; Ueyama et al., 1987;
Yells et al., 1992; Rampin et al., 1997b). Furthermore, it has previously been shown that DPN

60

stimulation activates LSt cells in a similar manner as ejaculatory behavior in freely moving
animals (Staudt et al., 2010; Staudt, 2011). The mechanism for LSt cell activation is through
NMDA receptors (Staudt et al., 2011) and map kinsase signaling (Staudt et al., 2010). Moreover,
this activation is required as pharmacological blockade of either of these components results in
the blockade of DPN stimulation-induced ejaculatory reflexes in male rats (Staudt et al., 2010;
Staudt, 2011). Therefore, the activation of LSt cells is essential for the transmission of sensory
information from the DPN to the outputs of the spinal cord ejaculation generator (Staudt, 2011).
A previous study demonstrated effects of GRP treatment on erectile and ejaculatory reflexes
using an ex copula paradigm in spinal intact rats (Sakamoto et al., 2008). However, in this
paradigm, it is not possible to eliminate actions of GRP on the supraspinal areas that control
ejaculation

from

the

spinal

ejaculation

generator,

including

the

nucleus

of

the

paragigantocellularis (nPGi) (Marson and McKenna, 1992; Yells et al., 1992; Normandin and
Murphy, 2011), the medial preoptic area (MPOA) (Marson, 2004) and the paraventricular
nucleus of the hypothalamus (Marson and McKenna, 1990, 1994; Murphy and Hoffman, 2001;
Normandin and Murphy, 2011). Moreover, emissions or ejaculations as observed in the excopula paradigm are not dependent on the spinal ejaculation generator (Staudt, 2011) as lesions
of the LSt cells did not block sexual reflexes using this paradigm. While, in contrast, intact LSt
cells were pivotal for ejaculatory reflexes as induced in three accepted paradigms for ejaculation
(Staudt, 2011), including DPN or urethrogenital stimulation, and pharmacological activation of
D3 receptors in spinal transected anesthetized male rats (Staudt, 2011) as well as for ejaculatory
behavior in freely mating male rats (Truitt and Coolen, 2002).
In conclusion, these data confirm that GRP receptor activation in the lumbosacral spinal cord is
required for sensory stimulation-induced ejaculation reflex in anesthetized, spinalized male rats.
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Furthermore, GRP appears to act by activating receptors in the outputs of the LSt cells. However,
GRP receptor expression in the target regions of the LSt cells remains to be elucidated. In
addition, the roles of other neuropeptides expressed in the LSt axons, including enkephalin,
galanin and cholecystokinin in the control of ejaculatory behavior and reflexes remain to be
investigated.
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Chapter 3: Activation of mu and delta opioid receptors
in the lumbosacral spinal cord is required for
ejaculatory reflexes in male rats
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3.1 Introduction

Ejaculation is a complex physiological phenomenon that is highly rewarding and culminates in
the ejection of seminal contents from the urethral meatus (Marberger, 1974; McKenna, 1999).
Ejaculation involves two phases, emission and expulsion. During the emission phase, seminal
fluids are secreted from the accessory sex glands, including the prostate, seminal vesicles and vas
deferens and the bladder neck and external urethral sphincter shut to avert retrograde ejaculation.
During the expulsion phase, rhythmic contractions of the striated perineal muscles, and the
bulbocavernosus muscle (BCM) in particular, forcefully expel semen from the urethral meatus
(Bohlen et al., 1980; Gerstenberg et al., 1990; Holmes et al., 1991; Holmes and Sachs, 1991).
Ejaculation is a reflex controlled by a spinal ejaculation generator in the lumbosacral spinal cord
(Pescatori et al., 1993; McKenna, 1999). The spinal ejaculation generator (Marberger, 1974;
McKenna, 1999; Carro-Juarez and Rodriguez-Manzo, 2007) is thought to control ejaculation by
closely coordinating sympathetic, parasympathetic, and motor components to initiate emission
and expulsion (Coolen et al., 2004; Allard et al., 2005; Coolen, 2005; Staudt et al., 2010;
Kozyrev et al., 2012). In addition, it is postulated that the spinal ejaculation generator triggers
ejaculation by integrating sensory inputs conveyed by the dorsal penile nerve (DPN), the sensory
branch of the pudendal nerve, during copulation with autonomic and motor outflow. The spinal
ejaculation generator consists of a set of interneurons in lamina 10 and the medial portion of
lamina 7 of lumbar segments 3 and 4 (L3-4) that are integral in the control of ejaculation. These
lumbar interneurons are referred to as lumbar spinothalamic (LSt) cells due to their anatomical
position in the lumbar spinal cord and projections to the subparafascicular parvocellular nucleus
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of the thalamus (Ju et al., 1987; McKenna, 1997; Coolen et al., 2003; Truitt et al., 2003). One
proposed role of LSt cells is to transform sensory signals associated with the summation of
sexual activity into motor or secretory outputs (Truitt and Coolen, 2002). LSt cells display neural
activation specifically with ejaculation but not with other components of sexual behavior
following copulation or electrical stimulation of the DPN in male rats (Sachs and Garinello,
1979; Pescatori et al., 1993; McKenna, 1997; Coolen et al., 2004). Markers of neural activation
in LSt cells with ejaculation include cFos (Truitt et al., 2003) and phosphorylated extracellular
signal-regulated kinases 1 and 2 (pERK) (Staudt et al., 2010) and ejaculation is triggered through
activation of the mitogen activated protein (MAP) kinase pathway (Staudt et al., 2010) following
mating in intact animals or DPN stimulation in anesthetized and spinalized male rats.
Furthermore, LSt cells have axonal projections to LSt target regions (Newton, 1993;
Allard et al., 2005; Xu et al., 2006) including preganglionic sympathetic, parasympathetic and
motor neurons in the thoracolumbar and lumbosacral spinal cord (Newton, 1993; McKenna,
1997; Sakamoto et al., 2008). LSt cells express several neuropeptides including galanin,
cholecystokinin, gastrin releasing peptide (GRP), and enkephalin (Ju et al., 1987; Nicholas et al.,
1999; Coolen et al., 2003; Truitt et al., 2003; Sakamoto et al., 2008). Thus, we hypothesize that
these neuropeptides act in the LSt target areas to modulate ejaculatory reflexes. Indeed, our
laboratory has recently revealed a critical role for GRP in the control of ejaculation in male rats
(Kozyrev et al., 2012). Intrathecal infusions of GRP antagonist RC-3095 completely abolished
ejaculatory reflexes while intrathecal infusion of GRP agonist GRP2029 triggered ejaculatory
reflexes in 43-66 % of animals and facilitated ejaculatory reflexes in response to subthreshold
frequencies (5-10 Hz) of DPN stimulation in 100 % of male rats (Kozyrev et al., 2012). In the
current study we test if the opioid peptide enkephalin is critical for regulation of ejaculation.
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A recent study has also identified a critical role for opioids in the control of ejaculatory
reflexes in male rats (Carro-Juarez and Rodriguez-Manzo, 2009). Specifically, it was reported
that intravenous injections of the opioid agonist morphine blocked ejaculatory reflexes in male
rats and that this effect was reversed by systemic pretreatment with the opioid antagonist
naloxone (Carro-Juarez and Rodriguez-Manzo, 2009). Furthermore, intravenous naloxone
induced the genital ejaculatory motor pattern (Carro-Juarez and Rodriguez-Manzo, 2009). From
these results, the authors concluded that endogenous opioids regulate the activity of the spinal
ejaculation generator by exerting inhibitory effects. However, the non-specific nature of the
opioid agonist and antagonist used in this study as well as the intravenous mode of drug delivery
constitute significant confounds in the interpretation of the results. Enkephalin, which is
expressed by LSt cells and axons (Nicholas et al., 1999), is an endogenous ligand for both mu
(MOR) and delta opioid receptors (DOR) (Cesselin, 1995), and can thus trigger ejaculation by
acting on MOR and/or DOR in LSt target regions. Hence, the purpose of the present study was to
investigate the individual contributions of MOR and DOR on ejaculatory reflexes induced by
electrical stimulation of the DPN in anesthetized and spinalized male rats. Stimulation of the
DPN in anesthetized and spinalized animals is a physiologically relevant model (Giuliano et al.,
2010), reliably inducing ejaculation in all mammals, including rodents (Pescatori et al., 1993),
primates (Herbert, 1973), and men (Wieder et al., 2000). First, it was tested whether enkephalin
is required for ejaculatory reflexes in male rats using intrathecal delivery of MOR and DOR
antagonists during simultaneous recordings of seminal vesicle (SV) pressure, a marker of
emission, and rhythmic contractions of the BCM, a marker of expulsion in anesthetized and
spinalized male rats. Next, it was tested whether enkephalin is sufficient to trigger ejaculation in
male rats in the absence of DPN stimulation or following subthreshold levels of DPN stimulation
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(5-10 Hz) that do not trigger ejaculatory reflexes in male rats in control conditions (Kozyrev et
al., 2012) and intrathecal infusions of specific MOR and DOR agonists in the lumbosacral spinal
cord during recordings of SV pressure and BCM contractions.

3.2 Materials and Methods

3.2.1

Animals

Adult male Sprague Dawley rats (225-250 grams) were acquired from Charles River
(Wilmington, MA, USA) and pair-housed in standard housing cages on a 12-hour light/dark
cycle with lights off at 9 pm. Food and water were available ad libitum. All procedures were
approved by the University Committee on Use and Care of Animals at the University of
Michigan and conformed to the guidelines outlined by the National Institutes of Health.

3.2.2

Experimental Designs

3.2.2.1 Surgical procedures

Male rats were anesthetized with urethane (1.5 g/kg, i.p.) and a laminectomy was carried out
between the sixth and the eighth thoracic spinal segments. A complete transaction of the spinal
cord was performed at the seventh thoracic spinal segment. Subsequently, animals were prepared
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for electromyographic (EMG) recordings of bulbocavernosus muscle (BCM) bursting and
seminal vesicle pressure (SVP); indicators of expulsion and emission components of ejaculations
respectively (Pescatori et al., 1993; Clement et al., 2008). The BCM and the dorsal penile nerve
(DPN) were surgically exposed and the surrounding connective tissue was removed. Silver
recording electrodes, connected to the PowerLab/7SP Data Acquisition System (AD Instruments,
Inc., Colorado Springs, CO, USA) were placed bilaterally into the BCM and a ground electrode
was inserted into the muscle of the right thigh. In a subset of animals, the right seminal vesicle
was exposed by coeliotomy and a pressure catheter (AD Instruments Inc., model number: SPR671(1.4 F, Single, Straight, 15 cm, Ny) connected to a catheter interface cable (AD Instruments
Inc., model number: AEC-IOD) and attached to a Bridge AMP (AD Instruments Inc.), was
gently guided into the lumen of the SV and fixed in place. Finally, for stimulation of the DPN, a
bipolar stimulating electrode connected to the SD9 Square Pulse Stimulator (Grass Technologies,
West Warwick, RI, USA) was arranged directly above the DPN. 2-4 Hours prior to any of the
experiments, the DPN was stimulated (4 V at 60 Hz square wave pulses of 1 ms duration, for
total of 10 seconds) in order to verify the completeness of the spinal cord transection. These
established stimulation parameters consistently trigger rhythmic bursting of the BCM, indicative
of the expulsion phase of ejaculation, in all animals (Staudt et al., 2010; Staudt, 2011; Kozyrev et
al., 2012).

3.2.2.2 Intrathecal infusion of opioid receptor antagonists
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Pharmacological experiments began at least two hours following transection of the spinal cord in
order to let the potential acute effects of spinal cord transection to diminish. A minor incision
was performed in the dura mater at the site of the laminectomy and a polyethylene catheter
(Caly-Adams PE-10, Parsippany, NJ, USA) was guided into the subarachnoid space until the
open end reached the mid-lumbar levels, such that saline or drug infused through the catheter
would bathe the entire lumbosacral spinal cord. First, 10 µL of saline was delivered (at 10
µl/minute rate) and BCM EMG activity was recorded for 25 minutes. Next, the DPN was
stimulated at 30 Hz and 60 Hz (4 V, square wave pulses of 1 ms duration, for total of 10
seconds) in a counterbalanced manner, with 5-minutes between the stimulations (testing trial 1;
control trial). BCM EMG and SVP were recorded. An hour later, the procedure was performed
again in the same animals, which were now administered a 10 µL infusion of opioid receptor
antagonists, after which the DPN was stimulated at 30 Hz and 60 Hz in a counterbalanced
manner, and BCM EMG activity and SVP were recorded (testing trial 2; drug trial). We
previously established that repeated stimulations and infusions of saline did not affect BCM
EMG bursting in response to or without DPN stimulation (Kozyrev et al., 2012), therefore all
animals received drug treatment in testing trial 2 (drug trial). In experiment 1, one of two doses
of the mu opioid receptor antagonist H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP)
0.3 nmol (N = 7) or 3 nmol (N = 8) were infused and BCM EMG was recorded. In experiment 2,
the most effective dose of CTOP was administered, 3 nmol, and BCM EMG and SVP were
recorded simultaneously (N = 6). In experiment 3, one of three doses of the delta opioid receptor
antagonist H-Tyr-Tic-Phe-Phe-OH (TIPP), [Bachem Americas, Inc. Torrance, CA, USA], 0.4
nmol (N = 6), 4 nmol (N = 7), or 40 nmol (N = 6) were infused and BCM EMG and SVP were
recorded.
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3.2.2.3 Intrathecal infusion of opioid receptor agonists

Four separate groups of male rats was anesthetized, spinalized, and prepared as described above.
In testing trial 1: control trial, all male rats received 10 µL intrathecal infusions of 0.9% saline (N
= 30) and BCM EMG and SVP were recorded for 10 minutes after infusion. Next, the DPN was
stimulated at 5 HZ, 10 HZ, 30 HZ and 60 HZ in a randomized and counterbalanced order, and
BCM EMG and SVP were recorded for the duration of 90 seconds following stimulation (testing
trial 1; control trial). We previously determined that repeated stimulation using these parameters
did not affect BCM EMG (Kozyrev et al., 2012). One hour following the final DPN stimulation,
the procedure was repeated in the same groups of animals, which now received 10 µL intrathecal
infusions of one of two doses of mu opioid receptor agonist (D-Ala2, N-Me-Phe4, glycinol5) –
Enkephalin [DAMGO 0.1 nmol, N = 7; 10 nmol, N = 8; (Bachem Americas, Inc. Torrance, CA,
USA)] or one of two doses of the delta opioid receptor agonist [DAla2] Deltorphin II, 1.3 nmol,
N = 8; 13 nmol, N = 8; [American Peptide Co, Sunnyvale, CA, USA] and BCM EMG and SVP
were recorded for 10 minutes after infusion. Finally, the DPN was stimulated at 5, 10, 30, and 60
HZ in a counterbalanced manner as described above and previously (testing trial 2; drug trial;
(Kozyrev et al., 2012)).

3.2.3

BCM EMG and SVP Analysis
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BCM EMG and SVP recordings were analyzed using methods we previously described (Kozyrev
et al., 2012). Briefly, data were analyzed for the 25 or 10 minutes following the infusion of the
antagonist or agonist, respectively. In addition, EMG and SVP were analyzed for 90 seconds
following each DPN stimulation, which is the time span of a characteristic DPN-stimulation
induced ejaculatory reflex in control male rats (Staudt et al., 2010; Staudt, 2011; Kozyrev et al.,
2012). The numbers of events, bursts, and SVP increases were analyzed (Kozyrev et al., 2012)
using LabChart 7.35 (AD Instruments Inc.). An event is defined as an increase in EMG above
baseline; a burst is a cluster of EMG events (10 or more events) without return to baseline; and
an increase in SVP is counted each time it occurs concurrently with BCM EMG activity. These
definitions were previously determined (Kozyrev et al., 2012). For the antagonist experiments,
the effects of antagonist treatments on the numbers of events, bursts and SVP increases were
compared both within animals (within the same drug dose, between testing trial 1: control trial
and testing trial 2: drug trial) and between groups (between different doses within testing trial 1
or 2: drug trial), separately for the 30 and 60 Hz stimulations, using two-way repeated Anova
(factors: Testing trial and Drug dose) and Holm-Sidak post hoc tests. For the agonist
experiments, numbers of events, bursts and SVP increases were compared within animals
(between testing trial 1: control trial and testing trial 2: drug trial) and between treatment groups
(between different doses within testing trial 1 or 2: drug trial), separately for each stimulation
setting (following infusion without stimulation, 5, 10, 30, 60 Hz), using a two-way repeated
Anova (factors: Testing trial and Drug Dose) and Holm-Sidak post hoc tests. A 95% confidence
level was used for all tests.
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3.2.4

Immunohistochemistry Experiments

3.2.4.1 DPN Stimulation-induced pERK after intrathecal opioid receptor antagonist treatment

To verify that mu opioid receptor antagonist CTOP and delta opioid receptor antagonist TIPP did
not prevent the activation of LSt cells, expression of phosphorylation of ERK (pERK) in LSt
cells was examined following stimulation of the DPN (Staudt et al., 2010; Kozyrev et al., 2012).
Male rats (N = 9) were anesthetized and spinalized as described above. Two hours after
spinalization, the DPN and BCM were exposed and vehicle (saline, N = 4) or drug (CTOP 3
nmol; N =3, TIPP 40 nmol; N = 2, Bachem Americas, Inc. Torrance, CA, USA) were infused in
a volume of 10 µL intrathecally as described above. Following a 25-minute infusion, the DPN
was stimulated at 30 Hz and BCM EMG activity and SVP were recorded for 90 seconds. Five
minutes following DPN stimulation, animals were perfused transcardially with 5 mL 0.9% saline
solution and 500 mL of 4% paraformaldehyde in 0.1 M PB. Spinal cords were removed and
postfixed for 1 hour in the same fixative and then transferred into a cryoprotective solution (20%
sucrose in 0.1 PB with 0.01% sodium azide) until further processing for immunohistochemical
visualization of pERK and galanin. The stimulation parameters and time of perfusion were
previously shown to be optimal for detection of pERK expression in LSt cells (Staudt et al.,
2010; Kozyrev et al., 2012). Furthermore, previous experiments have shown that spinalization
and the surgical exposure of the DPN and the BCM in the absence of electrical stimulation of the
DPN do not induce pERK expression in LSt cells (Staudt et al., 2010), hence negative control
groups were not included in this experiment.
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3.2.5

Immunohistochemistry: Galanin/pERK dual fluorescence

Spinal cords were cut using a freezing microtome (Thermo Fisher Scientific, Walldorf,
Germany) into 12 parallel series of 35 um coronal sections in cryoprotectant solution (30%
sucrose, 30% ethylene glycol in 0.1 M PB with 0.01% sodium azide) and stored at -20°C until
further processing. Free floating sections of the lower thoracic, lumbar, and sacral spinal levels
were thoroughly rinsed in 0.1 M saline buffered sodium phosphate (PBS) between incubations
and blocked with 1% H2O2 for 10 minutes before incubation. All antibody incubations were
performed in incubation solution containing 0.1% bovine serum albumin and 0.4% Triton X-100
(BP151-500, Thermo Fisher Scientific Inc, Pittsburgh, PA, USA) in PBS at room temperature
with gentle agitation. Spinal cord sections were incubated overnight with rabbit anti-pERK
(1:1,000; overnight; Cell Signaling #26 L) and with biotinylated goat anti-rabbit for one hour
(1:500; Vector Laboratories, Burlingame, CA, USA), avidin horseradish peroxidase complex
(ABC-elite, 1:1,000 in PBS; 1 hour;Vector Laboratories), biotinylated tyramine (BT; 1:250 in
PBS containing 1 uL/mL of 3% H2O2 for 10; NEL700/700A; PerkinElmer Life Sciences,
Boston, MA, USA), and Alexa 488-conjugated streptavidin (1:100 in PBS, 30 minutes (Jackson
ImmunoResearch Laboratories, West Grove, PA, USA). Next, sections were incubated with
rabbit anti-galanin (1:3,000; overnight, T-4334; Bachem, Torrance, CA, USA) and Alexa 555conjugated goat anti-rabbit for 30 minutes in PBS (1:100; Jackson Immuno-Research
Laboratories) and mounted on plus charged slides, cover-slipped with gelvatol and stored in the
dark at 4°C. For all immunohistochemistry procedures, the omission of primary antibodies
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resulted in a complete loss of signal at specific wavelengths and all primary antibodies have been
previously validated (Truitt et al., 2003; Staudt et al., 2010, 2011; Kozyrev et al., 2012)
3.2.6

Data Analysis

3.2.6.1 pERK Expression in LSt Cells

pERK expression in LSt cells was analyzed on a DM5000B Leica fluorescent microscope (Leica
Microsystems, Wetzlar, Germany). Specifically, all lumbar cells expressing galanin-ir were
analyzed for expression of pERK, as cytopplasmic galanin-ir is exclusively expressed in LSt
cells. Data are expressed as the mean percentages of LSt cells that display pERK for each
animal. The group means were calculated and compared between animals that received an
infusion of CTOP (3 nmol) or TIPP (40 nmol) and saline-treated controls, using Student t-tests
with 95% confidence levels.

3.3 Results

3.3.1

Mu Opioid Receptor Antagonist CTOP Suppressed Ejaculatory Reflexes

Mu opioid receptor antagonist CTOP significantly decreased DPN stimulation-induced
ejaculatory reflexes at both 30 and 60 Hz stimulation frequencies as reflected in the reduced
numbers of BCM events, bursts, and SVP increases. There were main effects of testing trial on
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the numbers of BCM events for both 30 Hz (F(1, 29) = 88.436; P < 0.001; Figure 11A)
1
and 60
Hz stimulation frequencies (F(1, 29) = 62.013; P < 0.001; Figure 11A).
A). Post hoc analyses
revealed that animals treated with either dose of CTOP during the second, drug trial had
significantly decreased BCM events in response to 30 or 60 Hz DPN stimulation compared to
their DPN stimulation induced BCM events following saline treatment in their first control trial
(trial 1; 60 Hz: P <0.001 (0.3 nmol); P = 0.009 (3 nmol); 30 Hz: P = <0.001 (0.3 nmol); P
<0.001 (3 nmol); Figure 11A).
A). There were no significant differences between the two groups
treated with the lower and higher doses of CTOP for each stimulation frequency.
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Figure 11 Effects of CTOP infusions on the numbers of BCM events and bursts induced by
DPN stimulation in male rats.
Quantitative analysis of BCM events (A) and bursts (B) in response to 30 and 60 Hz DPN
stimulations following infusions of saline in trial 1 (control trial; white bars) or one of two doses
of CTOP (0.4 or 4 nmol) in trial 2 (drug trial; filled bars). Data are presented as Mean SEM. *
denotes significant differences from trial 1 within the same treatment group, while # indicates
significant differences between treatment groups within the same testing trial. Representative
EMG traces (90 seconds duration) following 60 Hz DPN stimulation (arrow) after an intrathecal
infusion of saline (C: control trial) and CTOP (D: same animals as in C).

Similarly, there were main effects of testing trial on the numbers of BCM bursts for both
30 Hz (F(1, 29) = 108.732; P < 0.001; Figure 11B) and 60 Hz (F(1, 29) = 123.431; P < 0.001;
Figure 11B) stimulation frequencies. In addition, there were significant interactions between
testing trial and drug dosage for both stimulation frequencies (30Hz: F(1.29)=11.83; P = 0.023;
60 Hz: F(1,29) = 23.87; P = 0.016). CTOP during trial 2 (drug trial) significantly reduced BCM
bursts compared to trial 1 (control trial) with saline treatment (30 Hz: P < 0.001 [0.3 nmol], 30
Hz: P < 0.001 [3 nmol], 60 Hz: P < 0.001 [0.3 nmol] 60 Hz: P < 0.001 [3 nmol]; Figure 11B, C,
D). There was an effect of dose on the numbers of BCM bursts in testing trial 2: drug trial.
Specifically, there were significantly fewer BCM bursts following the higher dose compared to
the lower dose of CTOP (30 Hz: P = 0.003 [3 nmol]; Figure 11B, 60 Hz: P = 0.006 [3 nmol];
Figure 11B). Finally, during the first trial, there were no significant differences between groups
in the numbers of BCM events or bursts.
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In a separate group of males, CTOP (3 nmol) also severely impaired the emission
component of ejaculation as indicated by significantly decreased numbers of SVP increases
(Figure 12). There were main effects of testing trial on the numbers of SVP increases (F(1, 23) =
120.143; P < 0.001; Figure 12C, D, E), as well as BCM events (F(1, 23) = 513.688; P < 0.001;
Figure 12A, D, E), and BCM bursts (F(1, 23) = 118.433; P < 0.001; Figure 12B, D, E). Post hoc
analyses revealed that CTOP (3 nmol) in trial 2 (drug trial), male rats displayed significantly
fewer numbers of SVP increases, BCM events and bursts compared to control trial 1, for both 30
Hz (events: P < 0.001; bursts: P < 0.001; SVP: P < 0.001; Figure 12A-E) and 60 Hz (events: P
< 0.001; bursts: P < 0.001; SVP: P < 0.001; Figure 12A-E). Overall, these results confirm the
hypothesis that intrathecal CTOP suppresses both the emission and expulsion components of
ejaculation and that activation of mu opioid receptors in the lumbosacral spinal cord is required
for ejaculatory reflexes in male rats.
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Figure 12 Effects of CTOP on the numbers of BCM bursts and SVP increases induced by
DPN stimulation in male rats.
Quantitative analyses of BCM events (A) bursts, (B) and SVP increases (C) in response to 30
and 60 Hz DPN stimulation following infusions of saline in trial 1 (control trial; white bars) or
CTOP (4 nmol) in trial 2 (drug trial; filled bars). Data are presented as Mean SEM. * denotes
significant differences from trial 1 (control trial). EMG and concurrent SVP traces of 90 seconds
duration following 60 Hz DPN stimulation (arrow) after an intrathecal infusion of saline (D
control trial) and CTOP (E same animal as in D).
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3.3.2

Delta Opioid Receptor Antagonist TIPP Suppressed Ejaculatory Reflexes

Delta opioid receptor antagonist TIPP significantly decreased DPN stimulation-induced
ejaculatory reflexes at both 30 and 60 Hz stimulation frequencies as reflected in the reduced
numbers of BCM events, BCM bursts, and SVP increases. There were main effects of testing
trial on the numbers of BCM events for both 30 Hz (F(1,37) = 20.131; P < 0.001; Figure 13A)
and 60 Hz stimulation frequencies (F(1, 37) = 26.666; P < 0.001; Figure 13A), main effect of
drug dosage for 60 Hz (F(2,37)=6.18; P = 0.01) and significant interactions between testing trial
and drug dosage for both 30 and 60 Hz (30 Hz: (F(2,37) = 5.861; P = 0.012; 60 Hz (F(2,37) =
4.349; P = 0.031). Animals treated with the higher (4 nmol) and highest (40 nmol) but not the
lower (0.4 nmol) dose of TIPP during the second, drug trial had significantly decreased BCM
events in response to 30 Hz (P = 0.012: 4 nmol; P = <0.001: 40 nmol; Figure 13A) and 60 Hz
(60 Hz: P = 0.014, 4 nmol; P <0.001, 40 nmol; Figure 13A) stimulation frequencies compared to
saline treatment in trial 1 (control trial). In addition, there was an effect of dosage, as animals
treated with the highest dose of TIPP (40 nmol) in the second trial (drug trial) displayed
significantly fewer BCM events compared to those treated with the lower dose of TIPP (0.4
nmol) for both the 30 Hz (P = 0.004, 40 nmol; Figure 13A) and 60 Hz (P < 0.001, 40 nmol;
Figure 13A) stimulation frequencies and compared to animals treated with the middle dose of
TIPP (4 nmol) in response to the 60 Hz (P = 0.003, 4 nmol; Figure 13A) stimulation (with a
trend for the 30 Hz (P = 0.075, 4 nmol; Figure 13A)).
Similarly, numbers of BCM bursts were reduced for both 30 Hz (F(1, 37) = 23.209; P <
0.001; Figure 13B) and 60 Hz (F(1, 37) = 21.298; P < 0.001; Figure 13B) stimulation
frequencies. Males treated with the middle (4 nmol) and the highest (40 nmol) but not the lower
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(0.4 nmol) dose of TIPP during trial 2 (drug trial) had significantly fewer BCM bursts compared
to trial 1 (control trial) with saline treatment (30 Hz: P = 0.004 [4 nmol]; Figure 13B, 30 Hz: P <
0.001 [40 nmol]; Figure 13B, 60 Hz: P = 0.018 [4 nmol]; Figure 13B, 60 Hz: P < 0.001 [40
nmol]; Figure 13B, D, E).
Finally, TIPP reduced SVP increases and there were main effects of testing trial for both
30 Hz (F(1, 37) = 19.041; P < 0.001; Figure 13C) and 60 Hz (F(1, 37) = 9.059; P = 0.008; Figure
13C) stimulation frequencies. Males treated with the highest (40 nmol) but not the middle (4
nmol) or lower (0.4 nmol) doses of TIPP during trial 2 (drug trial) had significantly fewer SVP
increases compared to trial 1 (control trial) with saline treatment (30 Hz: P < 0.001 [40 nmol], 60
Hz: P = 0.002 [40 nmol]; Figure 13C, D, E).
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Figure 13 Effects of TIPP infusions on the numbers of BCM events, bursts and SVP
increases triggered by DPN stimulation in male rats
Quantitative analyses of BCM events (A), bursts (B) and SVP increases (C) in response to 30
and 60 Hz DPN stimulation following infusions of saline in trial 1 (control trial; white bars) or
one of three doses of TIPP (0.4, 4 or 40 nmol) in trial 2 (drug trial; filled bars). Data are
presented as Mean SEM. * denotes significant differences from trial 1 within the same treatment
group, while # indicates significant differences between treatment groups within the same testing
trial. EMG traces of 90 seconds duration following 60 Hz DPN stimulation (arrow) after an
intrathecal infusion of saline (D: control trial) and TIPP (E: same animal as in C).
There were no significant differences for any of the parameters between the two groups
of animals during trial 1 (control trial) when both groups received saline, indicating that group
differences in trial 2 were caused by drug treatment.

3.3.3

CTOP and TIPP did not affect DPN Stimulation-Induced pERK in LSt Cells

In order to test that mu opioid receptor antagonist CTOP and delta opioid receptor antagonist
TIPP suppressed BCM bursting and SV pressure via actions in LSt target areas rather than by
preventing activation of LSt cells, DPN stimulation-induced activation of LSt cells was
examined. In control treated males, DPN stimulation induced pERK in 95.4 ± 2.7 % of LSt cells,
as reported previously (Staudt et al., 2010, 2011; Kozyrev et al., 2012). Neither CTOP nor TIPP
infusions prior to DPN stimulation affected LSt activation (CTOP: 96.5 ± 3.5 % (Figure 14);
TIPP: 100 ± 0 % of LSt cells).
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Figure 14 CTOP infusions did not prevent the activation of LSt cells induced by DPN
stimulation in male rats.
Confocal images (1 µm optical sections) demonstating pERK expression in LSt cells induced by
DPN stimulation following infusions of saline (A) and the mu opioid receptor antagonist CTOP
(B). The pattern of pERK labeling is characteristic of all CTOP and saline-treated animals. Scale
bar indicates 20 µm.

3.3.4

Mu Opioid Receptor Agonist DAMGO Triggered and Facilitated Ejaculatory Reflex
The mu opioid receptor agonist DAMGO triggered BCM events, bursts and SVP

increases in the absence of DPN stimulation. In addition, DAMGO dose-dependently facilitated
BCM events, bursts and SVP increases induced by subthreshold levels of DPN stimulation (5-10
Hz). For the numbers of BCM events, there were main effects of testing trial for all stimulation
frequencies (Infusion (0 Hz: (F(1, 29) = 6.400; P = 0.025); 5 Hz: (F(1, 29) = 11.407; P = 0.005);
10 Hz: (F(1, 29) = 41.312; P < 0.001); 30 Hz (F(1, 29) = 42.443; P < 0.001); and 60 Hz (F(1, 29)
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= 73.256; P < 0.001); Figure 15A). Moreover, there were effects of drug dosage (5 Hz: (F(1, 29)
= 8.637; P = 0.012), 10 Hz: (F(1, 29) = 29.005; P < 0.001) and 30 Hz (F(1, 29) = 4.763; P =
0.048) DAMGO-induced BCM events in the absence of DPN stimulation, but only following the
higher dose (10 nmol) and in 100% of males (Infusion: P = 0.009 compared to saline in trail 1; P
= 0.024 compared to lower dosage in trial 2; Figure 15A). DAMGO treatment also induced
BCM events following subthreshold DPN stimulation; but this effect was only observed with the
lower dosage (0.1 nmol) and not the higher dose (10 nmol) (5-10 Hz: P < 0.001; compared to
saline treatment in trial 1; 5-10 Hz: P < 0.001 compared to higher dosage in trial 2; Figure 15A).
In contrast, DAMGO reduced numbers of BCM events following 30 and 60 Hz DPN stimulation
frequencies, which reliably triggered BCM activity following saline in trial 1 (Figure 15A; 30Hz:
P < 0.001, 10 nmol compared to saline in trial 1 and compared to lower dosage in trial 2; 60 Hz:
P < 0.001, 10 nmol; P < 0.001, 0.1 nmol; compared to saline in trial 1).
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Figure 15 Effects of DAMGO infusions on the numbers of BCM events, bursts and SVP
increases in male rats.
Quantitative analyses of BCM events (A), bursts (B) and SVP increases (C) in response to
infusion, 5 Hz, 10 Hz, 30 Hz and 60 Hz DPN stimulation following intrathecal infusions of
saline in trial 1 (control trial; white bars) or one of two doses of DAMGO (0.1 or 10 nmol) in
trial 2 (drug trial; filled bars). Data are presented aass Mean SEM. Note absence of white bars for
infusions, 5, and 10 Hz, as these stimulation frequencies do not trigger BCM events, bursts, nor
SVP increases in control conditions. * denotes significant differences from trial 1 within the
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same treatment group, while # indicates significant differences between treatment groups within
the same testing trial. Representative EMG traces (180 seconds duration) following an
intrathecal infusion of saline (D: control trial) and DAMGO (E: 10 nmol: Same animals as in
D) in the absence of DPN stimulation. EMG and concurrent SVP traces (90 seconds duration)
following 10 Hz DPN stimulation (arrow) after an intrathecal infusion of saline (F: control trial)
and DAMGO (G: 0.1 nmol: same animal as in F).

The effects of DAMGO on BCM bursts were nearly identical to those described above
for BCM events with main effects of testing trial and drug dosage for all stimulation frequencies
except 30 Hz (Figure 15B; Testing trial: Infusion, 0 Hz: (F(1, 29) = 10.726; P = 0.006; 5 Hz:
(F(1, 29) = 16.136; P = 0.001; 10 Hz: (F(1, 29) = 80.755; P < 0.001; and 60 Hz (F(1, 29) =
78.692; P < 0.001); Drug dosage: and main effects of drug dosages: Infusion: F(1, 29) = 4.960;
P = 0.044; 5 Hz: (F(1, 29) = 11.152; P = 0.005; 10 Hz: (F(1, 29) = 69.792; P < 0.001; and 60 Hz
(F(1, 29) = 8.074; P = 0.014). Post hoc tests showed that DAMGO induced BCM bursts in the
absence of DPN stimulation in males treated with the higher dose (10 nmol) but not the lower
dose (0.1 nmol; Infusion: P = 0.001; compared to saline in trial 1; P = 0.001 compared to lower
dosage in trail 2). DAMGO also facilitated BCM bursts following subthreshold DPN
stimulations, but only with the lower (0.1 nmol) and not the higher (10 nmol) dose (5 Hz: P <
0.001; 10 Hz P < 0.001; compared to saline in trial 1 or higher dose in trial 2). DAMGO reduced
numbers of BCM bursts following 60 Hz DPN stimulation (lower dose (0.1 nmol): P < 0.001
compared to saline in trial 1; higher dose (10 nmol): P < 0.001 compared to saline in trial 1 and
P = 0.014 compared to lower dose in trial 2).
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Finally, effects of DAMGO on SVP increases mirrored those on BCM activity (Figure
15C). There were main effects of testing trial (Infusion (0 Hz: (F(1, 27) = 8.168; P = 0.014; 5
Hz: (F(1, 27) = 28.106; P < 0.001; 10 Hz: (F(1, 27) = 63.157; P < 0.001; 30 Hz (F(1, 27) =
6.866; P = 0.022; and 60 Hz (F(1, 27) = 16.471; P < 0.002; Figure 15C) and of drug dosage
(Infusion: (F(1, 27) = 8.168; P = 0.014; 5 Hz: (F(1, 27) = 5.807; P = 0.033; 10 Hz: (F(1, 27) =
31.383; P < 0.001; 30 Hz:(F(1, 27) = 18.103; P = 0.001; and 60 Hz:(F(1, 27) = 9.874; P =
0.008). DAMGO infusions alone, in the absence of DPN stimulation, caused increases in SVP in
males treated with the higher dose (10 nmol) but not the lower dose (0.1 nmol) (Infusion: P <
0.001; compared to saline in trial 1 or to the lower dose in trial 2). Furthermore, DAMGO
increased SVP following subthreshold DPN stimulation (5 Hz: P < 0.001, 0.1 nmol; P = 0.047,
10 nmol ; 10 Hz: P < 0.001; 0.1 nmol) compared to saline treatment in trial 1. The lower dosage
of DAMGO was significantly more effective in causing SVP increases than the higher dosage (5
Hz: P < 0.001; 10 Hz: P < 0.001). Lastly, the higher dose of DAMGO (10 nmol) decreased SVP
increases induced by threshold DPN stimulation (30 Hz (P < 0.001) and 60 Hz (P < 0.001)
compared to saline in trial 1 or to the lower dose in trial 2).
During trail 1, there were no significant differences in BCM events, bursts, or SVP
increases between groups, indicating that the differences observed in trial 2 were due to the
effects of DAMGO.

3.3.5

Delta Opioid Receptor Agonist Deltorphin Facilitated Ejaculatory reflexes
In contrast to the effects of DAMGO, Deltorphin did not induce BCM activity or SVP

increases in the absence of DPN stimulation (Figure 16). However, deltorphin enhanced the
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emission and expulsion components of the ejaculatory reflex following subthreshold DPN
stimulation (Figure 16). There were main effects of testing trial on BCM events (5 Hz: (F(1, 31)
= 33.286; P < 0.001; 10 Hz: (F(1, 31) = 56.543; P < 0.001; 30 Hz (F(1, 31) = 6.059; P = 0.027;
60 Hz (F(1, 31) = 5.710; P < 0.031; Figure 16A), BCM bursts (5 Hz: (F(1, 31) = 121.00; P <
0.001; 10 Hz: (F(1, 31) = 108.432; P < 0.001; 60 Hz (F(1, 31) = 14.608; P < 0.002; Figure 16B),
and SVP increases (5 Hz: (F(1, 31) = 52.417; P < 0.001; 10 Hz: (F(1, 31) = 54.000; P < 0.001;
and 60 Hz (F(1, 31) = 8.590; P = 0.011; Figure 16C), and a significant interaction between
testing trial and drug dosage on BCM bursts for 60 Hz (F(1, 31) = 5.020; P = 0.042) stimulation.
Deltorphin II (1.3 nmol or 13 nmol) significantly increased numbers of BCM events, burst and
SVP increases following 5 Hz (events: 1.3 nmol: P < 0.001; 13 nmol: P = 0.006; bursts: 1.3
nmol: P < 0.001; 13 nmol: P < 0.001; SVP: 1.3 nmol: P < 0.001; 13 nmol: P < 0.001; Figure 16
A-E) and 10 Hz (events: 1.3 nmol: P < 0.001; 13 nmol: P < 0.001; bursts: 1.3 nmol: P < 0.001;
13 nmol: P < 0.001; SVP: 1.3 nmol: P < 0.001; 13 nmol: P < 0.001; Figure 16 C ) stimulation
frequencies. Deltorphin did also slightly increase BCM events following 30 Hz, but only after
the lower dosage, and without effects on BCM bursts or SVP increases and 60 Hz stimulation
frequencies (P = 0.012). Finally, the higher dose of deltorphin (13 nmol) reduced BCM activity
and SVP increases following 60 Hz DPN stimulation (events: P = 0.011; bursts: P < 0.001; SVP
increases: P = 0.011) compared to saline treatment in trial 1. As noted for each of the
experiments presented above, there were again no differences in BCM or SVP parameters
between groups during the saline control trial 1.
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Figure 16 Effects of Deltorphin II on the numbers of BCM events, bursts and SVP
increases in male rats.
Quantitative analyses of BCM events (A) bursts (B) and SVP increases (C) following infusion, 5
Hz, 10 Hz, 30 Hz and 60 Hz DPN stimulation after intrathecal infusions of saline in trial 1
(control trial; white bar) or deltorphin II (1.3 or 13 nmol) in trial 2 (drug trial; filled bars). Data
are presented as Mean SEM. Note absence of white bars for infusions, 5, and 10 Hz, as these
stimulation frequencies do not trigger BCM events, bursts, nor SVP increases in control
conditions.* denotes significant
ficant differences from trial 1 (control trial), while # indicates
significant differences from lower dosage within the same testing trial. EMG and SVP traces (90
seconds duration) following 5 Hz DPN stimulation (arrow) after an intrathecal infusion of saline
sal
(D: control trial) and deltorphin II (E: same animal as in D).

89

3.4 Discussion

The results of these experiments support the hypothesis that enkephalin plays a critical role in the
control of ejaculation by acting on mu and delta opioid receptors in LSt target areas in the
lumbosacral spinal cord. Antagonist studies showed that activation of either MOR or DOR is
critical for the emission and expulsion phases of ejaculation in response to sensory stimulation in
male rats. In addition, activation of either MOR or DOR by agonist administration at lower
dosages facilitated both the emission and expulsion phases of ejaculation following subthreshold sensory stimulation. Finally, stimulation of MOR, but not DOR was sufficient to
trigger ejaculatory reflexes in the absence of sensory stimulation in a large subset (75 %) of male
rats.
Together, these findings demonstrate that endogenous activation of MOR or DOR plays a
facilitative role in the control of ejaculation. However, infusions of higher dosages receptor
agonists for either the MOR or DOR disrupted ejaculation. This finding is in conformity with
previous studies which showed that systemic and intravenous morphine exerts inhibitory effects
on ejaculatory behavior (Myers and Baum, 1979; Szechtman et al., 1981; Wiesenfeld-Hallin and
Sodersten, 1984) and reflexes in male rats (Myers and Baum, 1979; Carro-Juarez and RodriguezManzo, 2009). The effects of morphine have been proposed to be partially mediated via actions
on peripheral tissues (Agmo et al., 1992). The current findings demonstrate that the inhibitory
effects of high doses of opioid receptor agonists are mediated via central actions within the
lumbosacral spinal cord. Noteworthy, our previous studies showed similar inhibitory effects of
higher doses of GRP agonists on ejaculatory reflexes, while lower doses of GRP agonists
triggered or facilitated ejaculation. Therefore, it is possible that high doses of GRP or opioid
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receptor ligands cause mechanisms of desensitization of the G-protein coupled receptors at the
LST target sites (Wess, 1997); thereby preventing the ability of DPN stimulation to trigger
further action of endogenous ligands on receptor activation. It is also possible that infusion of the
higher dose of mu and delta receptor agonists prevented DPN stimulation-induced ejaculatory
reflexes by acting on the processing of the sensory inputs relayed via the DPN. The DPN is
comprised of A δ and C-fibers (Johnson and Halata, 1991) but the specific contributions of A δ
and C-fibers to ejaculation have not been investigated. Intrathecal infusions of opioid agonists
inhibit A δ and C-fibers (Yeomans and Proudfit, 1996) raising the possibility that the disruption
of ejaculatory reflexes to threshold sensory stimulation after the higher dose but not the lower
dose of opioid agonists is mediated by inhibition of A δ and C-fibers in the dorsal horn of the
lumbosacral spinal cord. In addition, A δ and C-fiber neurons have cell bodies in the dorsal root
ganglia and express mu and delta opioid receptors (Ikoma et al., 2007) indicating that
presynaptic inhibition of DPN synaptic transmission may have contributed to disruption of
ejaculation. Finally, the primary excitatory neurotransmitter released from A δ and C-fibers is
glutamate (Russell, 2007) which activates NMDA receptors in LSt cells to trigger ejaculatory
reflexes in male rats (Staudt et al., 2011). Opioids in turn, can inhibit the release of glutamate
(Russell, 2007) thereby blocking the activation of LSt cells in the lumbosacral spinal cord.
One of the main findings of the current study was that infusion of the higher dose of
DAMGO (10 nmol) was sufficient to trigger ejaculatory reflexes in the absence of sensory
stimulation in a large proportion of male rats (75 %). Mu and delta opioid receptors are
inhibitory G-protein coupled receptors (Russell, 2007); therefore, it is likely that the mechanism
of action whereby endogenous opioids trigger or facilitate ejaculatory reflexes is by means of
inhibition of inhibitory neurons in LSt target regions. However, at this time, the localization of
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mu or delta opioid receptor in LSt target areas is unknown. Future studies identifying the exact
pre- or postsynaptic localization of these receptors are critical to elucidate the mechanisms by
which opioids influence ejaculatory function. For example, opioids can exert analgesia through
inhibition of inhibitory GABA (γ – aminobuteric acid) neurons (Basbaum and Fields, 1984).
Opioids inhibit GABA-mediated synaptic transmission by reducing the likelihood of presynaptic
neurotransmitter release (Capogna et al., 1993; Vaughan et al., 1997) and this effect is mediated
by voltage-dependent potassium conductance (Vaughan et al., 1997). Mu but not delta opioid
receptors are specifically coupled to this potassium conductance (Vaughan et al., 1997) and the
subsequent inhibition of GABAergic synaptic transmission; therefore we speculate that this may
explain that intrathecal infusions of DAMGO, a selective MOR agonist, but not deltorphin, a
selective DOR agonist, triggered ejaculatory reflexes in the absence of DPN stimulation.
However, localization of presynaptic MOR on LSt axons has not been confirmed.
A second main finding of the current study was intrathecal infusions of mu or delta
opioid antagonists CTOP or TIPP, severely disrupted ejaculatory reflex induced by DPN
stimulation that reliably triggered ejaculation under control conditions. Conversely, facilitation
of ejaculatory reflexes by infusions of mu or delta receptor agonists DAMGO or deltorphin, was
observed after DPN stimulation at sub-threshold parameters that do not trigger ejaculation in
control animals. Moreover, antagonist infusions did not disrupt activation of LSt cells, indicating
that opioid antagonists acted on neurons downstream from LSt cells, rather than on inputs to LSt
cells. These data support our hypothesis that endogenous opioids are primarily acting in LSt
target areas to regulate ejaculatory reflexes. As mentioned above, a critical next step is detailed
localization of the expression of mu and delta receptors within these LSt target areas. The
findings that both mu and delta receptors are involved in mediating ejaculation, indicates that
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enkephalin may act on both receptors. Indeed, studies have shown that opioid receptors may
form heterodimers (Gomes et al., 2000; Pfeiffer et al., 2003). In addition, activation of delta
receptors influences subsequent activation of mu receptors. Indeed, mu and delta opioid
receptors demonstrate a high degree of sequence homology and a common opioid receptor
binding site within the helical transmembrane core has been proposed to account for the liganddirected signaling or biased agonism which occurs at opioid receptors (Pradhan et al., 2012).
In addition to forming complex interaction between mu and delta receptors, opioid
receptors also form complex interaction with other GPCR. We have previously shown that GRP
regulates ejaculatory reflexes, showing findings similar to those described here. Thus, it is
possible that a complicated interplay exists between the actions of co-expressed neuropeptides,
including enkephalin and GRP (Kozyrev et al., 2012), in LSt cells and axons, such that corelease of multiple neuropeptides may be required to induce ejaculation, but inhibition of each
one alone may disrupt ejaculation.
In conclusion, these data support the hypothesis that activation of mu and delta opioid
receptors in the lumbosacral spinal cord is required for sensory stimulation-induced emission and
expulsion in anesthetized and spinalized male rats. The endogenous opioid ligand enkephalin
may act through the activation of both mu and delta receptors in the outputs of the LSt cells.
However, precise localization of mu and delta opioid receptor expression in the spinal
ejaculation generator is currently unknown and needs to be elucidated in future studies.
Furthermore, the roles of other neuropeptides expressed in the LSt cells and axons, including
galanin and cholecystokinin, in the control of ejaculation remain an open question. Finally, these
data indicate that mu and delta opioid antagonists may be useful for the treatment of ejaculatory
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dysfunction, specifically to delay the onset of ejaculation in men afflicted with premature
ejaculation.
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Chapter 4: Activation of galanin and cholecystokinin
receptors in the lumbosacral spinal cord is required for
ejaculatory reflexes in male rats

95

4.1

Introduction

Ejaculation refers to the forceful discharge of seminal contents from the urethral meatus
(Marberger, 1974; McKenna, 1999) and consists of two phases: emission and expulsion.
Emission refers to the secretion of seminal fluids from the prostate, seminal vesicles and vas
deferens and these processes are under the control of parasympathetic preganglionic neurons in
the sacral parasympathetic nucleus (SPN) in the upper sacral spinal cord (Hancock and Peveto,
1979b; Nadelhaft and Booth, 1984; Coolen et al., 2004). In addition, emission involves the
contraction of the ductus deferes and closure of the bladder neck, in order to prevent retrograde
ejaculation, and these processes are under the control of sympathetic preganglionic neurons in
the intermediolateral cell column (IML) and dorsal central autonomic nucleus (DCN) in the
thoracolumbar spinal cord (Hancock and Peveto, 1979a; Nadelhaft and McKenna, 1987; Baron
and Janig, 1991; Coolen et al., 2004). The expulsion component is characterized by rhythmic
contractions of the striated perineal muscles, particularly the muscle of the bulbocavernosus
(BCM), accompanied by the forceful expulsion of semen from the urethral meatus and is under
sympathetic and motor control (Bohlen et al., 1980; Gerstenberg et al., 1990; Holmes et al.,
1991; Holmes and Sachs, 1991; Coolen et al., 2004). Motorneurons that control the rhythmic
contraction of the BCM are located in the spinal nucleus of the bulbocavernosus (SNB) in the
lumbosacral spinal cord in male rats (Schroder, 1980; McKenna and Nadelhaft, 1986; Ueyama et
al., 1987). It well established that ejaculation is a spinal reflex and the essential components that
control this reflex are localized to the lumbosacral spinal cord (Pescatori et al., 1993; McKenna,
1999). This spinal control center is referred to as the spinal ejaculation generator (Marberger,
1974; McKenna, 1999; Truitt and Coolen, 2002; Truitt et al., 2003; Staudt et al., 2010; Staudt,
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2011; Staudt et al., 2011; Kozyrev et al., 2012; Kozyrev, 2013c) and contols ejaculation through
a complex coordination of the sympathetic, parasympathetic, and motor components required to
facilitate emission and expulsion (Coolen et al., 2004; Coolen, 2005; Staudt et al., 2010; Staudt,
2011; Kozyrev et al., 2012; Kozyrev, 2013c) with sensory inputs during sexual activity. The
latter are primarily relayed via the dorsal penile nerve (DPN) (Coolen et al., 2004; Coolen, 2005;
Staudt et al., 2010; Staudt, 2011; Kozyrev et al., 2012; Kozyrev, 2013c) . The spinal ejaculation
generator is composed of lumbar spinothalamic (LSt) cells, in lamina 10 and the medial portion
of lamina 7 of lumbar segments 3 and 4, (L3-4). LSt cells are essential for ejaculation
(McKenna, 1999; Truitt and Coolen, 2002) which they trigger via projections to DCN, IML,
SPN, and SNB (Newton, 1993; McKenna, 1997; Truitt and Coolen, 2002; Coolen et al., 2004;
Allard et al., 2005; Sakamoto et al., 2008; Sun et al., 2009; Young et al., 2009; Kozyrev et al.,
2012; Kozyrev, 2013c). The LSt cells express the neuropeptides galanin, cholecystokin (CCK),
enkephalin and gastrin-releasing peptide (GRP) (Ju et al., 1987; Nicholas et al., 1999; Coolen et
al., 2003; Sakamoto et al., 2008). It is hypothesized that LSt cells transform sensory signals
conveyed by the DPN associated with the summation of coitus into motor or secretory outputs to
trigger emission and expulsion (Truitt and Coolen, 2002). There is abundant evidence to support
the notion that LSt cells are an integral component of the spinal ejaculation generator and are
essential for ejaculation. Firstly, it has been shown that LSt cells express cFos (Truitt et al.,
2003) and phosphorylated extracellular signal-regulated kinases 1 and 2 (pERK) (Staudt et al.,
2010), markers of neural activation, exclusively with ejaculation but not with other components
of male rat sexual behavior (Truitt et al., 2003). Secondly, acute transection of the spinal cord at
the mid-thoracic spinal segments followed by electrical stimulation of the DPN triggers
ejaculatory reflexes in male rats (Staudt et al., 2010; Staudt, 2011; Staudt et al., 2011; Kozyrev et
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al., 2012; Kozyrev, 2013c). Thirdly, LSt cells display neural activation, specifically pERK
(Staudt et al., 2010) and phosphorylated NMDA receptor subunit 1 (pNR1) (Staudt et al., 2011)
following stimulation of the DPN, akin to mating animals. This neural activation is critical for
ejaculation in male rats since blocking ERK and NMDA receptor activation with specific
antagonists resulted in the absence of a coordinated pattern of BCM bursting, representative of
ejaculation, after electrical stimulation of the DPN (Staudt et al., 2010, 2011). Similarly, targeted
ablation of LSt cells completely abolished ejaculation but did not affect mounts or intromissions
in male rats (Truitt and Coolen, 2002).
LSt cells co-express several neuropeptides including gastrin releasing peptide (GRP),
enkephalin, galanin and cholecystokin (CCK) (Ju et al., 1987; Nicholas et al., 1999; Coolen et
al., 2003; Truitt et al., 2003; Sakamoto et al., 2008; Kozyrev et al., 2012). Therefore we
hypothesized that these neuropeptides are released from LSt cell axon terminals onto receptors of
preganglionic sympathetic (IML and CAN), parasympathetic (SPN) and motor (SNB) neurons to
modulate ejaculatory reflexes. Indeed, our laboratory has recently revealed a critical role for the
GRP and the mu and delta opioid receptors in the control of ejaculation in male rats (Kozyrev et
al., 2012; Kozyrev, 2013c). It was discovered that intrathecal infusions of the GRP antagonist
RC-3095, mu and delta opioid receptor antagonists CTOP and TIPP, respectively, severely
disrupted ejaculatory reflexes in male rats. Conversely, intrathecal infusion of GRP agonist
GRP2029 or the opioid receptor agonist DAMGO triggered ejaculatory reflexes in 43-66 % and 75
% of male rats respectively. In addition, intrathecal infusion of GRP2029, the delta receptor
agonist deltorphin II or DAMGO facilitated ejaculatory reflexes following subthreshold levels of
DPN stimulation in 100 % of male rats (Kozyrev et al., 2012; Kozyrev, 2013c).
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The purpose of the current study was to test the respective roles of galanin and CCK in the
control of ejaculatory reflexes in male rats. It was hypothesized that LSt cells release galanin and
CCK from their axon terminals onto their target regions, is critical for triggering the emission
and expulsion components of ejaculation. The current study aimed to investigate the individual
contributions of galanin and cholecystokin receptor activation in the control of emission and
expulsion reflexes induced by electrical stimulation of the DPN in anesthetized and spinalized
male rats, and simultaneously recordings of seminal vesicle (SV) pressure and concurrent
rhythmic contractions of the BCM, markers of emission and expulsion respectively.

4.2 Materials and Methods

4.2.1

Animals

For these experiments, adult male Sprague Dawley rats (225-250 grams) were obtained from
Charles River (Wilmington, MA, USA) and housed in pairs in standard housing cages on a
reverse 12-hour light/dark cycle with lights off at 9 a.m. Food and water were available ad
libitum. All procedures were approved by the University Committee on Use and Care of Animals
at the University of Michigan and conformed to the guidelines outlined by the National Institutes
of Health.
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4.2.2

Experimental Designs

4.2.2.1 Intrathecal infusions of Galanin or Cholecystokinin antagonists

Procedures were identical to our previously described studies(Brumovsky et al., 2006). Male rats
were deeply anesthetized with urethane (1.5 g/kg, i.p.), a laminectomy was performed between
the sixth and the eighth thoracic spinal segments and a complete transaction of the spinal cord
was performed at the same spinal level. Next, the bulbocavernosus muscle (BCM) and the dorsal
penile nerve (DPN) were surgically exposed and the surrounding connective tissue was removed.
Subsequently, silver recording electrodes, attached to the PowerLab/7SP Data Acquisition
System (AD Instruments, Inc., Colorado Springs, CO, USA) were inserted bilaterally into the
BCM and a ground electrode was placed into the muscle of the right thigh in preparation for
electromyographic (EMG) recordings. Additionally, the right seminal vesicle was exposed by
coeliotomy for the purpose of measuring and recording seminal vesicle (SV) pressure, an marker
of the emission component of ejaculation (Clement et al., 2008; Kozyrev et al., 2012; Kozyrev,
2013c). SV pressure (SVP) was measured with a pressure catheter (AD Instruments Inc., model
number: SPR-671(1.4 F, Single, Straight, 15 cm, Ny) attached to a catheter interface cable (AD
Instruments Inc., model number: AEC-IOD) and connected to a Bridge AMP (AD Instruments
Inc.). The pressure catheter was carefully inserted into the lumen of the SV and secured in place
prior to recording. In preparation for stimulation of the DPN, a bipolar stimulating electrode
connected to the SD9 Square Pulse Stimulator (Grass Technologies, West Warwick, RI, USA)
was positioned directly above the DPN. Initial stimulation of the DPN was performed
immediately after spinal cord transection was in order to verify that the spinal cord transection is
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complete, as evidenced by rhythmic bursting of the BCM and simultaneous SVP increases.
Initial electrical stimulation of the DPN comprised square wave pulses of 1 ms duration, 4 V at
60 Hz for 10 seconds. These established DPN stimulation parameters reliably trigger rhythmic
bursting of the BCM, corresponding to the expulsion phase of ejaculation, in all saline-treated
control animals (Staudt et al., 2010; Staudt, 2011; Staudt et al., 2011; Kozyrev et al., 2012;
Kozyrev, 2013c). Pharmacological experiments began two hours after spinal cord transection in
order to allow the acute effects of spinal cord transection to subside. Next, a small incision was
made in the dura mater at the site of the laminectomy and a polyethylene catheter (Caly-Adams
PE-10, Parsippany, NJ, USA) was carefully inserted into the subarachnoid space until the open
end reached the 3rd lumbar-4th lumbar (L3-L4) spinal segments.
In each animal, in trial 1, 10 µL of 0.9% sterile saline (or 0.9% sterile saline solution mixed with
a small amount of dimethyl sulfoxide (DMSO) for animals subsequently treated with galantide)
was infused through the polyethylene catheter to bath the entire lumbosacral spinal cord and
BCM EMG activity was recorded for 25 minutes. Following the saline infusion, the DPN was
stimulated at 30 Hz and 60 Hz in a counterbalanced order, with 5-minute rest periods between
the stimulations (testing trial 1; control trial). Recordings of BCM EMG and SVP spanned a
period of 90 seconds, corresponding to the duration of a representative ejaculatory reflex
triggered by DPN stimulation in male rats (Staudt et al., 2010; Staudt, 2011; Kozyrev et al.,
2012; Kozyrev, 2013c). The entire procedure was repeated one hour later in the same animals,
which now received a 10 µL infusion of one of two doses of the galanin antagonist galantide
dissolved in a solution of 0.9 % sterile saline mixed with a small amount of DMSO (1 nmol, N =
8; 10 nmol, N = 8; and N=6 in a second experiment [Phoenix Pharmaceuticals Inc. USA,
Burlingame, CA, USA]), or one of two doses of the cholecystokinin (CCK) antagonist
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proglumide (71 nmol, N = 6; 714 nmol, N = 6 [Sigma-Aldrich Corp. St. Louis, MO, USA]).
After drug infusion, BCM EMG and SVP were recorded for 25 minutes, followed by stimulation
of the DPN at 30 Hz and 60 Hz in a counterbalanced order, and concurrent recordings of BCM
EMG and SVP (testing trial 2; drug trial). Our previous experiments have demonstrated that
saline infusions or repeated DPN stimulations do not affect parameters of ejaculatory reflex
(Kozyrev et al., 2012; Kozyrev, 2013c).

4.2.2.2 Intrathecal infusions of galanin or cholecystokinin

Three separate groups of male rats were anesthetized, spinalized, and prepared as described
above. In testing trial 1: control trial, male rats received 10 µL intrathecal infusions of 0.9%
saline (N = 20) or 0.9% saline mixed with DMSO (N = 8; CCK group) and BCM EMG and SVP
were recorded for 10 minutes after infusion. Next, the DPN was stimulated at 5 HZ, 10 HZ, 30
HZ and 60 HZ in a randomized and counterbalanced order, and BCM EMG and SVP were
recorded for the duration of 90 seconds following stimulation (testing trial 1; control trial). One
hour following the final DPN stimulation, the procedure was repeated in the same groups of
animals, which now received 10 µL intrathecal infusions of one of two doses of galanin (0.16
nmol, N = 6 and N = 7 in a second experiment; 0.32 nmol, N = 7 (Bachem Americas, Inc.
Torrance, CA, USA)] or CCK dissolved in 0.9% sterile saline and DMSO solution [CCK (26-33)
(sulfated), 4.35 nmol; N = 8] (Phoenix Pharmaceuticals Inc. USA, Burlingame, CA, USA) and
BCM EMG and SVP were recorded for 10 minutes after infusion. Following each drug infusion,
the DPN was stimulated at 5, 10, 30, and 60 HZ in a counterbalanced order as described
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previously (testing trial 2 and 3; drug trials) (Kozyrev et al., 2012). Our previous studies have
demonstrated that saline infusions or repeated DPN stimulations do not affect parameters of
ejaculatory reflex (Kozyrev et al., 2012; Kozyrev, 2013c).

4.2.3

BCM EMG and SVP Analysis

Analyses were performed as described in or previous studies (Staudt et al., 2010; Kozyrev et al.,
2012; Kozyrev, 2013c). Analysis of BCM EMG and SVP recordings spanned 25 minutes or 10
minutes after infusion of the antagonist or agonist, respectively, and 90 seconds after every DPN
stimulation. The numbers of BCM events, bursts, and SVP increases were analyzed. The analysis
of numbers of BCM events was carried out using LabChart 7.35 (AD Instruments Inc.), and all
events that were above baseline activity were included in the analysis (Staudt et al., 2010; Staudt,
2011; Staudt et al., 2011; Kozyrev et al., 2012; Kozyrev, 2013c). Additionally, the numbers of
bursts and SVP increases were analyzed. The antagonist experiments were analyzed such that the
effects of antagonist treatments on the numbers of events, bursts and SVP increases were
compared within animals (within the same drug dose, between testing trial 1: control trial and
testing trial 2: drug trial) and between groups (between different doses within testing trial 1:
control trial and testing trial 2: drug trial), for the 30 and 60 Hz stimulations separately, using
two-way repeated anova (factors: Testing trial and Drug dose) and Holm-Sidak post hoc tests.
The galanin infusion experiments were analyzed such that the effects of neuropeptide treatment
on the numbers of events, bursts and SVP increases were compared within animals (within the
same drug dose, between testing trial 1: control trial and testing trial 2: drug trial) and between
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treatment groups (separately for each stimulation setting: Infusion, 5 Hz, 10 Hz, 30 Hz, and 60
Hz), and separately for each of the two testing trials, using a two-way repeated anova (factors:
Testing trial and DPN stimulation) and Holm-Sidak post hoc tests. A 95% confidence level was
utilized for all tests. The cholecystokinin experiment was analyzed using a two-way repeated
anova and the effects of CCK treatment on the numbers of events, bursts and SVP increases were
compared within testing trials (with the saline and drug trials) and between stimulation settings
(Infusion, 5 Hz, 10 Hz, 30 Hz, and 60 Hz) as well as between the two testing trials within each
stimulation setting using a two-way repeated anova (factors: Testing trial and DPN stimulation)
and Holm-Sidak post hoc tests.

4.2.4

Immunohistochemistry Experiments

4.2.4.1 DPN Stimulation-induced pERK after intrathecal opioid receptor antagonist treatment

To confirm that the galanin antagonist galantide and the CCK antagonist proglumide disrupted
ejaculatory reflexes by acting on LSt target regions and not by preventing the activation of LSt
cells, the expression of pERK in LSt cells was examined following intrathecal infusions of
galantide or proglumide and stimulation of the DPN (Staudt et al., 2010; Kozyrev et al., 2012;
Kozyrev, 2013c). Male rats (N = 9) were anesthetized and spinalized as described above. Two
hours after spinalization, the DPN and BCM were exposed and galantide (10 nmol, N =4) or
proglumide (714 nmol, N = 2) were infused in a volume of 10 µL intrathecally as described
previously. Following a 25-minute infusion, the DPN was stimulated at 30 Hz and BCM EMG
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and SVP were recorded for 90 seconds. Five minutes following DPN stimulation, animals were
perfused transcardially with 5 mL 0.9% saline solution and 500 mL of 4% paraformaldehyde in
0.1 M PB. Spinal cords were removed and postfixed for 1 hour in the same fixative and then
transferred into a cryoprotective solution (20% sucrose in 0.1 PB with 0.01% sodium azide) until
further processing for immunohistochemical visualization of pERK and galanin. The stimulation
parameters and time of perfusion were previously shown to be optimal for detection of pERK
expression in LSt cells (Staudt et al., 2010; Kozyrev et al., 2012; Kozyrev, 2013c). In addition, it
was previously shown that intrathecal infusions of saline do not prevent DPN stimulation
induced pERK experession in LSt cells (Kozyrev et al., 2012; Kozyrev, 2013c). Furthermore,
previous experiments have shown that spinal cord transection and the surgical exposure of the
DPN and the BCM without electrical stimulation of the DPN does not lead to pERK expression
in LSt cells (Staudt et al., 2010), hence negative control groups were not included in this
experiment.

4.2.5

Immunohistochemistry: Galanin/pERK dual fluorescence

Spinal cords were sliced with a freezing microtome (Thermo Fisher Scientific, Walldorf,
Germany) into 12 parallel series of 35 um coronal sections, placed into a cryoprotectant solution
(30% sucrose, 30% ethylene glycol in 0.1 M PB with 0.01% sodium azide) and stored at -20°C
until further processing. Free floating sections of the lower thoracic, lumbar, and sacral spinal
cord were thoroughly rinsed in 0.1 M saline buffered sodium phosphate (PBS) between
incubations and blocked with 1% H2O2 for 10 minutes prior to incubation. All antibody
incubations were performed in incubation solution containing 0.1% bovine serum albumin and
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0.4% Triton X-100 (BP151-500, Thermo Fisher Scientific Inc, Pittsburgh, PA, USA) in PBS at
room temperature with gentle agitation. Spinal cord sections were incubated overnight with
rabbit anti-pERK (1:1,000; overnight; Cell Signaling #26 L) and with biotinylated goat antirabbit for one hour (1:500; Vector Laboratories, Burlingame, CA, USA), avidin horseradish
peroxidase complex (ABC-elite, 1:1,000 in PBS; 1 hour;Vector Laboratories), biotinylated
tyramine (BT; 1:250 in PBS containing 1 uL/mL of 3% H2O2 for 10; NEL700/700A;
PerkinElmer Life Sciences, Boston, MA, USA), and Alexa 488-conjugated streptavidin (1:100 in
PBS, 30 minutes (Jackson ImmunoResearch Laboratories, West Grove, PA, USA). Next,
sections were incubated with rabbit anti-galanin (1:3,000; overnight, T-4334; Bachem, Torrance,
CA, USA) and Alexa 555-conjugated goat anti-rabbit for 30 minutes in PBS (1:100; Jackson
Immuno-Research Laboratories) and mounted on plus charged slides, cover-slipped with
gelvatol and stored in the dark at 4°C. For all immunohistochemistry procedures, the omission of
primary antibodies resulted in a complete loss of signal at specific wavelengths and all primary
antibodies have been previously characterized (Truitt et al., 2003; Staudt et al., 2010, 2011;
Kozyrev et al., 2012; Kozyrev, 2013c).

4.2.6

Data Analysis

4.2.6.1 pERK Expression in LSt Cells

pERK expression in LSt cells was analyzed using a DM5000B Leica fluorescent microscope
(Leica Microsystems, Wetzlar, Germany). Essentially, all neurons in the lumbar spinal cord
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expressing galanin-ir were analyzed for expression of pERK and percentages of galanin-ir cells
co-expressing pERK were calculated for each animal. Differences between groups were analyzed
using ANOVA and Holms-Sidak post hoc tests.

4.3 Results

4.3.1

Galantide Suppressed Ejaculatory Reflexes

The galanin antagonist galantide significantly suppressed DPN stimulation-induced ejaculatory
reflexes at both 30 and 60 Hz stimulation frequencies as evidenced in the reduced numbers of
BCM events, and bursts. There were main effects of testing trial on the numbers of BCM events
for both 30 Hz (F (1, 29) = 50.905; P < 0.001; Figure 16A) and 60 Hz stimulation frequencies (F
(1, 29) = 30.213; P < 0.001; Figure 17A). Post hoc analyses revealed that animals treated with
either dose of galantide during the second trial (drug trial) had significantly decreased BCM
events in response to 30 and 60 Hz DPN stimulations compared to saline treatment in their first
control trial (trial 1; 30 Hz: P = 0.003 (1 nmol); P < 0.001 (10 nmol); 60 Hz: P = 0.008 (1 nmol);
P <0.001 (10 nmol); Figure 17A, C, D). In addition, animals treated with the higher dose of
galantide during trial 2 displayed significantly fewer BCM events in response to 60 Hz (trial 1; P
= 0.022 [10 nmol]) DPN stimulation frequency compared to saline treatment in trial 1 (Figure 17
A, C, D). None of these effects were attributable to pre-existing group differences, as in control
trial 1, when all animals received saline there were no significant differences in the numbers of
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BCM events in response to either 30 or 60 Hz DPN stimulations between groups (control trial;
Figure 17 A, C).
The effects of galantide on BCM bursts paralleled the effects on BCM events. There were
main effects of testing trial on the numbers of BCM bursts for both 30 Hz (F(1, 29) = 100.213; P
< 0.001) and 60 Hz (F(1, 29) = 218.400; P < 0.001) stimulation frequencies (Figure 17 B).
Specifically, male rats treated with either dose of galantide during trial 2 (drug trial)
demonstrated significantly fewer BCM bursts compared to trial 1 (control trial) with saline
treatment (trial 1; 30 Hz: P < 0.001 [1 nmol]; P < 0.001 [10 nmol]; 60 Hz: P < 0.001 [1 nmol]; P
< 0.001 [10 nmol]; Figure 17 B, C, D). In addition, there were significant interactions between
factors of testing trial and drug dosage on the number of BCM bursts for both 30 Hz (F(1, 29) =
4.916; P = 0.045) and 60 Hz (F(1, 29) = 6.067; P = 0.029) stimulation frequencies. Post hoc
analyses demonstrated that male rats treated with the higher dose of galantide during trial 2 (drug
trial) had significantly fewer BCM bursts in response to 60 Hz (trial 2: P = 0.041 [10 nmol])
DPN stimulation frequency compared to trial 1 (Figure 17 B, C, D). There were no significant
differences in the numbers of BCM bursts after 30Hz or 60 Hz DPN stimulation within testing
trial 1, control trial, indicating that differences in dosage in trial 2 (drug trial) were due to the
effects of galantide (Figure 17 B, C).
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Figure 17 Effects of galantide on numbers of BCM events and bursts in male rats.
Quantitative analyses and accompanying EMG traces of BCM events and bursts following
intrathecal infusions of galantide. Quantitative analysis of BCM events ((A)) and bursts (B)
( in
response to 30 and 60 Hz DPN stimulation following infusions of saline in trial 1 (control trial)
or one of two doses of galantide (1 or 10 nmol) in tri
trial
al 2 (drug trial). EMG traces of 90 seconds
duration following 60 Hz DPN stimulation (arrow) after an intrathecal infusion of saline (C:
(
control trial) and galantide (D:: same animals as in C).
). * denotes significant differences from trial
1 within the same treatment group, while # indicates significant differences between treatment
groups within the same testing trial.
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The effects of galantide on SVP increases, a marker of the emission component of
ejaculation, was tested in a separate group of animals in which BCM EMG and SVP were
recorded simultaneously following intrathecal infusion of the higher dose of galantide (10 nmol)
(N = 6). The effects on BCM events and bursts were completely replicated, and moreover were
paralleled by significant decreases in numbers of SVP increases. There were main effects of
testing trial on the numbers of BCM events (F(1, 23) = 30.227; P = 0.003), BCM bursts (F(1,
23) = 53.382; P < 0.001) and SVP increases (F(1, 23) = 110.401; P < 0.001). Post hoc analyses
revealed that male rats treated with galantide in trial 2 showed significantly fewer numbers of
BCM events, bursts and SVP increases for both 30 Hz (events: P = 0.004; bursts: P < 0.001
(Figure 18A); SVP: P < 0.001; Figure 18B) and 60 Hz (events: P = 0.001; bursts: P <
0.001(Figure 18A); SVP: P < 0.001; Figure 18B, C, D) stimulation frequencies compared to
saline treatment in trial 1. Overall, these results confirm that intrathecal galantide suppresses
both the emission and expulsion components of ejaculation, indicating that activation of galanin
receptors in the lumbosacral spinal cord is required for ejaculatory reflexes in male rats.
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Figure 18 Effects of galantide on the numbers of BCM bursts and SVP increases in male
rats.
alyses and accompanying EMG traces of BCM bursts and SVP increases
Quantitative analyses
following intrathecal infusions of galantide. Quantitative analysis of BCM bursts (A)
( and SVP
increases (B)) in response to 30 and 60 Hz DPN stimulation following infusions of saline in trial
tria
1 (control trial) or galantide (10 nmol) in trial 2 (drug trial). EMG and concurrent SVP traces of
90 seconds duration following 60 Hz DPN stimulation (arrow) after an intrathecal infusion of
saline (C:: control trial) and galantide ((D: same animals as in C).
). * denotes significant differences
from trial 1 (control trial).
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4.3.2

Proglumide Dose-Dependently Suppresses Ejaculatory Reflexes

The CCK antagonist proglumide dose-dependently disrupted DPN stimulation-induced
ejaculatory reflexes in response to 30 and 60 Hz stimulation frequencies as reflected in the
reduced numbers of BCM events, bursts, and SVP increases. There were main effects of testing
trial on the numbers of BCM events for both 30 Hz (F(1, 23) = 23.289; P < 0.001) and 60 Hz
(F(1, 23) = 5.446; P = 0.042) stimulation frequencies. Post hoc analyses revealed that animals
treated with the higher but not the lower dose of proglumide during the second trial (drug trial)
had significantly decreased BCM events in response to 30 and 60 Hz DPN stimulation compared
to saline treatment in the first control trial (30 Hz: P < 0.001 (714 nmol); 60 Hz: P = 0.020 (714
nmol); Figure 19A).
There was also a main effect of drug dosage on the numbers of BCM events following 60
Hz DPN stimulation (F(1, 23) = 5.025; P = 0.049) and a significant interaction between factors
of drug dosage and testing trial on the numbers of BCM events following 30 Hz DPN stimulation
(F(1, 23) = 9.846; P = 0.011). Post hoc analyses revealed that male rats treated with the higher
dose of proglumide (714 nmol) during trial 2 (drug trial) displayed significantly fewer BCM
events following 30 Hz (P = 0.015) and 60 Hz DPN stimulation frequencies (P = 0.018)
compared to animals that received the lower dose of proglumide (71 nmol); Figure 19A. There
were no significant differences in the numbers of BCM events in response to 30 or 60 Hz DPN
stimulation frequencies between the groups during trial 1 (control trial) when both groups of
animals received infusions of saline (Figure 19A).
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Figure 19 Effects of proglumide on the numbers of BCM events, bursts and SVP increases
in male rats.
lyses and accompanying EMG traces of BCM events, bursts and SVP increases
Quantitative analyses
following intrathecal infusions of proglumide. Quantitative analysis of BCM events (A),
(A) bursts
(B) and SVP increases (C) in response to 30 and 60 Hz DPN stimulation following infusions
infusio of
saline in trial 1 (control trial) or one of two doses of proglumide (71 or 714 nmol) in trial 2 (drug
trial). EMG traces of 90 seconds duration following 60 Hz DPN stimulation (arrow) after an
intrathecal infusion of saline (D: control trial) and gal
galantide
antide (E: same animals as in C). * denotes
significant differences from trial 1 within the same treatment group, while # indicates significant
differences between treatment groups within the same testing trial.

113

Similarly, there were main effects of testing trial on the numbers of BCM bursts for 60
Hz (F(1, 23) = 6.680; P = 0.027) stimulation frequency, and for drug dosage on the numbers of
BCM bursts for 30 Hz (F(1, 23) = 8.007; P = 0.018) DPN stimulation frequency. Post hoc
analyses revealed that male rats that received infusions of the higher dose (714 nmol) of
proglumide during testing trial 2 (drug trial) displayed significantly fewer BCM bursts following
30 Hz (P = 0.022; Figure 19B) and 60 Hz (P = 0.014; Figure 19B, D, E) DPN stimulation
frequencies. Furthermore, male rats treated with the higher dose (714 nmol) of proglumide
showed a significant reduction in the numbers of BCM bursts following 30 Hz (P = 0.003) with
a trend towards significance following 60 Hz (P = 0.062) DPN stimulation frequency compared
to male rats treated with the lower dose of proglumide (71 nmol; Figure 19B). There were no
significant differences between the groups in the numbers of BCM bursts following 30 or 60 Hz
DPN stimulations during trial 1 (control trial; Figure 19B).
In addition, intrathecal infusions of proglumide dose-dependently suppressed SVP
increases. There were main effects of testing trial on the numbers of SVP increases following 30
Hz (F(1, 23) = 10.565; P = 0.009) and 60 Hz (F(1, 23) = 6.288; P = 0.031) stimulation
frequencies. Post hoc analyses demonstrated that the higher dose (714 nmol) of proglumide
significantly reduced numbers of SVP increases following 30 Hz (P = 0.012; 714 nmol; Figure
19C) and 60 Hz (P = 0.014; 714 nmol; Figure 19C) stimulation frequencies. Furthermore, there
was an effect of dosage during trial 2 (drug trial) whereby animals receiving the higher dose of
proglumide (714 nmol) displayed significantly fewer SVP increases in response to 30 Hz (P =
0.039; Figure 19C) and 60 Hz (P = 0.021; Figure 19C, D, E) stimulation frequencies. Finally,
there were no differences between groups during trial 1 (control trial; Figure 19C).
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4.3.3

Galantide and Proglumide Did Not Prevent DPN Stimulation-Induced pERK in LSt
Cells

In order to test that the galanin antagonist galantide and the CCK antagonist proglumide
suppressed BCM bursting and SV pressure by acting in LSt target areas instead of acting directly
on LSt cells, DPN stimulation-induced neural activation of LSt cells was examined following
intrathecal infusions of each antagonist. It has previously been shown that in control treated
animals, DPN stimulation induced pERK in 97 ± 0.03 % of LSt cells (Kozyrev et al., 2012).
Similarly, intrathecal infusions of galantide and proglumide did not prevent DPN stimulationinduced activation of LSt cells. Indeed, DPN stimulation induced pERK in 94.05 ± 0.03% and
87.93 ± 0.07 % of LSt cells in galantide (10 nmol) and proglumide (714 nmol) treated male rats,
respectively. These results indicate that galantide and proglumide are primarily acting in LSt
target regions to suppress the emission and expulsion components of ejaculation, and not directly
on LSt cells.

4.3.4

Galanin Facilitated BCM Events, Bursts and SVPs

In control trial 1, it was confirmed that 30 and 60 Hz DPN stimulation triggered BCM
events and burst, while saline infusion or DPN stimulation at 5 and 10 Hz did not trigger BCM
activity. In Trial 2, galanin facilitated BCM events, bursts and SVP increases. There were main
effects of testing trial on the numbers of BCM events for Infusion: (F(1, 25) = 17.937; P =
0.001); 5 Hz: (F(1, 25) = 17.853; P = 0.001; 10 Hz: (F(1, 31) = 54.000; P < 0.001) stimulation
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frequencies. Post hoc tests demonstrated that infusions of the lower dose of galanin, in the
absence of DPN stimulation, during trial 2 (drug trial) increased number of BCM events
e
(0.15
nmol P = 0.003; 0.3 nmol; P=0.051) compared to trial 1 (control trial; Figure 20A).
20
Moreover,
galanin facilitated BCM events after sub threshold DPN stimulation in male rats treated with
either dose of galanin demonstrated significantly greater numbers of BCM events following 10
Hz (0.15 nmol: P < 0.001; 0.3 nmol: P < 0.001; Figure 20A)
A) DPN stimulation. There was an
effect of dosage for the 5 Hz stimulation frequency during trial 2 (drug trial). Specifically,
animals treated with the higher dose of galanin demonstrated significantly greater numbers of
BCM events following 5 Hz DPN stimulation compared to animals treated with the lower dose
of galanin (0.3 nmol: P = 0.014; Figure 20
20A).
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Figure 20 Effects of galanin on numbers of BCM events and bursts in male rats
Quantitative analyses and accompanying EMG traces of BCM events and bursts following
intrathecal infusions of galanin. Quantitative analysis of BCM events (A) and bursts (B) in
response to infusion and DPN stimulation at 5 Hz, 10 Hz, 30 Hz and 60 Hz (counterbalanced)
following infusions of saline in trial 1 (control trial) or one of two doses of galanin (0.15 or 0.3
nmol) in trial 2 (drug trial). EMG traces of 90 seconds duration following 10 Hz DPN
stimulation (arrow) after an intrathecal infusion of saline (C: control trial) and galanin (D: same
animals as in C). * denotes significant differences from trial 1 within the same treatment group,
while # indicates significant differences between treatment groups within the same testing trial.
The effects of galanin on BCM bursts were similar to the effects on BCM events, except
that galanin infusions in the absence of DPN stimulation did not trigger BCM bursting activity.
However, galanin did facilitate BCM bursts induced by DPN stimulation. There were main
effects of testing trial on the numbers of BCM bursts for 5 Hz: (F(1, 25) = 31.406; P < 0.001 and
10 Hz: (F(1, 25) = 30.305; P < 0.001) stimulation frequencies. There were also main effects of
drug dosage for 5 Hz (F(1, 25) = 17.453; P = 0.002; 10 Hz: (F(1, 25) = 16.183; P = 0.002) and
60 Hz (F(1, 25) = 9.739; P = 0.010) stimulation frequencies. and significant interactions between
the factors for 5 Hz (F(1, 25) = 17.453; P = 0.002; 10 Hz: (F(1, 25) = 16.183; P = 0.002 and 30
Hz (F(2, 25) = 6.119; P = 0.018). Post hoc tests revealed that the higher dose (0.3 nmol) of
galanin during trial 2 (drug trial) significantly increased numbers of BCM bursts following 5 Hz
(P < 0.001), 10 Hz (P < 0.001), 30 Hz (P < 0.001), and 60 Hz (P=0.049) stimulation frequencies
compared to trial 1 (control trial) (Figure 20B, C, D). Post hoc analyses demonstrated that male
rats treated with the higher dose of galanin in trial 2 (drug trial: 0.3 nmol) had significantly more
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BCM bursts compared to the lower dose of agalnin (0.15 nmol) (5 Hz: P < 0.001; 10 Hz: P <
0.001; 30 Hz: P = 0.004; and 60 Hz: P = 0.006; Figure 20B).
Effects of galanin (0.3 nmol) in SVP increases were tested in a separate group of male
rats (N = 7) with simulatenous recordings of SVP and BCM EMG. In this group of animals,
intrathecal infusions of galanin (0.3 nmol) facilitated both the emission and expulsion
components of ejaculation as evidenced in the increased numbers of BCM events, bursts and
SVP increases following subthreshold levels (5-10 Hz) of DPN stimulation. First, there were
main effects of stimulation frequency on the numbers of BCM events (F (4, 69) = 36.451; P <
0.001), bursts (F(4, 69) = 37.889; P < 0.001) and SVP increases (F(4, 69) = 18.603; P < 0.001).
In saline-treated males, in trial 1 (saline trial), only 30 and 60 Hz DPN stimulation frequencies
increased NCM events, bursts, and SVP increases as expected (all P < 0.001 compared to saline
infusion) (Figure 21A, B). There were also significant interactions between main factors of
testing trial and stimulation frequency on the numbers of BCM events (F (4, 69) = 11.633; P <
0.001), bursts (F(4, 69) = 10.774; P < 0.001) and SVP increases (F(4, 69) = 8.779; P < 0.001).
Post hoc analyses demonstrated that male rats treated with galanin in trial 2 had
significantly greater numbers of BCM events, bursts and SVP following 5 Hz (events: P <
0.001; bursts: P < 0.001; Figure 21A, C, D; SVP: P < 0.001; Figure 21B, C, D) and 10 Hz
(events: P = 0.008; bursts: P = 0.003; Figure 21A; SVP: P = 0.003; Figure 21B) DPN
stimulation frequencies compared to control trial 1. Overall, these results indicate that intrathecal
galanin facilitates but does not trigger the emission and expulsion components of ejaculation.
However, contrary to the first galanin experiment where it was found that intrathecal galanin
facilitated numbers of BCM events and bursts not only in response to subthreshold (5-10 Hz) but
also following threshold (30-60 Hz) levels of DPN stimulation, in this second experiment,
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threshold levels of DPN stimulation (60 Hz) significantly decreased the numbers of BCM bursts
and SVP increases following galanin infusions in trial 2 (bursts: P = 0.041; Figure 21A;
21 SVP: P
= 0.036; Figure 21B).

Figure 21 Effects of galanin on numbers of BCM bursts and SVP increases in male rats.
Quantitative analyses and accompanying EMG traces of BCM bursts and SVP increases
following intrathecal infusions of galanin. Quantitative analysis of BCM bursts (A) and SVP
increases(B) in response to infusion, 5 Hz, 10 Hz, 30 Hz and 60 Hz DPN stimulation
(counterbalanced) following intrathecal infusions of saline in trial 1 (control trial) or galanin (0.3
nmol) in trial 2 (drugg trial). EMG traces of 90 seconds duration following 10 Hz DPN
stimulation (arrow) after an intrathecal infusion of saline (C: control trial) and galanin (D: same
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animals as in C). * denotes significant differences from trial 1 (control trial), while # indicates
significant differences from infusion, 5Hz and 10 Hz within the same testing trial.

4.3.5

Cholecystokinin (CCK) Facilitated BCM Events, Bursts and SVPs

CCK (26-33) facilitated both the emission and expulsion components of ejaculation as
evidenced by the increased numbers of BCM events, bursts and SVP increases following
subthreshold levels of DPN stimulation. There were main effects of stimulation frequency on the
numbers of BCM events (F(4, 59) = 51.540; P < 0.001), bursts (F(4, 59) = 56.316; P < 0.001)
and SVP increases (F(4,59) = 38.292; P < 0.001). As expected, during trial 1 (saline trial) 30
and 60 Hz DPN stimulation increased numbers of BCM events, bursts and SVP increases
compared to saline infusion, 5 or 10 Hz stimulation (all P < 0.001; Figure 22A-B). . There were
also significant interactions between main factors of testing trial and stimulation frequency on
the numbers of BCM events (F(4, 59) = 4.897; P = 0.006) and bursts (F(4, 59) = 5.493; P =
0.004). Post hoc analyses revealed that following CCK in trial 2 there were significantly greater
numbers of BCM events, bursts and SVP increases following 10 Hz (events: P = 0.040; Figure
22A; bursts: P = 0.005; Figure 22B; SVP: P = 0.013; Figure 22C) DPN stimulation in trial 2
(drug trial) compared to trial 1 (saline trial). CCK did not significantly affect SVP increased
following 5 Hz DPN stimulation during trial 2 compared to trial 1, even though BCM bursts and
events were increased (P = 0,05 and 0.001; Figure 22B). Taken together, the results indicate that
intrathecal infusions of CCK facilitate both the emission and expulsion components of
ejaculatory reflexes following subthreshold levels of DPN stimulation (10 Hz) in male rats.
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Figure 22 Effects of CCK on the numbers of BCM events, bursts and SVP increases in
male rats.
Quantitative analyses and accompanying EMG traces of BCM events, bursts and SVP increases
following intrathecal infusions of CCK.. Quantitative analysis of BCM events (A),
(A) bursts (B) and
SVP increases (C) in response to infusion, 5 Hz, 10 Hz, 30 Hz and 60 Hz DPN stimulation
(counterbalanced) following intrathecal infusions of saline in trial 1 (control trial) or CCK (4.35
nmol) in trial 2 (drug trial). EMG traces of 90 seco
seconds
nds duration following 5 Hz DPN stimulation
(arrow) after an intrathecal infusion of saline (D: control trial) and CCK (E: same animals as in
D). * denotes significant differences from trial 1 (control trial), while # indicates significant
differences from infusion, 5 Hz and 10 Hz within the same testing trial.
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4.4 Discussion

These data support the hypothesis that galanin and CCK receptor activation in LSt target areas is
critical for ejaculatory reflexes in male rats by acting on galanin and CCK receptors in LSt target
areas in the lumbosacral spinal cord. As predicted, intrathecal infusions of galanin or CCK
receptor antagonists, galantide and proglumide respectively, prevented both the emission and
expulsion phases of ejaculation in response to sensory stimulation of the DPN in male rats.
Conversely, galanin and CCK agonists facilitated ejaculatory reflexes following sub- threshold
sensory stimulation (5–10 Hz) in 100% of male rats. In contrast, galanin or CCK infusions in the
absence of DPN stimulation were not sufficient to trigger ejaculatory reflexes. This finding is in
contrast with our previous observations that agonists for GRP or mu opioid receptors do trigger
ejaculatory reflexes (Kozyrev et al., 2012; Kozyrev, 2013c). It is therefore possible that galanin
and CCK act synergistically with the endogenous release of neuropeptides from LSt axon
terminals, including galanin (Newton, 1992a, 1993), CCK (Phan and Newton, 1999), GRP
(Sakamoto et al., 2008; Kozyrev et al., 2012) and enkephalin (Nicholas et al., 1999; Kozyrev,
2013c), upon sensory stimulation of the DPN.
Even though the group data presented in the results shows a lack of significant induction by
galanin or CCK of ejaculation in the absence of sensory stimulation, intrathecal infusions of
galanin and CCK triggered ejaculatory reflexes in 15 % (3/20) and 16 % (1/6) of male rats
respectively. Perhaps the ability of intrathecal infusions of galanin or CCK to trigger ejaculatory
reflexes in the absence of sensory stimulation in a minority of male rats may be explained by the
presence of individual differences in galanin and CCK receptor densities in the lumbosacral
spinal cord. It is possible that male rat ‘responders’ in the current study have a lower threshold to
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ejaculation and are more likely to exhibit the characteristic aspects of ‘premature ejaculation’.
Indeed, a previous study observed inherent differences in the spinal command of ejaculation
between rats classified as ‘rapid ejaculators’ as compared to ‘sluggish ejaculators’ and ‘normal
ejaculators’ based on their ejaculation frequency in a set of mating tests (Borgdorff et al., 2009).
Specifically, BCM contractions following microstimulation of the spinal ejaculation generator,
corresponding to the expulsion phase of ejaculation, were significantly accelerated in ‘rapid
ejaculators’ compared with ‘sluggish ejaculators’ and ‘normal ejaculators’(Borgdorff et al.,
2009). Overall, the agonist experiments indicate that activation of galanin and CCK receptors in
the lumbosacral spinal cord facilitates ejaculatory reflexes following subthreshold levels of DPN
stimulation (5-10 Hz) but is not sufficient to trigger ejaculatory reflexes in the majority of male
rats in the absence of sensory stimulation of the DPN.
LSt cells and axons co-express galanin and CCK and the expression of both
neuropeptides has been shown to be sexually dimorphic (Newton, 1992a, 1993; Phan and
Newton, 1999). Specifically, male rats have a significantly greater number of both galanin and
CCK-ir neurons and greater optical densities for both galanin and CCK than female rats and
males with a testicular feminization mutation (Tfm) that lack functional androgen receptors
(Newton and Phan, 2006). Therefore, androgens and functional androgen receptors regulate the
expression of galanin and CCK in LSt cells. In addition, the expression of GRP, another
neuropeptide expressed in LSt cells and axons, has been shown to be androgen-dependent since
castration significantly reduced the intensity of GRP-ir fibers in the lumbar spinal cord in male
rats and this reduction was prevented by androgen replacement (Sakamoto et al., 2008).
Galanin is a 29/30 amino acid long neuropeptide encoded by the GAL gene (Evans et al.,
1993) that is widely distributed in the brain, spinal cord and gastrointestinal tract of mammals
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(Kask et al., 1997; Hokfelt et al., 1999) and is involved in a variety of physiological functions
including feeding, nociception, cognition, regulation of blood pressure and mood (Mechenthaler,
2008) . Galanin-ir is expressed in dorsal root ganglion cells (DRG) (Hokfelt et al., 1993; Kask et
al., 1997; Landry et al., 2005), but in the lumbosacral spinal cord, is expressed exclusively in LSt
cells (Truitt and Coolen, 2002; Truitt et al., 2003; Staudt, 2011). Furthermore, galanin-ir axon
terminals exclusively deriving from LSt cells are in close proximity to cell bodies and proximal
dendrites of autonomic preganglionic and motor neurons (Newton, 1992b; Ohmachi et al., 1996).
A predominately inhibitory, hyperpolarizing neuropeptide (Ito, 2009), galanin mediates its
effects through its receptors: GALR1, GALR2 and GALR3. Galanin receptors are inhibitory Gprotein-coupled receptors that are associated with G-protein coupled inwardly-rectifying K+
(GIRK) channels (Kask et al., 1997; Wang et al., 1998) and GALR1 receptors have the highest
densities postsynaptically compared to the other two receptor types (Brumovsky et al., 2006;
Landry et al., 2006). In the lumbosacral spinal cord, GalR1 receptors have been observed in
dorsal and ventral horns, lateral spinal nuclei (Brumovsky et al., 2006) and numerous GALR1
positive mRNA neurons were detected in lamina X, presumably in the vicinity of the LSt cells
(Brumovsky et al., 2006). GALR2 mRNA expression is considerably diminished compared to
GALR1 mRNA expression and is confined primarily to the dorsal horn (Brumovsky et al.,
2006). However, the most intensely labeled neurons are observed in the ventral horn, likely on
motorneurons, and a few GALR2 positive mRNA neurons are detected in the sympathetic and
parasympathetic lateral cell columns, in the locations of the IML and SPN (Brumovsky et al.,
2006). In light of these findings, it is likely that galanin facilitates emission and expulsion by
acting on GALR1 and GALR2 receptors in LSt target regions, specifically on autonomic
preganglionic neurons in the lateral cell columns and on motoneurons in the ventral horns of the
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lumbosacral spinal cord in male rats. As previously mentioned, GALR1 receptors have been also
observed in lamina X, in the region of LSt cells. However, it remains to be tested whether these
receptors are expressed on LSt cells or other types of neurons in the lumbosacral spinal cord. If
GALR1 receptors are indeed expressed on LSt cells, this suggests the possibility of autoreceptor
interactions or reciprocal connections. However, intrathecal pretreatment with galantide in the
current study did not prevent the activation of LSt cells following DPN stimulation suggesting
that autoreceptors are not the primary targets of galanin released from the axon terminals of LSt
cells. Alternatively, galantide did not diffuse deeply into the spinal cord to the location of the LSt
cells.
Similarly to galanin, CCK is one of the first peptide hormones to be isolated from the
gastrointestinal tract and is widely distributed in the nervous system of mammals
(Vanderhaeghen et al., 1975). CCK is involved in many physiological processes including
digestion, satiety, and is known to induce anxiety and drug tolerance to opioids (Bradwejn, 1993;
Greenough et al., 1998; Fukazawa et al., 2007). The actions of CCK are mediated by two classes
of receptors: CCKA and CCKB subtypes (Oz et al., 2007) which belong to a family of Gprotein-coupled receptors (Oz et al., 2007). As galanin, CCK is expressed in DRG cells and
involved in the maintenance of neuropathic pain following nerve injury (Brewer et al., 2003;
Kim et al., 2009) reflected in substantial increases in CCK mRNA following injuries to the CNS
(Xu et al., 1993; Brewer et al., 2003). In the spinal cord, CCK is expressed in LSt cells and LSt
axons. CCK receptor expression has been described in motor neurons (Cortes et al., 1990;
Schiffmann et al., 1991; Truitt et al., 2003). In addition, CCK depolarized neurons in lamina X in
the lumbar spinal cord (Phelan and Newton, 2000), the precise location of LSt cells. Bath
application of CCK has also been shown to depolarize isolated, hemisected lumbar spinal cord
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ventral horn neurons and motorneurons in neonatal rats (Suzue et al., 1981) and this depolarizing
action was mediated by CCKB type receptors (Oz et al., 2007). Activation of postsynaptic
CCKB receptors can enhance the excitability of motoneurons and other types of neurons in
ventral spinal cord of rats (Oz et al., 2007). This may also be the mechanism by which CCK
facilitated BCM bursting.
CCK is an antagonist of endogenous opioids in the brain and spinal cord (Cesselin, 1995;
Wiesenfeld-Hallin et al., 1999). It appears that CCK mediates its noxious effects through CCKB
type receptors. The systemic administration of the CCKB receptor antagonist but not opioids
successfully reduced mechanical allodynia in an ischemic model of SCI (Xu et al., 1994). The
tendency of CCK to antagonize opioids may explain why the effect of CCK infusions on
ejaculatory reflexes following subthreshold sensory stimulation (5-10 Hz) was somewhat
dampened compared to galanin infusions in this study (Figures 4 – 6). LSt cells are hypothesized
to release their co-expressed neuropeptides, including enkephalin, onto neurons in their target
regions, thereby triggering ejaculation. Indeed, our laboratory recently found that intrathecal
infusions of the mu opioid receptor agonist DAMGO consistently triggered ejaculatory reflexes
in the absence of sensory stimulation in 75 % of male rats (Kozyrev, 2013c). Thus, activation of
mu opioid receptors in the lumbosacral spinal cord was sufficient in a large majority of animals
to trigger ejaculatory reflexes in male rats. Infusions of CCK in the current study may have
suppressed the facilitative effects of opioids on ejaculatory reflexes in male rats by antagonizing
endogenous opioids released from the LSt cells onto target regions following stimulation of the
DPN. Although data from the two neuropeptide experiments were not directly compared, it is
evident that the numbers of events, bursts and SVP increases following infusions of galanin
(Figures 20 – 21) are somewhat higher compared to the numbers of events, bursts and SVP
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increases following infusions of CCK (Figure 22). Furthermore, infusions of galanin produced a
coordinated bursting pattern of the BCM and a robust increase in the numbers of BCM bursts
and concurrent SVP increases (Figure 20D and 21D) while infusions of CCK resulted in a
modest increase in BCM bursts and simultaneous SVP increases but not a full coordinated
bursting pattern characteristic of ejaculation (Figure 22E).
In the first set of experiments, the higher dose of galanin (0.3 nmol; Figure 20) facilitated
ejaculatory reflexes not only in response to subthreshold levels of DPN stimulation (5-10 Hz) but
also following threshold stimulation frequencies (30-60 Hz). However, in the subsequent group
of male rats, intrathecal infusion of the same dose of galanin (0.3 nmol; Figure 21) significantly
decreased numbers of BCM events, bursts and SVP increases following 60 Hz DPN stimulation.
In these animals, galanin (0.3 nmol) still facilitated numbers of BCM events, bursts and SVP
increases in response to subthreshold levels of DPN stimulation (5-10 Hz). However, the
discrepancies in ejaculatory responses between the two groups of male rats suggest that galanin
consistently facilitates ejaculatory reflexes to subthreshold (5-10 Hz) but not to threshold (30-60
Hz) levels of DPN stimulation.
Since the activation of galanin or CCK receptors was not sufficient to trigger ejaculatory
reflexes in the majority of male rats tested, the activation of galanin or CCK receptors may be
required in combination with activation of other receptors in LSt target areas in order to trigger
ejaculation. One candidate is the GRP receptor. Indeed, it was recently shown by our laboratory
that activation of GRP receptors is required to trigger ejaculation and that intrathecal infusions of
GRP triggered ejaculatory reflexes in up to 66% of male rats (Kozyrev et al., 2012). Other
candidates include the mu and delta opioid receptors, whose ligand enkephalin is co-localized in
LSt cells and axons (Nicholas et al., 1999) along with galanin (Newton, 1993; Newton and Phan,
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2006), CCK (Newton, 1993; Newton and Phan, 2006) and GRP (Sakamoto et al., 2008; Kozyrev
et al., 2012).
Infusions of galanin significantly reduced the numbers of BCM events, bursts and SVP
increases following threshold DPN stimulation (60 Hz). This finding is in agreement with
previous reports of intrathecal infusions of GRP, DAMGO and deltorphin II that have all
significantly reduced the numbers of BCM events, bursts and SVP increases following 60 Hz
DPN stimulation (Kozyrev et al., 2012; Kozyrev, 2013c). This consistent suppression of
ejaculatory reflexes to threshold DPN stimulation (60 Hz) may be due to the effects of
intrathecal infusions of neuropeptides combined with the endogenous release of opioids
following DPN stimulation that cumulatively act to inhibit or desensitize the G-protein coupled
receptors in autonomic and motor regions involved in ejaculation and suppress the transmission
of sensory inputs to the LSt cells which are required to trigger ejaculation.
In conclusion, these data support the hypothesis that activation of galanin and CCK
receptors in the lumbosacral spinal cord is required for sensory stimulation-induced emission and
expulsion in anesthetized and spinalized male rats. Galanin and CCK likely act on receptors in
LSt cell target regions, including motoneurons in the SNB, and autonomic preganglioninc
neurons in the IML, CAN and SPN in the lumbosacral spinal cord. Overall, these data suggest
that the co-release of neuropeptides from LSt cell axon terminals including galanin, CCK,
enkephalin and GRP, triggers ejaculatory reflexes in male rats. Conversely, the release of only
one of these neuropeptides is not sufficient to trigger ejaculatory reflexes in all animals in the
absence of added sensory stimulation. Finally, these data suggest that galanin and CCK
antagonists may be promising pharmacological agents in the treatment of ejaculatory disorders,
particularly for the purpose of delaying the onset of emission and expulsion in men suffering
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from premature ejaculation.
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Chapter 5: Activation of mu opioid and GRP
receptors in the lumbosacral spinal cord can
improve ejaculatory reflexes in male rats with
chronic contusion spinal cord injury
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5.1 Introduction

Ejaculatory function is severely impaired in men with spinal cord injuries (SCI) (Brackett et al.,
1998). A great majority of these patients are men with 85% between the ages of 18 - 45 years
(Ohl et al., 1989). Of these SCI men, just 12 – 15 % are able to ejaculate but only with the aid of
intense vibratory stimulation or electro-ejaculation (Elliott, 2006). Among paraplegic men,
regaining sexual function is of the utmost importance, and is even ranked higher than regaining
locomotor function (Anderson, 2004). However, the mechanisms whereby chronic SCI so
dramatically disrupts ejaculation in men with SCI are currently unknown.
Male sexual behavior is a complex and highly rewarding behavior which includes several
components including the pursuit and investigation of a female, mounts and intromissions,
finally culminating in ejaculation (Coolen et al., 2004; Allard et al., 2005; Coolen, 2005) In men,
ejaculation occurs concurrently with the pleasurable experience of orgasm (Bohlen et al., 1980;
Elliott, 2002). Similarly, male rats associate ejaculation with reward (Tenk et al., 2009)
Therefore, ejaculation is an exceptionally rewarding and complex physiological process which
terminates in the expulsion of seminal contents from the urethral meatus (Giuliano and Clement,
2005; Clement P, 2011) and comprises two phases: emission and expulsion. The emission phase
involves the secretion of seminal fluids from the prostate, seminal vesicles and vas deferens and
closure of the bladder neck and external urethral sphincter. The expulsion phase comprises
rhythmic contractions of the striated perineal muscles, particularly the bulbocavernosus muscle
(BCM), to forcefully expel seminal contents from the urethral meatus (Bohlen et al., 1980;
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Gerstenberg et al., 1990; Holmes et al., 1991; Holmes and Sachs, 1991). Ejaculation is a reflex
under the control of the spinal ejaculation generator, located in the lumbosacral spinal cord
(Pescatori et al., 1993; McKenna, 1999; Coolen et al., 2004; Allard et al., 2005; Coolen, 2005).
The spinal ejaculation generator is comprised of interneurons in lamina 10 and the medial
portion of lamina 7 of lumbar segments 3 and 4 (L3-4). These lumbar interneurons are known as
lumbar spinothalamic (LSt) cells because of their anatomical location in the lumbar spinal cord
and direct projections to the subparafascicular parvocellular thalamic nucleus (Coolen et al.,
2003; Truitt et al., 2003; Giuliano and Clement, 2005; Clement P, 2011). Moreover, they are
pivotal in the control of ejaculatory behavior (Truitt et al., 2003) and reflexes (Staudt, 2011) in
male rats. The spinal ejaculation generator is thought to regulate ejaculation by coordinating
sympathetic, parasympathetic, and motor ouflow required to stimulate emission and expulsion
(Coolen et al., 2004; Coolen, 2005) and by integrating the sensory inputs, conveyed by the dorsal
penile nerve (DPN) during sexual activity, with autonomic and motor ouflow to produce
ejaculation (Coolen et al., 2004; Allard et al., 2005; Coolen, 2005; Giuliano and Clement, 2005;
Clement P, 2011). The LSt cells, which form an integral component of the spinal ejaculation
generator, are hypothesized to transform sensory signals associated with copulation into motor or
secretory outputs (Truitt and Coolen, 2002). In support of this notion, LSt cells are activated
specifically with ejaculation but not with other components of male sexual behavior (Truitt et al.,
2003). In addition, LSt cells express neural activation, including cFos (Truitt et al., 2003) and
phosphorylated extracellular signal-regulated kinases 1 and 2 (pERK) (Staudt et al., 2010)
following ejaculation triggered by mating or electrical stimulation of the dorsal penile nerve
(DPN) in male rats (Sachs and Garinello, 1979; Pescatori et al., 1993; McKenna, 1997; Coolen et
al., 2004). Moreover, activation of the

MAP kinase pathway is required for ejaculation
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following mating in intact animals or DPN stimulation in anesthetized and spinalized male rats
(Staudt et al., 2010). Finally, LSt cells control ejaculation via their axon projections to numerous
target regions involved in ejaculation (Newton, 1993; Allard et al., 2005; Xu et al., 2006)
including preganglionic sympathetic, parasympathetic and motor neurons in the thoracolumbar
and lumbosacral spinal cord (Newton, 1993; McKenna, 1997; Sakamoto et al., 2008). LSt cells
and axons co-express various neuropeptides including enkephalin, galanin, cholecystokinin and
gastrin releasing peptide (GRP) (Ju et al., 1987; Nicholas et al., 1999; Coolen et al., 2003; Truitt
et al., 2003; Sakamoto et al., 2008). Thus, it was predicted that these neuropeptides modulate
ejaculatory reflexes by acting in the LSt target areas. Indeed, our laboratory utilized a
physiological paradigm to test that hypothesis, using stimulation of the DPN in spinalized,
anestitized male rats. This DPN stimulation model is a physiologically relevant model of
ejaculation (Clement P, 2011) which utilizes anesthetized and spinalized animals and
consistently triggers ejaculatory reflexes in male rats (Pescatori et al., 1993), primates (Herbert,
1973), and men (Wieder et al., 2000). It has been demonstrated that antagonism of each of the
neuropeptides receptors in LSt target areas abolish ejaculatory reflexes (Kozyrev et al., 2012;
Kozyrev, 2013c, 2013b). Moreover, infusions of agonists for the receptors these neuropeptides
triggered ejaculatory reflexes in the absence of sensory stimulation (Kozyrev et al., 2012;
Kozyrev, 2013c, 2013b) or facilitated ejaculation following subthreshold sensory stimulation
incapable of triggering ejaculation in control conditions.
The purpose of the present study was to test whether intrathecal infusions of receptor
agonists for the neuropeptides enkephalin, galanin, and GRP, individually and in combination,
can restore ejaculatory reflexes in a chronic model of contusion SCI in anesthetized and
spinalized male rats. Specifically, it was tested whether infusion of each agonist individually or
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infusions of a cocktail of these agonists is sufficient to trigger ejaculatory reflexes in male rats in
the absence of sensory stimulation or followed by electrical stimulation of the DPN. Parameters
of emission and expulsion were analyzed during neuropeptide infusions and following DPN
stimulation.

5.2 Materials and Methods

5.2.1

Animals

Adult male Sprague Dawley rats (225-250 grams) were acquired from Charles River
(Wilmington, MA, USA) and pair housed in standard housing cages on a reverse 12-hour
light/dark cycle with lights off at 9 a.m. Food and water were available ad libitum. All
procedures were approved by the University Committee on Use and Care of Animals at the
University of Michigan and conformed to the guidelines outlined by the National Institutes of
Health.

5.2.2

Spinal Cord Surgeries

Male rats were randomly assigned to either the spinal cord injury (SCI) group (N = 16) or
the sham group (N = 17) for these experiments. All surgical procedures were performed under
ketamine (87 mg/ml) / xylazine (13 mg/ml) anesthesia (1 ml/kg i.p. injection). Backs were
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shaved and thoroughly cleaned with betadine, iodine and 70 % alcohol solution. Lacrilube
opthalamic ointment (Allergen, Irevine, CA) was applied to the eyes in order to avoid drying. In
both SCI and sham animals, a laminectomy was performed between the 6th and 7th thoracic
spinal segments (T6-T7) and was made large enough in order to ensure accessibility of the spinal
cord during the impact injury. Only the SCI group of male rats was subjected to the contusion
spinal cord injury, performed with the IH-400 impactor (Precision Systems and Instrumentation,
LLC, Lexington, KY), positioned 3 mm above the cord and a force of 200-216 kdyn was applied
directly to the intact dura of the exposed spinal cord at the T6/7 segments. After the contusion,
the layers of muscle and skin were sutured separately, the muscle was sutured with absorbable
sutures and the skin was closed using wound clips. Subcutaneous injections of the analgesic
ketoprofen (5 mg/ml/kg s.c.), and the antibiotic Baytril (5 mg/ml/kg s.c.), were administered
immediately following the surgery and for up to three days thereafter in order to alleviate pain
and prevent infection. The sham animals were injected with ketoprofen and Baytril in the same
manner and for the same period of time as the SCI animals. Bladders of SCI males were
expressed twice daily until bladder function returned (typically after 7-10 days).

5.2.3

Locomotor testing

Locomotor testing was conducted three times beginning one week following the
contusion/sham surgeries and each week thereafter in order to assess locomotor recovery
following spinal cord contusion. Locomotor activity was measured during the first half of the
light phase, for 15 minutes, in a large area and using 16 × 16 photobeam array (Med Associates
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Inc, Vermont). Locomotor activity was expressed as the time animals spent ambulatory in the
horizontal position, or rearing in a vertical position. Locomotor activity was analyzed using a
two-way repeated anova (factors: SCI and time) and Holm-Sidak post-hoc tests to compare
locomotor activity two, three and four weeks following spinal cord contusion (or sham) surgery
within each group of animals and between sham and SCI animals, separately for ambulatory and
vertical time.

5.3 Experimental Designs

5.3.1

Intrathecal infusions of neuropeptides

Four to five weeks following the spinal cord contusion surgeries, ejaculatory reflexes
were measured as described before (Kozyrev et al., 2012; Kozyrev, 2013b, 2013a). Male rats
were deeply anesthetized with urethane (1.5 g/kg, i.p.), backs were shaved and a laminectomy
was made between the seventh and the eighth thoracic spinal segments, immediately caudal to
the injury site, and a complete transaction of the spinal cord was performed at the same spinal
level. Next, animals were positioned supine and the skin, fat, connective tissues and ligaments
surrounding the reproductive organs were removed to expose the muscle of the bulbocavernosus
(BCM) and the dorsal penile nerve (DPN). Then, silver recording electrodes, attached to the
PowerLab/7SP Data Acquisition System (AD Instruments, Inc., Colorado Springs, CO, USA)
were bilaterally implanted into the BCM and a ground electrode was inserted into the muscle of
the right thigh prior to the start of electromyographic (EMG) recordings. In addition, a small
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incision was made in the abdomen and the right seminal vesicle was located for the purpose of
measuring and recording seminal vesicle (SV) pressure, a marker of the emission phase of
ejaculation (Clement et al., 2008; Kozyrev et al., 2012; Kozyrev, 2013c, 2013b). SV pressure
(SVP) was measured with a pressure catheter (AD Instruments Inc., model number: SPR-671(1.4
F, Single, Straight, 15 cm, Ny) connected to a catheter interface cable (AD Instruments Inc.,
model number: AEC-IOD) and attached to a Bridge AMP (AD Instruments Inc.). The pressure
catheter was carefully guided into the lumen of the SV and fixed in place before recording
commenced. Lastly, a bipolar stimulating electrode connected to the SD9 Square Pulse
Stimulator (Grass Technologies, West Warwick, RI, USA) was arranged directly on top of the
DPN, in preparation for stimulation. Immediately following spinal cord transection, the DPN
was stimulated in order to verify the completeness of the spinal transection, reflected in the
release of supraspinal inhibition and the corresponding rhythmic bursting of the BCM and
concurrent increases in SVP. The initial electrical stimulation of the DPN was composed of
square wave pulses of 1 ms duration, 4 V at 60 Hz for 10 seconds. These DPN stimulation
parameters have been well established to reliably trigger increases in SVP and concurrent
rhythmic bursting of the BCM, corresponding to the emission and expulsion components of
ejaculation, in all saline-treated control animals (Staudt et al., 2010; Staudt, 2011; Kozyrev et al.,
2012; Kozyrev, 2013c, 2013b).
Pharmacological experiments were conducted as described previously (Kozyrev et al.,
2012; Kozyrev, 2013a, 2013b) and began two hours after spinal cord transection in order to
allow the acute effects of spinal cord transection to subside. In preparation for neuropeptide
infusions, a small opening was made in the dura mater in the location of the laminectomy and a
polyethylene catheter (Caly-Adams PE-10, Parsippany, NJ, USA) was gently guided into the
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subarachnoid space until the open end reached the 3rd lumbar-4th lumbar (L3-L4) spinal
segments.
In the first testing trial (saline trial; Figure 23A), 10 µL of 0.9 % saline was intrathecally
infused with a polyethylene catheter to bathe the entire lumbosacral spinal cord. The catheter
was left in place for 10 minutes after injection in order to let the contents diffuse in the
lumbosacral spinal cord and SVP and BCM EMG activity were recorded for the entire duration.
After the saline infusion, the DPN was stimulated at 5, 10, 30 Hz and 60 Hz in a counterbalanced
manner, with 5-minute intervals between the stimulations. We have previously established that
saline infusions and repeated stimulations do not affect ejaculatory reflexes (Kozyrev et al.,
2012) . Moreover, we established that 5 and 10 Hz DPN stimulations in control conditions do not
trigger ejaculation, while 30 and 60 Hz DPN stimulations under control conditions reliably
trigger ejaculatory reflexes in all control animals. SVP and BCM EMG were recorded for at least
90 seconds following nerve stimulation, corresponding to the duration of a characteristic
ejaculatory reflex triggered by DPN stimulation in male rats (Staudt et al., 2010; Staudt, 2011;
Kozyrev et al., 2012; Kozyrev, 2013b, 2013c). One hour later, this procedure was repeated twice
in the same animals, but using neuropeptide receptor agonists (Trials 2 and 3). Half the animals
received a 10 µL infusion of galanin (0.3 nmol [Bachem Americas, Inc. Torrence, CA, USA];
Figure 23B) and a 10 µL infusion of the delta opioid receptor agonist [DAla2] Deltorphin II (13
nmol ; [American Peptide Co, Sunnyvale CA, USA]; N (SCI) = 5; N (sham) = 6; Figure 23B:
Trial 3. The other half of the animals received 10 µL infusion of gastrin releasing peptide (GRP
20-29

; 0.2 nmol; [Phoenix Pharmaceuticals Inc. Burlingame, CA, USA]; Figure 23B: Trial 2) and

a 10 µL infusion of the mu opioid receptor agonist (D-Ala2, N-Me-Phe4, glycinol5) –
Enkephalin (DAMGO; [Bachem Americas, Inc. Torrence, CA, USA]; 1 nmol; N (SCI) = 11, N
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). Each pair of drugs was delivered in a counterbalanced order of infusion
(sham) = 11; Figure 23).
and there was a rest period of 22-3
3 hours between neuropeptide infusions in order to allow the
effects of the previous neuropeptide on ejaculatory reflexes to subside. Recordings of SVP and
BCM EMG were obtained during and following drug infusion for a total period of 10 minutes.
Next, the DPN was stimulated at 5, 10, 30 and 60 Hz in a counterbalanced manner, and
concurrent recordings of SVP and BCM EMG were obtained for 90 seconds following DPN
stimulation (Testing trial 2 and 3; drug trials).

Figure 23 Timeline of experimental manipulations.
In trial 1, all male rats received intrathecal infusions of saline (A; Arrow) followed by intrathecal
infusions of DAMGO (1 nmol) and GRP (0.2 nmol) or galanin (0.3 nmol) and deltrophin II (13
nmol) in trials 2 and 3 (B: Arrow [in a counterbalanced order])
order]).. Finally in trial 4, three hours
following infusion of the last neuropeptide, male rats received intrathecal infusions of a cocktail
of neuropeptides (C: Arrow). Following each infusion, BCM EMG and SVP activity was
recorded for 15 minutes. Next, the DPN was stimulated at 5, 10, 30 and 60 Hz in a
counterbalanced manner (A – C) and SVP and BCM EMG activity was recorded for 90 seconds
following each DPN stimulation.

139

5.3.2

Intrathecal infusions of a cocktail of neuropeptides

Three hours following the last neuropeptide infusion, male rats (N (SCI) = 11; N (sham)
= 7) received 10 µL intrathecal infusion of a cocktail of neuropeptides composed of galanin (0.3
nmol), deltorphin (13 nmol,), DAMGO (1 nmol) and GRP (0.2 nmol) and recordings of SVP and
BCM EMG were obtained for 15 minutes (Figure 23C: Trial 4). After the infusion, the DPN was
stimulated at 5, 10, 30, and 60 Hz in a counterbalanced manner with five minute intervals
between stimulations.

5.3.3

BCM EMG and SVP Analysis

SVP and BCM EMG recordings were analyzed for 10 minutes following infusion of each
neuropeptide, and for 90 seconds each time the DPN was stimulated. The numbers of SVP
increases and concurrent BCM events and bursts were analyzed. Analysis of the numbers of
BCM events was performed with LabChart 7.35 (AD Instruments Inc.) software and all events
that were above baseline activity were included in the analysis (Kozyrev et al., 2012; Kozyrev,
2013b, 2013a). The numbers of SVP increases and BCM bursts were analyzed as previously
described (Kozyrev et al., 2012; Kozyrev, 2013b, 2013a). Briefly, 8 or more consecutive BCM
events above baseline were considered a ‘burst’ and all concurrent increases in SVP above
baseline were included in the analysis.
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5.3.4

Statistical analyses

Statistical analyses of the neuropeptide experiments involved comparing the effects of
each neuropeptide on the numbers of SVP increases, BCM events and bursts within animals
(within the same drug, between testing trial 1: control trial and testing trial 2 and 3: drug trials)
and between SCI and sham groups of animals (separately for each stimulation setting: Infusion, 5
Hz, 10 Hz, 30 Hz, and 60 Hz), and separately for each of the three testing trials, using a two-way
repeated anova (factors: drug and SCI) and Holm-Sidak post hoc tests. A 95% confidence level
was utilized for all tests. In a separate analysis, the effects of the order of drug delivery were
tested for Trials 2 and 3. One way ANOVA was conducted to determine differences in the
effects of each drug between the half the animals receiving the drug in the second and in the third
trial. Only if no differences were detected were all animals included in the analysis. Similarly,
the cocktail infusion experiment was analyzed by comparing the effects of the cocktail on the
numbers of SVP increases, BCM events and bursts within animals (between different stimulation
settings: Infusion, 5 Hz, 10 Hz, 30 Hz and 60 Hz) as well as between sham and SCI male rats
using a two-way repeated anova (factors: DPN stimulations and SCI) and Holm-Sidak post hoc
tests.

5.4 Results

5.4.1

Locomotor activity was impaired in SCI male rats
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There was no evidence of recovery in either ambulatory or vertical time in the SCI group
of male rats. Moreover, SCI males did not differ in activity at 4 weeks compared to 2 weeks
post-injury.
injury. In addition, both ambulatory (horizontal) and vertical time were significantly
reduced in SCI male rats compared to sham male rats following surgery (contusion or sham
spinal cord trauma). There were main effects of SCI on ambulator
ambulatory
y time (F(1, 68) = 5.360; P =
0.031; Figure 24A)
A) and vertical time (F(1, 68) = 11.537; P = 0.003; Figure 24B).
2
Post hoc
analyses demonstrated that sham males spent significantly more ambulatory time exploring their
chamber compared to SCI males three weeks following surgery (P = 0.007; Figure 24A).
2
In
addition, sham males spent significantly greater vertical time in the chamber compared to SCI
males two weeks (P = 0.004), 3 weeks ((P = 0.002) and four weeks (P = 0.010) following
surgery (Figure 24B).

142

Figure 24 Locomotor activity in sham and SCI male rats 2, 3 and 4 weeks after surgery.
Locomotor acitivity expressed as the mean combined time (ms) sham and SCI male rats spent in
ambulatory (A) and vertical (B) locomotion during three 15-minute trials, two, three and four
weeks following spinal cord contusion injury (or sham surgery).

5.4.2

Experiment 1: Ejaculatory reflexes were absent in SCI males

In the first experiment, ejaculatory reflexes were examined in sham and SCI males
following saline (control Trial 1), and subsequently following GRP or DAMGO (Trials 2 and 3).
First, under control saline conditions, in trial 1, SCI male rats demonstrated severely disrupted
BCM events, bursts, and SVP increases following 30 and 60 HZ DPN stimulation, parameters
that reliable trigger ejaculation in control animals (Figures 25D, 25E, 25D, 26E, 27D, 27E). For
both stimulation parameters, there were main effects of SCI on BCM events (F(1,59) = 31.25; P
< 0.001 and F(1,59) = 33.53; P < 0.001), BCM bursts (F(1,59) = 48.94; P < 0.001 and F(1,59) =
83.55; P < 0.001), and SVP increases (F(1,59) = 39.38; P < 0.001 and F(1,59) = 72.98; P <
0.001). Specifically, whereas sham animals (following saline infusions), display increased BCM
events, bursts and SVP increases following either 30 or 60 Hz (all P < 0.001); SCI animals
display no BCM activity nor SVP changes at all and were significantly different from sham
controls in all parameters (all P < 0.001). Hence, SCI severely disrupted the ability of DPN
stimulation to trigger ejaculatory reflexes.
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Figure 25 Effects of DAMGO and GRP infusions on the numbers of BCM events in sham
and SCI male rats.
Quantitative analysis of BCM events following intrathecal infusions of saline (A: trial 1[ control
trial]) and DAMGO and GRP (A: trials 2 and 3 [ drug trials]), followed by 5 Hz (B), 10 Hz (C),
30 Hz (D), and 60 Hz (E) DPN stimulations (in a counterbalanced order) in sham and SCI male
rats. * denotes significant differences from saline (trial 1: control trial) within sham or SCI; #
denotes significant differences between treatment groups (sham vs. SCI) within the same testing
trial.
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Figure 26 Effects of GRP and DAMGO infusions on the numbers of BCM bursts in sham
and SCI male rats.
Quantitative analysis of BCM bursts following intrathecal infusions of saline (A: trial 1[ control
trial]) and DAMGO and GRP (A: trials 2 and 3 [ drug trials]), followed by 5 Hz (B), 10 Hz (C),
30 Hz (D), and 60 Hz (E) DPN stimulations (in a counterbalanced order) in sham and SCI male
rats. * denotes significant differences from saline (trial 1: control trial) within the same treatment
group. # denotes significant differences between treatment groups (sham vs. SCI) within the
same testing trial.
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Figure 27 Effects of GRP and DAMGO infusions on the numbers of SVP increases in sham
and SCI male rats.
Quantitative analysis of SVP increases following intrathecal infusions of saline (A: trial 1[
control trial]) and DAMGO and GRP (A: trials 2 and 3 [ drug trials]), followed by 5 Hz (B), 10
Hz (C), 30 Hz (D), and 60 Hz (E) DPN stimulations (in a counterbalanced order) in sham and
SCI male rats. * denotes significant differences from saline (trial 1: control trial) within the same
treatment group. # denotes significant differences between treatment groups (sham vs. SCI)
within the same testing trial.

5.4.3

Infusions of GRP and DAMGO in sham and SCI male rats

Following the saline trial (Trial 1), animals received GRP and DAMGO infusions in
counter balanced order during Trials 2 and 3. However, preliminary data showed that DAMGO
infusions prevented the facilitatory effects of the subsequent GRP infusions, although this effect
was not significant because of the small numbers of animals tested. In contrast, GRP infusions
did not affect the facilitatory effects of subsequent DAMGO infusions. Therefore, data for GRP
in Trial 3 were not included in the analysis, and analysis was based on effects of GRP in Trial 2
and DAMGO in Trails 2 and 3.
There were main effects of drug treatment (GRP and DAMGO in Trials 2 and 3) on all
three parameters of ejaculatory reflex: numbers of BCM events (infusion: (F(2,59) = 11.578; P <
0.001; Figure 25A); 5 Hz: (F(2, 59) = 11.637; P < 0.001; Figure 25B); 10 Hz: (F(2, 59) = 14.755;
P < 0.001; Figure 25C); 30 Hz: (F(2, 59) = 22.937; P < 0.001; Figure 25D); 60 Hz: (F(2, 59) =
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20.186; P < 0.001; Figure 25E), BCM bursts (infusion: (F(2, 59) = 12.987; P < 0.001; Figure
26A), 5 Hz: (F(2, 59) = 17.113; P < 0.001; Figure 26B), 10 Hz: (F(2, 59) = 13.326; P < 0.001;
Figure 26C), 30 Hz: (F(2, 59) = 26.569; P < 0.001; Figure 26D), 60 Hz: (F(2, 59) = 42.239; P <
0.001; Figure 26E), and SVP increases (infusion: (F(2, 59) = 9.086; P < 0.001; Figure 27A), 5
Hz: (F(2, 59) = 15.422; P < 0.001; Figure 27B), 10 Hz: (F(2, 59) = 13.295; P < 0.001; Figure
27C), 30 Hz: (F(2, 59) = 19.958; P < 0.001; Figure 27D), 60 Hz (F(2, 59) = 35.523; P < 0.001;
Figure 27E). In addition, there were main effects of SCI on the numbers of SVP increases, BCM
events and bursts for 30 and 60 Hz (30 HZ: SVP increases: (F(1, 59) = 39.381; P < 0.001); BCM
events: (F(1, 59) = 31.248; P < 0.001); BCM bursts: (F(1, 59) = 48.942; P < 0.001; 60 Hz: SVP
increases: (F(1, 59) = 72.984; P < 0.001); BCM events: (F(1, 59) = 33.530; P < 0.001); BCM
bursts: F(1, 59) = 83.552; P < 0.001), and on numbers of SVP increases for 10 Hz (F(1, 59) =
5.681; P = 0.026) . Furthermore, there were significant interactions between SCI and drug
treatment on the numbers of SVP increases, BCM events and bursts for 30 and 60 Hz (30 Hz:
SVP increases: (F(2, 59) = 18.420; P < 0.001); BCM events (F(2, 59) = 17.185; P < 0.001);
BCM bursts: (F(2, 59) = 19.344; P < 0.001; and 60 Hz: SVP increases: (F(2, 59) = 40.377; P <
0.001); (BCM events: (F(2, 59) = 23.978; P < 0.001); BCM bursts: (F(2, 59) = 47.729; P <
0.001), and on the numbers of SVP increases and BCM bursts for 10 Hz (SVP increases: (F(2,
59) = 4.491; P = 0.019; Figure 27C); BCM bursts: F(2, 59) = 3.413; P = 0.045; Figure 26C).

5.4.4

Infusions of GRP triggered and facilitated ejaculatory reflexes in male SCI rats
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Intrathecal infusions of the gastrin-releasing peptide (GRP) agonist GRP2029 improved
ejaculatory reflexes in male rats with SCI, following drug infusion alone and in response to
subthreshold (5 – 10 Hz) levels of DPN stimulation (Figures 25 – 27, 28C, 28D, 29A-29D).
First, in sham control males, GRP infusions in trial 2, in the absence of DPN stimulation
triggered ejaculatory reflexes and increased numbers BCM events (P = 0.001), bursts (P <
0.001), and SVP (P = 0.001) compared to saline infusions in trial 1, replicating our previous
findings (Kozyrev et al., 2012). Moreover, GRP infusions facilitated ejaculatory reflexes
following 5 and 10 Hz DPN stimulation, evidenced by significant increases in numbers of BCM
events (P = 0.002 and P < 0.001), BCM bursts (P < 0.001 both), and SVP increases (P < 0.001
both), and again confirming our previous findings (Kozyrev et al., 2012). Moreover, in SCI
males, GRP infusions alone, and in conjunction with subthreshold DPN stimulation triggered and
facilitated ejaculatory reflexes. In SCI males, GRP infusions increased numbers of BCM events
(P = 0.006), BCM bursts (P = 0.002), and SVP increases (P = 0.003) compared to saline in trial
1. Also, in SCI males GRP increased these parameters following 5 Hz (BCM events: P = 0.005;
BCM bursts: P = 0.004; SVP increases: P = 0.004) and 10 Hz (BCM events: P = 0.014)
compared to saline infusions and DPN stimulation. Furthermore, ejaculatory reflexes in SCI
males treated with GRP were identical to those of sham males.
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SV increases
Figure 28 Representative BCM EMG and SVP recording traces showing SVP
and concurrent BCM activity induced by intrathecal infusions of GRP and DAMGO in
sham and SCI male rats.
Infusions of saline did not trigger SVP increases or BCM activity in sham (A) or SCI (B) male
rats. In contrast, intrathecal infusions of G
GRP (C: Sham, D: SCI) and DAMGO (E: Sham [
same animal as in A], F: SCI [ same animal as in B]) induced SVP increases and simultaneous
BCM bursts in the absence of DPN stimulation in a subset of sham and SCI male rats. Each trace
represents 200 seconds of recordings.
ecordings.
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Figure 29 Representative BCM EMG and SVP recording traces depicting SVP and
concurrent BCM EMG activity triggered by subthreshold (5 Hz) and threshold (30 Hz)
levels of DPN stimulation following infusions of saline and GRP in sham and SCI male rats
Representative BCM EMG and SVP recording traces depicting SVP and concurrent BCM EMG
activity triggered by subthreshold (5 Hz) and threshold (30 Hz) levels of DPN stimulation in
sham and SCI male rats. Subthreshold DPN stimulation (5 Hz) following saline infusions did not
induce BCM EMG or SVP activity in sham (A) or SCI (C) male rats. Conversely, subthreshold
DPN stimulation (5 Hz) following infusions of GRP triggered emission (SVP) and explusion
(EMG) reflexes in both sham (B [same animal as in A]) and SCI (D [same animal as in C])
male rats. Next, threshold DPN stimulation (30 Hz) triggered BCM EMG and SVP activity in
sham (E) but not in SCI (G) males. Intrathecal infusions of GRP followed by threshold DPN
stimulation (30 Hz) triggered BCM EMG and SVP increases in sham males (F [same animal as
in E]) and rescued ejaculatory reflexes in SCI males (H [same animal as in G]).

Finally, in sham males, numbers of BCM events, bursts and SVP increases were
significantly lower compared to those following 30 or 60 Hz stimulation after saline treatment in
Trail 1 (all P < 0.001), but still appeared increased compared to subthreshold or no stimulation
(statistical comparisons were not conducted). Hence, although GRP inhibited ejaculatory
reflexes, they were still triggered by DPN stimulation. However, SCI males were even more
affected by these inhibitory effects of GRP, and numbers of BCM bursts and SVP increases were
significantly lower compared to sham males under the same GRP and DPN stimulation
conditions (BCM bursts: 30 Hz: P < 0.001and 60 Hz: P = 0.036; SVP increases: 30 Hz P =
0.01).
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5.4.5

Infusions of DAMGO triggered ejaculatory reflexes in male SCI rats

In sham animals, DAMGO (1 nmol) triggered ejaculatory reflexes (BCM events: P =
0.001; BCM bursts: P < 0.001; SVP increases: P = 0.011). Moreover, DAMGO infusions
triggered ejaculatory reflexes in SCI males, even though this only reached statistical significance
for SVP increases (P = 0.028), with strong trends for BCM events (P = 0.053) and bursts (P =
0.07). There were no differences between sham and SCI males in these parameters. In sham
males, DAMGO did not facilitate ejaculatory reflexes following sub threshold DPN stimulation.
Moreover, DAMGO completely ablated the ability of 30 and 60 Hz DPN stimulation to trigger
ejaculation. These findings replicate our previous findings (Kozyrev, 2013b: Chapter 3) and
indicate that once DAMGO is infused to stimulate ejaculation, subsequent ejaculatory reflexes
can no longer be triggered by DPN stimulation. DAMGO infusions in SCI animals had the same
lack of effect on DPN stimulation-induced ejaculatory reflexes.

5.4.6

Experiment 2: SCI disrupts ejaculatory reflexes, but deltorphin or galanin do not
improve function.

First, the effects of SCI observed in the first experiment, were again observed in this
second experiment. Whereas, 30 and 60 Hz DPN stimulation following saline infusions (control
Trial 1) reliably triggered ejaculatory reflexes in sham males; SCI males showed no ejaculatory
reflexes under any conditions (Figures 30, 31, 32).
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Figure 30 Effects of galanin and deltorphin II infusions on the numbers of BCM events in
sham and SCI male rats.
Quantitative analysis of BCM events following intrathecal infusions of saline (A: trial 1[ control
trial]) and galanin and deltorphin II (A: trials 2 and 3 [drug trials]), followed by 5 Hz (B), 10 Hz
(C), 30 Hz (D), and 60 Hz (E) DPN stimulations (in a counterbalanced order) in sham and SCI
male rats. * denotes significant differences from saline (trial 1: control trial) within the same
treatment group. # denotes significant differences between treatment groups (sham vs. SCI)
within the same testing trial.
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Figure 31 Effects of galanin and deltorphin infusions on the numbers of BCM bursts in
sham and SCI male rats
Quantitative analysis of BCM bursts following intrathecal infusions of saline (A: trial 1[control
trial]) and galanin and deltorphin II (A: trials 2 and 3 [drug trials]), followed by 5 Hz (B), 10 Hz
(C), 30 Hz (D), and 60 Hz (E) DPN stimulations (in a counterbalanced order) in sham and SCI
male rats. * denotes significant differences from saline (trial 1: control trial) within the same
treatment group. # denotes significant differences between treatment groups (sham vs. SCI)
within the same testing trial.
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Figure 32 Effects of galanin and deltorphin infusions on the numbers of SVP increases in
sham and SCI male rats
Quantitative analysis of SVP increases following intrathecal infusions of saline (A: trial 1[
control trial]) and galanin and deltorphin II (A: trials 2 and 3 [drug trials]), followed by 5 Hz (B),
10 Hz (C), 30 Hz (D), and 60 Hz (E) DPN stimulations (in a counterbalanced order) in sham and
SCI male rats. * denotes significant differences from saline (trial 1: control trial) within the same
treatment group & denotes significant differences between treatment groups (sham vs. SCI)
within the same testing trial.

There were main effects of SCI on the numbers of BCM events and bursts, and SVP
increases for all stimulation parameters (Infusions: Events: (F(1,32) = 12.685; P = 0.006; 5 Hz
BCM events: F(1, 32) = 12.685; P = 0.006; BCM bursts: F(1, 32) = 54.144; P < 0.001; SVP
increases: F(1, 32) = 47.903; P < 0.001; 10 Hz: BCM events: F(1, 32) = 38.976; P < 0.001; BCM
bursts: F(1, 32) = 36.113; P < 0.001; SVP increases: F(1, 32) = 36.113; P < 0.001; Figure 32C;
30 Hz: BCM events: F(1, 32) = 41.255; P < 0.001; BCM bursts: F(1, 32) = 229.685; P < 0.001;
SVP increases: F(1, 32) = 95.582; P < 0.001; and 60 Hz BCM events: F(1, 32) = 31.001; P <
0.001; BCM bursts: F(1, 32) = 29.730; P < 0.001; SVP increases: F(1, 32) = 20.089; P = 0.002).
There were main effects of drug on the numbers of BCM events, bursts and SVP increases for 5,
10, and 60 Hz DPN stimulation frequencies (5 Hz: BCM events: F(2, 32) = 7.942; P = 0.003;
BCM bursts: F(2, 32) = 19.753; P < 0.001; SVP increases: F(2, 32) = 5.395; P = 0.015; 10 Hz:
BCM events: F(2, 32) = 5.984; P = 0.010; BCM bursts: F(2, 32) = 4.547; P = 0.025; SVP
increases: F(2, 32) = 7.409; P = 0.004; 60 Hz: BCM bursts: F(2, 32) = 4.054; P = 0.035).
Additionally, there were significant interactions between main factors of SCI and drug on the

161

numbers of SVP increases, BCM events and bursts for 5, 10, and 60 Hz (5 Hz: BCM events: F(2,
32) = 7.942; P = 0.003; BCM bursts: F(2, 32) = 19.753; P < 0.001; SVP increases: F(2, 32) =
5.395; P = 0.015; 10 Hz: BCM events: F(2, 32) = 5.671; P = 0.012; BCM bursts: F(2, 32) =
4.547; P = 0.025; SVP increases: F(2, 32) = 7.409; P = 0.004; 60 Hz: BCM bursts: F(2, 32) =
4.054; P = 0.035).
Post hoc tests showed that infusion of galanin and deltorphin facilitated ejaculatory
reflexes in 100 % of sham males but did not affect ejaculatory reflexes in SCI males (Figures
30B, 30C, 31B, 31C, 32B, 32C, and 33A-33F). In sham males, both galanin and deltorphin
facilitated ejaculatory reflexes following subthreshold DPN stimulation, evidenced by
significantly greater numbers of BCM events and bursts, and SVP increases (all P < 0.001),
confirming our previous findings (Kozyrev, 2013b) (Chapter 4). Also, as we reported previously,
galanin and deltorphin infusions had a slight dampening effect on ejaculatory reflexes induced
by 30 (galanin: BCM bursts: P = 0.024) or 60 Hz (galanin: BCM bursts: P < 0.001 and SVP
increases: P = 0.009; deltorphin: BCM bursts: P = 0.006) DPN stimulation in sham males,
compared to saline conditions in Trial 1. In contrast, galanin and deltorphin had no effect on
ejaculatory reflexes in SCI males (Figure 30, 31, 32, 33, 34).
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Figure 33 Representative BCM EMG and SVP recording traces depicting SVP and
concurrent BCM EMG activity triggered by subthreshold (5 Hz) DPN stimulation
following infusions of saline, galanin and deltorphin in sham and SC
SCII male rats.
Subthreshold DPN stimulation (5 Hz) following saline infusions did not induce BCM EMG or
SVP activity in sham (A) or SCI (B) male rats. Next, subthreshold DPN stimulation (5 Hz)
following infusions of galanin and deltrophin II triggered emission (SVP) and explusion (EMG)
reflexes in sham (C [galanin]; E [deltorphin II]) but not in SCI (D [galanin]; F [deltorphin II])
male rats. Each trace shown represents 90 seconds of recordings.
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Figure 34 Representative BCM EMG and SVP recording traces depicting SVP and
concurrent BCM EMG activity induced by threshold (30 Hz) DPN stimulation following
infusions of saline, galanin and deltorphin in sham and SCI male rats.
30 Hz DPN stimulations following saline infusions induced BCM EMG and SVP activity in
sham (A) but not in SCI (B) male rats. Next, 30 Hz DPN stimulation following infusions of
galanin and deltrophinn II triggered SVP increases and concurrent BCM bursts in sham (C
(
[galanin]; E [deltorphin II]) but not in SCI ((D [galanin]; F [deltorphin II]) male rats. Each trace
shown represents 90 seconds of recordings.
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5.4.7

Experiment 3: Cocktail infusions triggered ejaculatory reflexes in a subset of SCI
males

In the final intrathecal infusion experiment, all sham and SCI animals received intrathecal
infusions of a cocktail of all four receptor agonists (10 µl of 0.3 nmol galanin, 1 nmol DAMGO,
13 nmol deltrophin II and 0.2 nmol GRP). There were main effects of DPN stimulation
parameters on the numbers of BCM events (F(4, 89) = 4.862; P = 0.002) and bursts (F(4, 89) =
2.930; P = 0.027), but only a trend on SVP increases (P = 0.074). Post hoc tests showed that in
sham males, cocktail infusions did not trigger or facilitate ejaculatory reflexes. However, in
contrast, in SCI males, cocktail infusions did trigger ejaculatory reflexes in the absence of DPN
stimulation; but cocktail infusions did not facilitate ejaculatory reflexes following DPN
stimulation. In SCI males infused with the cocktail, numbers of BCM events and bursts were
higher compared to all DPN stimulation frequencies (compared to 5 Hz: BCM events: P < 0.001;
BCM bursts: P = 0.002; 10 Hz: BCM events: P < 0.001; BCM bursts: P = 0.008; 30 Hz: BCM
events: P < 0.001; BCM bursts: P = 0.01; 60 Hz: BCM events: P < 0.001; BCM bursts: P =
0.003; Figure 35).
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Figure 35 Effects of cocktail infusion on BCM EMG and SVP in sham and SCI male rats
Quantitative analysis of BCM events (A), bursts (B) and SVP increases (C) following intrathecal
infusions of a cocktail of neuropeptides (galanin, deltorphin, GRP and DAMGO) and subsequent
DPN stimulations (5 – 60 Hz counterbalanced) and representative BCM EMG and SVP traces in
sham (D:: Cocktail infusion) and SCI ((E: Cocktail infusion)
nfusion) male rats. * represents significant
differences from 5, 10, 30 and 60 Hz DPN stimulations within the same treatment group. #
denotes significant differences between treatment groups (sham vs. SCI) within the same DPN
stimulation frequency. Each trace
race shown represents 10 minutes of recordings.
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5.5 Discussion

The current study demonstrated that SCI following contusion injury severely disrupted
ejaculatory reflexes in male rats. Moreover, the current study sought to determine if intrathecal
infusions of four receptor ligands known to be expressed in LSt cells, were able to improve
ejaculatory function in SCI males. We had previously shown facilitative effects of these four
receptor ligands on ejaculatory reflexes in control animals (Kozyrev et al., 2012; Kozyrev,
2013b, 2013c). Indeed, GRP and DAMGO, but not galanin and deltoprhin had a beneficial
impact on ejaculatory function.

Infusions of GRP rescued ejaculatory reflexes in a large subset of male rats with chronic SCI.
GRP infusions were most effective in triggering emission and expulsion following drug infusion
alone or in combination with subthreshold levels of DPN stimulation (5 – 10 Hz) in both sham
and SCI males. Similarly, intrathecal infusions of the MOR agonist DAMGO restored emission
in male rats with chronic SCI. Although the effects of DAMGO on expulsion, including the
numbers of BCM events and bursts were not statistically significant across the group of SCI
males, DAMGO infusions restored expulsion reflexes in a large percentage of SCI males (54 %).
Future studies are required to investigate whether lower doses of DAMGO can restore
ejaculatory reflexes in response to subthreshold levels of DPN stimulation in male rats with
chronic SCI.
In contrast, intrathecal infusions of galanin and deltorphin significantly enhanced ejaculatory
reflexes following subthreshold DPN stimulation (5 – 10 Hz) in sham males but had no effect on
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emission or expulsion in SCI male rats. One possible explanation for the inefficacy of galanin
and deltrophin in the recovery of ejaculatory reflexes in male rats with chronic SCI may be a
substantial reduction in delta opioid receptor and galanin receptor expression in the lumbosacral
spinal cord as a result of the chronic SCI. Since infusions of GRP and DAMGO, but not galanin
or deltorphin were sufficient in restoring ejaculatory reflexes in a subset of SCI males, this
suggests that the densities of mu opioid receptors and GRP receptors may remain relatively
unchanged in male rats with chronic SCI. Our laboratory has previously observed that galanin
immunoreactivity in LSt cells and axons in male rats with chronic SCI was not changed
(unpublished observations), but a detailed investigation of neuropeptide or receptor expression
has not yet been conducted.

The disruption of descending pathways to the lumbosacral spinal cord following chronic SCI
may constitute another reason why DPN stimulation may be ineffective in triggering ejaculation
in SCI males (de Groat, 2010). This disruption of descending pathways can result in the
denervation of spinal neurons triggering the release of neurotrophic factors which in turn trigger
spinal cord plasticity and remodeling, including altered properties of afferent neurons, afferent
nerve sprouting and changes in the synaptic connections between these neurons (de Groat, 2010).
Indeed, SCI male rats exhibited profoundly impaired DPN-stimulation induced ejaculatory
reflexes compared to sham males. The inability to trigger ejaculatory reflexes in response to
sensory stimulation in SCI males may be due to a number of factors including neuroplasticity of
the sensory pathways to the spinal ejaculation generator as a consequence of the chronic SCI
which presumably may alter the sensitivity and/or the efficiency of the DPN to transmit sensory
signals to the LSt cells. Electrophysiological studies in cats demonstrated the presence of
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alterations in the afferent limb of the micturition reflex pathway as well as remodeling of
synaptic connections in the spinal cord associated with the recovery of bladder function after
chronic SCI (de Groat et al., 1981; de Groat et al., 1990; Araki and de Groat, 1997; Cheng et al.,
1999). Reorganization of the micturition reflex pathway after chronic SCI suggests the
possibility of reorganization of the spinal ejaculation generator as well. This reorganization
likely involves A δ and C-fibers in the DPN. Both types of fibers have been previously
characterized in the DPN (Johnson and Halata, 1991). However, the contribution of each type of
fiber to ejaculation is currently unclear. Interestingly, alterations in morphology, neuropeptide
expression and function of C-fiber afferents have been observed in the rat after chronic SCI.
These changes include increased soma size of bladder afferent neurons in the L6-S1 dorsal root
ganglion, (Yoshimura et al., 1998) the precise point of entry into the spinal cord of the DPN,
after joining the pudendal nerve (Nunez et al., 1986), as well as increased neuropeptide
expression and considerable afferent axonal expansion in the lumbosacral spinal cord (Zvarova
et al., 2005; Vizzard, 2006). Based on these observations, it appears that C-fiber bladder
afferents contribute to the synaptic remodeling in the lumbosacral spinal cord after chronic SCI.
Moreover, the inability to trigger DPN stimulation-induced ejaculatory reflexes in SCI males in
the current study suggests that the C-fiber mediated synaptic remodeling in the lumbosacral
spinal cord may be the culprit. Future studies will be required to test the hypothesis that selective
degeneration of C-fibers in the DPN will restore DPN-stimulation induced ejaculatory reflexes in
male rats with chronic SCI.

It is likely that the neuroplasticity resulting after chronic SCI considerably alters the sensory
pathways to the spinal ejaculation generator, including the DPN, thereby rendering sensory
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stimulation of the DPN an ineffective means of triggering ejaculatory reflexes in male rats with
chronic SCI. A future experiment may utilize DPN stimulation to induce activation of the MAP
kinase pathway in LSt cells in SCI and sham control animals. A finding that LSt cells in SCI
males do not express pERK (Staudt et al., 2010; Kozyrev et al., 2012) or cFos (Truitt et al.,
2003) may be indicative of reduced sensory inputs to the LSt cells.
Taken together, the results of the current study demonstrated that infusions of both GRP and
DAMGO improved ejaculatory reflexes in a subset of chronic SCI male rats, with greater effects
of GRP. However, it should be noted that in the current study, all animals received an acute
transection of the mid thoracic spinal cord prior to the intrathecal infusions of the drugs. The
rationale for this procedural decision is that ejaculatory reflexes in sham control animals can only
be triggered upon removal of the supraspinal influences on the spinal ejaculation generator.
Hence, it is currently unknown if GRP or DAMGO treatments will be effective in triggering
ejaculatory reflexes in male rats with chronic SCI, but otherwise intact remaining suprasinal
connections. Thus, additional preclinical studies will be required before GRP may be considered
for its potential therapeutic properties in the treatment of ejaculatory dysfunction in SCI men.
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Chapter 6: Systemic infusions of 7-OH-DPAT rescued
ejaculatory reflexes in male rats with chronic contusion
spinal cord injury
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6.1 Introduction

Ejaculation is a complex physiological process, that is composed of two successive
phases: emission and expulsion (Marberger, 1974; McKenna, 1999). During the emission phase,
seminal fluids are secreted from the accessory sexual organs, including the prostate, seminal
vesicles and vas deferens, and moved through the urethra, while the bladder neck and external
urethral sphincter shut to deter retrograde ejaculation. During the expulsion phase, the striated
perineal muscles, including the bulbocavernosus muscle (BCM), undergo coordinated, rhythmic
contractions and in this way vigorously eject seminal contents from the urethral meatus (Bohlen
et al., 1980; Gerstenberg et al., 1990; Holmes et al., 1991; Holmes and Sachs, 1991). Ejaculation
is radically altered in men with chronic spinal cord injuries (SCI) (Brackett et al., 1998) the
majority of whom ( 85%) are men between the ages of 18-45 (Ohl et al., 1989). Of all SCI men,
only 12 – 15 % are able to ejaculate by means of intense vibratory stimulation or electroejaculation (Elliott, 2006). Recovery of normal sexual function is the highest priority for
paraplegic men, followed by bladder function (Anderson, 2004). However, the neural
mechanisms that alter ejaculation following chronic SCI are currently unknown.
Ejaculation is a reflex (Pescatori et al., 1993; McKenna, 1999) controlled by a spinal
ejaculation generator, comprised of a set of interneurons located in lamina 10 and the medial
aspect of lamina 7 in lumbar segments 3 and 4 (L3-4) in the lumbosacral spinal cord and their
projections to spinal autonomic and motor neurons (Truitt and Coolen, 2002). The interneurons,
known as lumbar spinothalamic (LSt) cells due to their anatomical positioning in the lumbar
spinal cord and thalamic projections (Ju et al., 1987; McKenna, 1997; Coolen et al., 2003; Truitt
et al., 2003), are critical for ejaculation. Previous studies from our laboratory have shown that
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targeted lesion of these interneurons completely ablates ejaculation while sparing all other
components of male sexual behavior in freely-moving male rats during coitus (Truitt and Coolen,
2002; Staudt, 2011) and abolishes ejaculatory reflexes induced by stimulation of sensory inputs
from the dorsal penile nerve (DPN) or urethra, or triggered by infusion of the selective dopamine
D3 receptor agonist 7-hydroxy-2-(di-N-propylamino) tetralin (7OHDPAT) in anesthetized and
spinalized male rats (Staudt, 2011). The mechanisms whereby the spinal ejaculation generator
controls ejaculation involve the coordination of sympathetic, parasympathetic, and motor ouflow
necessary to trigger emission and expulsion (Carro-Juarez et al., 2003; Coolen et al., 2004;
Coolen, 2005; Carro-Juarez and Rodriguez-Manzo, 2007) as well as the integration of the DPNtransmitted sensory signals during mating with this autonomic and motor ouflow to initiate
ejaculation (Coolen et al., 2004; Coolen, 2005). Specifically, the LSt cells are postulated to
convert sensory signals associated with mating into motor or secretory outputs (Staudt et al.;
Truitt and Coolen, 2002; Coolen et al., 2004; Coolen, 2005; Staudt, 2011). LSt cell axons
directly project to sympathetic, parasympathetic and motor spinal nuclei in the thoracolumbar
and lumbosacral spinal cord implicated in emission and expulsion components of ejaculation
(Newton, 1993; Allard et al., 2005; Xu et al., 2006; Sakamoto et al., 2008; Kozyrev et al., 2012;
Kozyrev, 2013c, 2013b). LSt cells and axons co-contain the neuropeptides enkephalin, galanin,
cholecystokinin and gastrin releasing peptide (GRP) (Ju et al., 1987; Newton, 1993; Nicholas et
al., 1999; Coolen et al., 2003; Truitt et al., 2003; Sakamoto et al., 2008; Kozyrev et al., 2012).
Release of these neuropeptides is critical for ejaculation, as blockade of each of the neuropeptide
receptors in the lumbosacral spinal cord prevents ejaculatory reflexes triggered by DPN
stimulation (Kozyrev et al., 2012; Kozyrev, 2013c, 2013b).
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Moreover, the neurotransmitter dopamine, has also been shown to play a critical role in
ejaculation (Hull et al., 2004; Peeters and Giuliano, 2008). In evidence of this,
intracerebroventricular (i.c.v) or systemic infusions of the selective dopamine D3 receptor
agonist 7-hydroxy-2-(di-N-propylamino) tetralin (7OHDPAT) dramatically reduces the number
of intromissions prior to ejaculation as well as the latency to ejaculation in freely mating male
rats (Ahlenius and Larsson, 1995; Ferrari and Giuliani, 1996). In addition, i.c.v administration of
7OHDPAT consistently triggers coordinated, rhythmic contractions of the BCM and concurrent
increases in SVP in anesthetized spinal intact male rats (Clement et al., 2007; Kitrey et al., 2007;
Clement et al., 2008; Clement et al., 2009a; Staudt, 2011). 7OHDPAT can also trigger
ejaculatory reflexes in spinalized anesthetized male rats, demonstrating that it acts on D3
receptors in the lumbosacral spinal cord to mediate ejaculation (Staudt, 2011). Moreover, effects
of 7OHDPAT are dependent on intact LSt cells, suggesting that this D3 agonist acts either on
LSt cells or on D3 receptor-containing neurons that provide inputs to LSt cells.
Given the facilitatory effects of 7OHDPAT on ejaculatory reflexes, the current study
aimed to test whether subcutaneous infusions of the D3 receptor agonist 7OHDPAT can rescue
ejaculatory reflexes in anesthetized and spinalized male rats with chronic SCI. It was predicted
that subcutaneous infusion of 7OHDPAT will restore ejaculatory reflexes in chronic SCI male
rats without added sensory stimulation by acting on D3 receptors in the lumbosacral spinal cord.
Additionally, it was predicted that subcutaneous infusions of 7OHDPAT will rescue emission
and expulsion reflexes in SCI males following threshold levels of DPN stimulation (30 – 60 Hz).
The DPN stimulation model was utilized for these experiments because it is a physiologically
relevant model of ejaculation (Clement P, 2011). The DPN stimulation model reliably triggers
ejaculatory reflexes in rodents (Pescatori et al., 1993; Staudt et al., 2010; Kozyrev et al., 2012;
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Kozyrev, 2013b, 2013c), primates (Herbert, 1973), and men (Wieder et al., 2000) and all
experiments are performed on anesthetized male rats.

6.2 Materials and Methods

6.2.1

Animals

Adult male Sprague Dawley rats (225-250 grams) were obtained from Charles River
(Wilmington, MA, USA) and pair housed in standard housing cages on a reverse 12-hour
light/dark cycle with lights off at 9 a.m. Food and water were available at all times. All
procedures were approved by the Use and Care of Animals at the University of Michigan and
conformed to the guidelines outlined by the National Institutes of Health.

6.2.2

Spinal Cord Surgeries

Male rats were divided in a spinal cord injury (SCI) group or sham group. All surgical
procedures were performed under ketamine (87 mg/ml) / xylazine (13 mg/ml) anesthesia (I
ml/kg i.p. injection), and as described in Chapter 5. The entire back of the males was shaved and
cleaned with betadine, iodine and 70 % alcohol solution. Eyes were covered with Lacrilube
opthalamic ointment (Allergen, Irevine, CA) to prevent them from drying. All animals received a
laminectomy between the 6th and 7th thoracic spinal segments (T6-T7) and SCI male rats
received a contusion injury of the spinal cord, performed with the IH-400 impactor (Precision
Systems and Instrumentation, LLC, Lexington, KY). The impactor was positioned 1.5 inches
above the cord and a force of 200 kdyn was applied to the dura of the exposed spinal cord.
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Afterwards, the layers of muscle and skin were sutured separately, with absorbable sutures and
wound clips respectively. In order to alleviate pain and prevent bacterial infection animals
received subcutaneous injections of the analgesic ketoprofen (5 mg/ml/kg), and the antibiotic
Baytril (5 mg/ml/kg), immediately following surgery and for three days thereafter. The sham
animals underwent all procedures, including ketoprofen and Baytril treatment, except for the
contusion injury. In SCI animals, bladders were expressed twice per day until bladder function
returned (typically 7-10 days after injury). Sham animals were handled, but bladders were not
expressed.

6.2.3

Locomotor testing

Locomotor activity was measured as described in Chapter 5, at 2, 3, and 4 weeks after contusion
injury or sham procedures, sham (N= 7) and SCI (N = 13) males were placed in an Open Field
Apparatus (Med Associates Inc, Vermont) surrounded by two 16x16 photobeam arays, during
the first half of the dark phase. Locomotor activity was measured and expressed ambulatory time
in the horizontal plane, and vertical rearing. Both measures of locomotor activity were analyzed
using a two-way repeated anova (factors: SCI and time) and Holm-Sidak post-hoc tests.

6.3 Experimental Designs

6.3.1

General Methods:

Recording parameters of expulsion and emission: All experiments started four to five weeks
following the spinal cord contusion surgeries. Male rats were deeply anesthetized with urethane
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(1.5 g/kg, i.p.) and procedures for recordings are identical as we described previously (Staudt et
al., 2010; Kozyrev et al., 2012; Kozyrev, 2013b, 2013c). Connective tissues and ligaments
enclosing the reproductive organs were carefully removed to expose the muscle of the
bulbocavernosus

(BCM)

and

the

dorsal

electromyographic (EMG) recordings,

penile

nerve

(DPN).

silver recording electrodes

In

preparation

connected

to

for
the

PowerLab/7SP Data Acquisition System (AD Instruments, Inc., Colorado Springs, CO, USA)
were inserted bilaterally into the BCM and a ground electrode was implanted into the muscle of
the right thigh. For simultaneous recordings of seminal vesicle (SV) pressure, a marker of the
emission component of ejaculation (Clement et al., 2008; Kozyrev et al., 2012; Kozyrev, 2013b,
2013c; Kozyrev, 2013a), a small abdominal incision was performed and the right seminal vesicle
was located. SV pressure (SVP) was recorded using a pressure catheter (AD Instruments Inc.,
model number: SPR-671(1.4 F, Single, Straight, 15 cm, Ny) coupled to a catheter interface cable
(AD Instruments Inc., model number: AEC-IOD) and connected to a Bridge AMP (AD
Instruments Inc.). The pressure catheter was gently inserted into the lumen of the SV and fixed in
place before the start of recordings. The initial electrical stimulation of the DPN comprised
square wave pulses of 1 ms duration, 4 V at 30 or 60 Hz for 10 seconds. These established DPN
stimulation parameters consistently induce emission and expulsion reflexes in all saline-treated
control male rats, reflected in rhythmic increases in SVP and concurrent bursting of the BCM
respectively (Staudt et al., 2010; Staudt, 2011; Staudt et al., 2011; Kozyrev et al., 2012; Kozyrev,
2013c, 2013b; Kozyrev, 2013a).
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6.3.2

BCM EMG and SVP Analysis

For these experiments, SVP and BCM EMG recordings were analyzed for 15 minutes following
infusions of saline and 7OHDPAT, and for 90 seconds following each DPN stimulation.
Specifically, the numbers of SVP increases and concurrent BCM events and bursts were
analyzed following DPN stimulation and subcutaneous infusion of saline and 7OHDPAT. The
numbers of BCM events were analyzed using LabChart 7.35 (AD Instruments Inc.) software and
all events above baseline activity were incorporated in the analysis (Staudt et al., 2010; Kozyrev
et al., 2012). The numbers of BCM bursts and SVP increases were analyzed as previously
described (Kozyrev et al., 2012; Kozyrev, 2013b; Kozyrev, 2013a; Kozyrev, 2013c).
Specifically, 8 or more successive BCM events above baseline activity were counted as a ‘burst’
and all simultaneous increases in SVP (greater than baseline) were incorporated in the analysis.

Acute spinal transection: Depending on the experimental design (see below), animals received a
complete acute spinal transection before and after 7OHDPAT infusions. A laminectomy was
performed at the eighth thoracic segment (T8), caudal to the injury site, and the spinal cord was
completely transected.

Drug infusions: 7-Hydroxy-2-(di-n-propylamino) tetralin hydrobromide (7OHDPAT; Sigma
Alderich Co. LLC) was dissolved in sterile saline (0.9%) and injected s.c. at dose 1 mg/ml/kg.
This dose was previously shown to trigger ejaculatory reflexes in anesthetized, spinalized male
rats (Staudt, 2011).
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6.3.3

Experiment 1: 7OHDPAT or saline infusions after acute spinal transection

This second experiment was a partial repeat of the first experiment, but without the high
stimulation frequencies prior to 7OHDPAT infusions. Moreover, each animal received both
saline and 7OHDPAT infusions to allow for within animal comparisons. Anesthetized and
spinally-transected sham (N = 6) and SCI (N = 6) male rats received DPN stimulation at 30 and
60 Hz in a counterbalanced manner and SVP and BCM EMG were recorded for 90 seconds
following each stimulation (trial 1). Next, sterile saline was infused subcutaneously and SVP and
BCM EMG were recorded for a 15 minutes. Afterwards, 7OHDPAT was infused subcutaneously
and once again SVP and BCM EMG were recorded for 15 minutes following drug infusion.
Following drug infusion, the DPN was stimulated at 30 and 60 Hz in a counterbalanced manner
and SVP and BCM EMG were recorded for 90 seconds after each stimulation (trial 2; Figure
36A).

179

DPAT experiments: Timeline of experimental manipulations.
Figure 36 7-OH-DPAT
A) In the first experiment, spinalized sham and SCI male rats received 30 and 60 Hz DPN
stimulations (indicated by empty bolt arrows) in a counterbalanced manner with five-minute
five
intervals between stimulations and recordings of BCM EMNG and SVP, in Trial 1. Next,
animals received saline (arrow) and subsequently 7OHDPAT (arrow), each followed by 15
minutes recording of BCM EMG and SVP, in Trial 2. Next, animals received 30 and 60 Hz DPN
stimulations in a counterbalanced order (filled bolt arrows) and BCM EMG and
a SVP were
recorded for 90 seconds following each DPN stimulation, in Trial 3. B) In the second
experiment, sham and SCI male rats received 60 Hz DPN stimulation (bolt arrow), followed by
consecutive saline and 7OHDPAT infusions (arrows: Trial 1) and BCM EMG and SVP were
recorded for 15 minutes following each infusion. Next, animals received acute spinal transection
and DPN stimulation at 60 Hz (bolt arrow)
arrow). Subsequently, animals received consecutive
infusions of saline and 7OHDPAT (arrows: Trial 2) and BC
BCM
M EMG and SVP were again
recorded for 15 minutes each. Finally, males received DPN stimulation at 30 and 60 Hz
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(counterbalanced: Bolt arrows) and BCM EMG and SVP were recorded for 90 seconds
following each DPN stimulation.

Statistical analysis: The effects of SCI (Factor: SCI versus sham) on numbers of BCM
events and bursts, and SVP increases were compared between saline and 7OHDPAT infusion
trials (Factor: drug versus saline) using two-way repeated ANOVA. In separate two way
repeated ANOVAs, effects of SCI (factor: SCI versus sham) on responses to each 30 or 60 Hz
DPN stimulation were compared for before and after spinal cord transection (factor: spinal
transection). Holms Sidak tests were used for all post hoc analyses. 95% confidence level was set
for all tests.

6.3.4

Experiment 2: 7OHDPAT infusions before and after acute spinal transection
In this experiment, anesthetized and spinally-intact sham (N = 7) and SCI (N = 8) male

rats received initial DPN stimulation at 60 Hz to confirm lack of ejaculatory reflexes. Next, all
animals received subcutaneous infusion of sterile saline (1ml/kg; 0.9%) and SVP and BCM
EMG were recorded for 15 minutes after saline infusion (trial 1: Saline trial). Again, no reflexes
are expected under these circumstances. Next, male rats received subcutaneous injections of
7OHDPAT (1mg/ml/kg) and SVP and BCM EMG were recorded for 15 minutes immediately
following drug infusion (trial 2: Drug trial). After a rest period of 3 hours, selected to allow the
effects of the 7OHDPAT on ejaculatory reflexes to subside, the spinal cord was completely
transected at T8. Next, the DPN was stimulated at 60 Hzand SVP and BCM EMG were recorded
for 90 seconds following stimulation, in order to verify the completeness of the spinal cord
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transection. Next, sterile saline was infused subcutaneously and SVP and BCM EMG were
recorded for 15 minutes following saline injection (trial 1: Saline trial). Subsequently,
7OHDPAT was infused subcutaneously and SVP and BCM EMG were recorded for another 15
minutes following drug infusion (trial 2: Drug trial). Finally, the DPN was stimulated at 30 and
60 Hz (in a counterbalanced manner) and SVP and BCM EMG were recorded for 90 seconds
after each DPN stimulation with a 5 minute rest period between stimulations (Figure 36B).

Statistical analysis: Numbers of SVP increases, BCM events and bursts were compared within
animals between saline or 7OHDPAT treatment, and between SCI and sham groups within saline
or 7OHDPAT using a two-way repeated anova (factors: drug and SCI). Data were analyzed
separately for before and after spinal transection.

6.4 Results

6.4.1

Locomotor activity was impaired in SCI male rats

Locomotor activity was impaired in SCI rats, but not completely absent. Animals
displayed comparable levels of ambulatory activity, as there were no significant differences
between sham and SCI male rats in time spent in horizontal activity (Figure 37A). However, SCI
males had impaired ability to rear and thus time spent on vertical activity (Figure 37B). There
were main effects of SCI on vertical activity (F(1, 59) = 9.361; P = 0.007; Figure 37B). Vertical
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activity was significantly reduced in SCI male rat
ratss compared to sham male rats three weeks (P
( =
0.006; Figure 37B)
B) and four weeks ((P = 0.005; Figure 37B)
B) following contusion injury, with a
trend towards significance 2 weeks following surgery ((P = 0.081; 2 tailed test).

DPAT experiments: Locomotor activity in sham and SCI male rats 2, 3,
Figure 37 7-OH-DPAT
and 4 weeks after surgery.
Locomotor acitivity expressed as the mean time (ms) sham and SCI male rats spent in
ambulatory (A) and vertical (B) locomotion during three 15-minute tests,
sts, two, three and four
weeks following spinal cord contusion injury (or sham surgery).
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6.4.2

7OHDPAT infusions improved ejaculatory reflexes in chronic SCI male rats after
acute spinal transection

First, DPN stimulation did not trigger ejaculatory reflexes in SCI males, confirming the
detrimental effects of SCI we reported previously (Kozyrev, 2013a). The initial 60 Hz DPN
stimulation increased numbers of BCM events, bursts, and SVP increases in sham, but not SCI
males (Table 2).

Table 2 Initial 60 Hz DPN stimulation facilitates BCM events, bursts and SVP increases in
sham but not in SCI male rats.
60 Hz

SHAM (N=6)

SCI (N=6)

EVENTS

411.5 ± 61.956

27.5 ± 15.718*

BURSTS

5.833 ± 0.801

0.666 ± 0.422*

SVP

2.006 ± 0.571

0.666 ± 0.422*

Data are presented as mean and standard error of the mean for numbers of BCM events, bursts
and SVP increases in sham (N=6) and SCI (N=6) male rats. * indicates significant differences
between groups (events: P < 0.001; Bursts: P < 0.001; SVP: P = 0.005).

However, 7OHDPAT infusions (Trial 2) triggered both emission and expulsion reflexes
in SCI male rats, similar to the effects in sham males (Figure 38). In addition, 7OHDPAT
amplified ejaculatory reflexes following 30 and 60 Hz DPN stimulation in SCI males compared
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to DPN stimulation without drug infusion delivered following spinal cord transection in trial 1
(Figure 39). Of all sham males tested, 83% responded to 7OHDPAT infusion alone, compared
to 100% of SCI males. ‘Responders’ had at least one SVP increase and accompanying BCM
burst following 7OHDPAT treatment. Moreover, 100 % of SCI and sham male rats responded to
30 and 60 HZ DPN stimulation following infusions of 7OHDPAT (Figures 39B, 39D).
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Figure 38 Single-infusion 7-OH-DPAT experiment: Effects of 30 and 60 Hz DPN
stimulations on the numbers of BCM events, bursts and SVP increases in sham and SCI
male rats.
Representative BCM EMG and SVP traces in response to 30 Hz DPN stimulation after spinal
cord transection (A) and following 7OHDPAT infusion (B – same animal as in A) in a sham
male and corresponding traces triggered by 30 Hz DPN stimulation after spinal transection (C)
and after 7OHDPAT infusion (D – same animal as in C) in an SCI male. Quantitative analysis of
BCM events (E) bursts (F) and SVP (G) triggered by 30 and 60 Hz DPN stimulations following
spinal transection and infusions of 1mg/kg 7OHDPAT. # indicates significant differences from
transection (trial 1: control trial) within the same treatment group. * denotes significant
differences between treatment groups (sham and SCI) within the same testing trial and
stimulation.
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Figure 39 Single-infusion 7-OH-DPAT experiment: Effects of subcutaneous 7-OH-DPAT
infusions on the numbers of BCM events, bursts and SVP increases in sham and SCI male
rats
Single-infusion 7OHDPAT experiment: Effects of subcutaneous 7OHDPAT infusion on the
numbers of BCM events, bursts and SVP increases in sham and SCI male rats. Representative
BCM EMG and SVP traces in response to saline (A) and 7OHDPAT (B – same animal as in A)
infusion in a sham male and corresponding saline (C) and 7OHDPAT (D – same animal as in C)
infusion traces in a SCI male rat. Quantitative analysis of BCM events (E) bursts (F) and SVP
(G) in sham and SCI male rats triggered by infusions of 1mg/kg 7OHDPAT. # indicates
significant differences from saline (trial 1: control trial) within the same treatment group.

189

There were main effects of saline versus 7OHDPAT treatment on the numbers of BCM
events and bursts (events: F(1,23) = 14.851; P = 0.003; bursts: (F(1,23) = 17.163; P = 0.002;)
and numbers of SVP increases (F(1, 23) = 12.484; P = 0.005), but there were no main effects of
SCI on any parameter of ejaculatory behavior. Post hoc analyses revealed that both sham and
SCI males had significantly greater numbers of BCM events (sham: P = 0.014; SCI: P = 0.033)
and bursts (sham: P = 0.013; SCI: P = 0.018) and SVP increases (sham: P = 0.043; SCI: P =
0.023) following infusions of 7OHDPAT compared to saline infusions; Figure 38). There were
no differences between sham and SCI groups in their responses to 7OHDPAT, indicating the D3
agonist fully triggered ejaculatory reflexes in SCI males.

However, only SCI males had significantly greater numbers of SVP increases following
30 Hz DPN stimulation in trial 2 (7OHDPAT infusion; P = 0.005; Figure 39G). In addition,
there were main effects of trauma on the numbers of SVP increases, BCM events and bursts
following 30 Hz (SVP: F(1,23) = 19.912; P = 0.001; Figure 39G; Events: F(1,23) = 46.677; P <
0.001; Figure 39E); Bursts: F (1,23) = 23.100; P < 0.001; Figure 39F) and 60 Hz (SVP: F(1,23)
= 29.091; P < 0.001; Figure 39G; Events: F(1,23) = 29.748; P < 0.001; Figure 39E; Bursts:
F(1,23) = 47.451; P < 0.001; Figure 39F) DPN stimulation frequencies. Moreover, there were
significant interactions between factors of testing trial and trauma on the numbers of SVP
increases, BCM events and bursts following 30 Hz DPN stimulations (SVP: F(1,23) = 7.168; P
= 0.023; Events: F(2,23) = 5.900; P = 0.036; Bursts: F(2,23) = 12.484; P = 0.005; Figures 39E,
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39F, 39G). Post hoc analyses demonstrated that sham male rats had significantly more BCM
bursts following 60 Hz DPN stimulation after spinal cord transection in trial 1 compared to
infusion of 7OHDPAT in trial 2 (P = 0.031; Figure 39A, 39B, 39F). In contrast, SCI males had
significantly greater numbers of SVP increases, BCM events and bursts following 30 Hz DPN
stimulation and with a trend for numbers of BCM events following 60 Hz DPN stimulation after
7OHDPAT treatment, in trial 2, than after spinal cord transection, in trial 1 (SVP: 30 Hz: P =
0.005; Events: 30 Hz: P = 0.014; Bursts: 30 Hz: P = 0.004; Events: 60 Hz: P = 0.055; Figures
39C, 39D, 39E, 39F, 39G). Following spinal cord transection in trial 1, sham males had
significantly greater numbers of SVP increases, BCM events and bursts following 30 Hz DPN
compared to SCI males (SVP: P < 0.001; Events: P < 0.001; Bursts: P < 0.001; Figures 39A,
39C, 39E, 39F, 39G). In addition, sham males had significantly greater numbers of BCM events
following 30 Hz DPN stimulation in trial 2, after 7OHDPAT infusions, compared to SCI males
(BCM events: P = 0.002; Figure 39B, 39D, 39E). Similarly, sham males had significantly
greater numbers of SVP increases, BCM events and bursts following 60 Hz DPN stimulation in
both trials 1 and 2 after transection and 7OHDPAT treatment respectively, compared to SCI
males (SVP (trial 1): P = 0.001; (trial 2): P = 0.020; Figure 39G; Events (trial 1): P < 0.001;
(trial 2): P = 0.002; Figure 39E; and Bursts: (trial 1): P < 0.001; (trial 2): P = 0.001; Figure
39F).

6.4.3

7OHDPAT double infusion experiment: Results
Prior to spinal cord transection in trial 1, subcutaneous injections of 7OHDPAT triggered

ejaculatory reflexes in 2/7 sham (29%) and 1/8 SCI (13%) males with intact spinal cords in the
absence of DPN stimulation (Figures 40A, 40B, 40C, 40D, 40I, 40J, 40K). Conversely, infusions

191

of 7OHDPAT after spinal cord transection triggered ejaculatory reflexes in 100% of sham and
88% of SCI male rats (Figures 40G, 40H, 40I, 40J, 40K). There were main effects of infusion on
the numbers of BCM events in sham male rats (F (1, 29) = 5.112; P = 0.042). Post hoc tests
demonstrated that infusions of 7OHDPAT (trial 2) in anesthetized, intact sham males
significantly increased the numbers of BCM events compared to saline treatment (trial 1: P =
0.033; Figures 40A, 40B, 40I). In addition, there was a significant interaction between factors of
infusion and trauma on the numbers of SVP increases prior to spinal cord transection (F (2, 29) =
4.718; P = 0.049). Specifically, sham males with intact spinal cords (prior to transection)
demonstrated significantly enhanced numbers of SVP increases after 7OHDPAT infusions in
trial 2 compared to saline infusion in trial 1(P = 0.023; Figures 40A, 40B, 40K). There were also
main effects of infusion on the numbers of SVP increases, BCM events and bursts in
anesthetized and spinalized sham and SCI male rats (SVP: (F (1, 29) = 16.136; P = 0.001; Figure
40K); Events: (F (1, 29) = 14.498; P = 0.002; Figure 40I); Bursts: (F (1, 29) = 16.136; P =
0.001; Figure 40J). Post hoc tests revealed that spinally-transected sham and SCI males
demonstrated significantly greater numbers of SVP increases and BCM bursts following
infusions of 7OHDPAT in trial 2 compared to saline infusions in trial 1 (SVP: (sham): P =
0.042; (SCI): P = 0.004); (Bursts: (sham): P = 0.042; (SCI): P = 0.004; Figures 40E, 40F, 40G,
40H, 40J, 40K). However, only spinalized SCI males demonstrated significantly greater numbers
of BCM events following 7OHDPAT infusions in trial 2 compared to saline injections in trial 1
(P = 0.004; Figures 40G, 40H, 40I) while there was a trend towards significance for sham males
(P = 0.071; Figures 40E, 40F).
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Figure 40 Double-infusion 7-OH-DPAT experiment: Effects of 7-OH-DPAT infusions on
the numbers of BCM events, bursts and SVP increases in spinally-intact and transected
sham and SCI male rats.
Representative BCM EMG and SVP traces in response to saline (A) and 7OHDPAT (B – same
animal as in A) infusions in an intact sham male and corresponding saline (C) and 7OHDPAT
(D – same animal as in C) infusions in an intact SCI male rat. Representative BCM EMG and
SVP traces triggered by saline (E) and 7OHDPAT (F – same animal as in E) infusions in a
transected sham and corresponding saline (G) and 7OHDPAT (H – same animal as in H) traces
in a transected SCI male rat. Quantitative analysis of BCM events (I) bursts (J) and SVP (K)
triggered by infusions of 1mg/kg 7OHDPAT in intact and subsequently spinally-transected sham
and SCI male rats. # indicates significant differences from saline (trial 1: control trial) within the
same treatment group.

6.5 Discussion

These studies demonstrate that systemic administration of the dopamine D3 receptor agonist
7OHDPAT improved ejaculatory reflexes in anesthetized and spinalized SCI male rats.
Specifically, 7OHDPAT infusions triggered emission and expulsion reflexes in both sham and
SCI male rats in the absence of sensory stimulation. However, an acute spinal transection is
required for this effect of the D3 agonist. These results suggest that supraspinal influences inhibit
the mechanisms by which D3 receptor agonist 7OHDPAT facilitates ejaculation. In addition,
infusions of 7OHDPAT facilitated ejaculatory reflexes in SCI males following threshold (30 –
60 Hz) levels of DPN stimulation. In all experiments, sham males demonstrated considerably
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more robust ejaculatory reflexes prior to 7OHDPAT treatment. However, there were no
significant differences between sham and SCI males in the numbers of SVP increases, BCM
events or bursts triggered by infusions of 7OHDPAT with one exception.
In the single-infusion experiment, SCI males clearly showed severe impairment in
ejaculatory reflexes compared to sham males prior to 7-OH-DPAT treatment, as evidenced by
the dramatically reduced numbers of SVP increases, BCM events and bursts following DPN
stimulation (30 – 60 Hz) in SCI males compared to sham males in trial 1, following spinal cord
transection. Undoubtedly, 7-OH-DPAT treatment restored ejaculatory reflexes in SCI males.
However, even after 7-OH-DPAT infusions, SCI males still had reduced numbers of SVP
increases, BCM events and bursts following DPN stimulation compared to sham males
suggesting the presence of an underlying problem with the transmission of sensory information
to the spinal ejaculation generator required to activate the LSt cells, and in turn, trigger emission
and expulsion. One reason for the altered transmission of sensory information to the lumbosacral
spinal cord in SCI males might be the disruption of descending pathways to the lumbosacral
spinal cord following chronic SCI (de Groat, 2010). Impaired descending pathways can lead to
the denervation of spinal neurons promoting the release of neurotrophic factors leading to
synaptic remodeling and plasticity of afferent neurons, marked changes in the properties of these
neurons and their connections (de Groat, 2010).

Another reason for the impaired DPN-

stimulation induced ejaculatory reflexes in SCI males may be the reorganization of sensory
pathways, particularly the DPN, resulting in reduced transmission of sensory information from
the sexual organs to the dorsal horn of the lumbosacral spinal cord. Indeed, previous studies
reported reorganization of sensory fibers of the micturition reflex pathway in cats following
chronic SCI (de Groat et al., 1981; de Groat et al., 1990; Araki and de Groat, 1997; Cheng et al.,
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1999) indicating that reorganization of afferent fibers may also occur in other reflex pathways in
the spinal cord, namely in the spinal ejaculation generator. The DPN is composed of A δ and Cfibers (Johnson and Halata, 1991) but the role of each fiber type in ejaculation is presently
unknown. However, previous studies reported changes in soma size, neuropeptide expression
and function of C-fiber afferents (Yoshimura et al., 1998) as well as neuroplasticity of sensory
fibers in the lumbosacral spinal cord in rats with chronic SCI (Zvarova et al., 2005; Vizzard,
2006). Therefore, C-fiber bladder afferents undergo synaptic remodeling and reorganization
following chronic SCI and the inefficacy of DPN stimulation to trigger ejaculatory reflexes in
chronic SCI males may be the result of synaptic remodeling of C-fibers in the DPN.
The DPN represents the sensory branch of the pudendal nerve that conveys sensory
information associated with copulation to the spinal ejaculation generator and in turn, leads to
the activation of LSt cells with ejaculation (Hart, 1968; McKenna and Nadelhaft, 1986; Staudt et
al., 2010; Staudt, 2011; Kozyrev et al., 2012). Moreover, stimulation of the DPN produces
coordinated and rhythmic contractions of the BCM akin to those observed in male rats during
mating (Pescatori et al., 1993) and bilateral lesion of the DPN completely ablates ejaculation in
copulating rats (Lodder and Zeilmaker, 1976). Direct stimulation of the DPN results in the neural
activation of LSt cells, in anesthetized and spinalized male rats (Staudt et al., 2010; Kozyrev et
al., 2012). Specifically, DPN stimulation activates the LSt cells through map kinase signaling
(Staudt et al., 2010) and the activation of NMDA receptors (Staudt et al., 2011) and
pharmacologically blocking either of these components inhibits ejaculatory reflexes triggered by
DPN stimulation in male rats (Staudt et al., 2010, 2011). Anatomically, it is known that fibers of
the DPN innervate the dorsal horn and the dorsal central grey (DCG) in lumbosacral spinal cord,
in the vicinity of the LSt cells (McKenna and Nadelhaft, 1986; Ueyama et al., 1987; Tang et al.,
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1999). However, precisely how sensory information associated with mating or DPN stimulation
is transmitted to the LSt cells and more importantly, any direct functional connections between
the DPN and LSt cells are presently unknown. Clearly, spinal cord trauma appears to alter the
functional properties of the DPN, since DPN stimulation (30 – 180 Hz) alone was ineffective in
triggering ejaculatory reflexes in SCI males. However, it is likely that other intraspinal
connections, acting through D3 receptors, remain intact after chronic spinal trauma, since
systemic infusions of 7-OH-DPAT successfully induced ejaculatory reflexes in 100% of
anesthetized and spinally-transected chronic SCI male rats without added sensory stimulation. It
is known from previous studies that systemic treatment with 7-OH-DPAT enhances mating by
lowering the latency to ejaculation and the number of intromissions required to ejaculate in male
rats (Ahlenius and Larsson, 1995). In addition, i.c.v infusions of 7-OH-DPAT have been shown
to trigger coordinated BCM bursting (Clement et al., 2007). Furthermore, i.c.v administration of
a D2/D3 or a specific D3 antagonist prevented BCM bursting following infusions of 7-OHDPAT (Clement et al., 2007) indicating that ejaculatory reflexes are triggered by activation of
D3 receptors. The medial preoptic area has been shown to play an important role in ejaculation
through the activation of D3 receptors since targeted injections of 7-OH-DPAT into this brain
region induced ejaculatory reflexes in anesthetized male rats (Kitrey et al., 2007). Finally,
previous studies from our laboratory have clearly shown that subcutaneous infusions of 7-OHDPAT in anesthetized and spinally-transected male rats triggered ejaculatory reflexes (Staudt,
2011). Moreover, LSt lesions blocked ejaculatory reflexes induced by 7-OH-DPAT injections
suggesting that D3 receptors are also expressed in the spinal ejaculation generator and that 7OH-DPAT activates these receptors to induce ejaculatory reflexes (Staudt, 2011). Although the
expression of D3 receptors in the spinal ejaculation generator is currently unknown, it has been
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suggested that because intact LSt cells are critical for the effects of 7-OH-DPAT on ejaculatory
reflexes, D3 receptors may be expressed directly on LSt neurons as well as/or on neurons in the
spinal cord that convey sensory signals associated with mating or DPN stimulation to the LSt
cells (Staudt, 2011).
Unexpectedly, very few anesthetized but spinally-intact sham and SCI animals responded to
systemic infusions of 7OHDPAT with enhanced emission and expulsion reflexes compared to
saline infusions (29% of sham and 13% of SCI males). In contrast, 7OHDPAT infusions
triggered ejaculatory reflexes in 100% of sham and 88% of SCI males (in the same animals) after
complete spinal cord transection. This finding provides further evidence for the presence of D3
receptors in the spinal ejaculation generator since transection of the cord would have limited
activation of D3 receptors in supraspinal regions. Although a previous study has demonstrated
high densities of D3 receptor binding in the dorsal horn and around the central canal in the
lumbar spinal cord (Levant and McCarson, 2001), the expression of D3 receptors in the spinal
ejaculation generator is still unclear. Therefore, future studies are required to localize and
determine the densities of dopamine D3 receptors in the spinal ejaculation generator of sham and
chronic SCI male rats.
In the current study, all SCI males clearly showed evidence of hindpaw paralysis as reflected
in the significantly reduced time SCI males engaged in vertical locomotion. In addition, prior to
7OHDPAT treatment, all SCI animals had profoundly diminished BCM events, bursts and SVP
increases in response to 30 and 60 Hz DPN stimulations compared to sham males. The current
study clearly demonstrated that systemic infusions of 7OHDPAT consistently triggered
ejaculatory reflexes as indicated in the coordinated pattern of BCM bursting and concurrent
increases in SVP observed in anesthetized and spinalized chronic SCI males. Therefore,
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7OHDPAT treatment restored ejaculatory reflexes in SCI males. Indeed, ejaculatory reflexes
were significantly enhanced in SCI males following 7OHDPAT infusions compared to saline
treatment. However, sham males still showed significantly greater numbers of BCM events,
bursts and SVP increases, particularly following 60 Hz DPN stimulation, compared to SCI males
suggesting that transmission of sensory information by the DPN is severely altered following
chronic SCI and cannot be completely restored by activation of dopamine D3 receptors. Perhaps
future anatomical tract tracing studies can reveal the specific changes to the reflex pathways of
the spinal ejaculation generator following chronic SCI in male rats.
In conclusion, these data established that systemic administration of the dopamine D3
receptor agonist 7-OH-DPAT restored ejaculatory reflexes in anesthetized and spinalized male
rats with chronic SCI. It should be emphasized that 7-OH-DPAT likely triggered ejaculatory
reflexes through the activation of D3 receptors in the lumbosacral spinal cord since complete
transection of the cord resulted in a robust increase in the percentages of sham and SCI males
that responded to 7-OH-DPAT infusions with coordinated, rhythmic bursting of the BCM and
concurrent increases in SVP, compared to 7-OH-DPAT treatment prior to spinal transection in
the same animals. Furthermore, 7-OH-DPAT infusions facilitated emission and expulsion
reflexes in anesthetized and spinalized SCI males. However, even after 7-OH-DPAT treatment,
SCI males had significantly reduced ejaculatory reflexes following DPN stimulation compared to
sham males indicating that the transmission of sensory information via the DPN is hindered in
chronic SCI animals, likely due to the reorganization and plasticity of the DPN following chronic
spinal trauma. Finally, the current data suggest that 7OHDPAT may be utilized in the treatment
of ejaculatory dysfunction in men with chronic SCI.
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Chapter 7: General Discussion
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7.1 Summary of Results and Conclusions

Taken together, the findings of these studies determined that activation of GRP, DOR, MOR,
galanin, and CCK receptors in the lumbosacral spinal cord is required for ejaculatory reflexes in
anesthetized and spinalized male rats. However, the activation of only one of these receptors was
not sufficient to trigger ejaculatory reflexes in all male rats in the absence of sensory stimulation
suggesting that the co-release of multiple neuropeptides may be required to elicit emission and
expulsion reflexes without added sensory stimulation in male rats. Furthermore, these studies
demonstrated that activation of MOR and GRP receptors in the lumbosacral spinal cord can
rescue ejaculatory reflexes in male rats with chronic contusion SCI. Conversely, the activation of
DOR and galanin receptors in the lumbosacral spinal cord failed to restore ejaculatory reflexes in
SCI males. These findings suggest that the densities of DOR and galanin, but not MOR and GRP
receptors in are severely reduced in the lumbosacral spinal cord following chronic SCI. Lastly,
systemic infusions of 7-OH-DPAT significantly improved ejaculatory reflexes in SCI males.
However, DPN-induced ejaculatory reflexes remained impaired in SCI males even after
treatment with GRP and D3 receptor agonists indicating that the transmission of sensory
information via the DPN to the spinal ejaculation generator is severely disrupted following
chronic SCI. In conclusion, GRP, MOR, DOR, galanin and CCK receptor antagonists can be
used in the treatment of premature ejaculation to delay ejaculation in afflicted individuals.
Finally, GRP and the D3 agonist 7-OH-DPAT can be useful in the treatment of ejaculatory
dysfunction, specifically to restore anterograde ejaculation, perhaps in conjunction with intense
penile vibratory stimulation or electro-ejaculation, in men with chronic SCI.
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7.1.1

Chapter 2: Activation of gastrin-releasing peptide receptors in the lumbosacral
spinal is required for ejaculation in male rats

The main finding of Chapter 2 is that GRP is critically involved in the control of ejaculation in
anesthetized and spinalized male rats (Kozyrev et al., 2012). This finding is consistent with a
previous report that spinal GRP is involved in the control of male sexual reflexes (Sakamoto et
al., 2008). GRP acts on the outputs of LSt cells, specifically on autonomic and motor areas in the
lumbosacral spinal cord. Indeed, the expression of GRP was observed in 100% of LSt cells and
LSt axons projecting to autonomic nuclei including the IML, CAN and SPN and to motor
neurons in the SNB. Furthermore, intrathecal infusions of the GPR receptor antagonist RC-3095
dramatically impaired ejaculatory reflexes induced by DPN stimulation in male rats. This
reduction in ejaculatory reflexes was reflected in the significant decrease in numbers of BCM
events, bursts and SVP increases following electrical stimulation of the DPN. In contrast,
infusions of the GRP receptor agonist GRP

20-29

enhanced both emission and expulsion reflexes

as evidenced by the amplified numbers of SVP increases and concurrent BCM events and bursts
respectively. GRP was particularly enhancing for ejaculation when accompanied by subthreshold
levels of DPN stimulation (5 – 10 Hz). These subtle levels of DPN stimulation are normally not
sufficient to trigger ejaculatory reflexes in male rats. However, this mild intensity of electrical
stimulation was sufficient to trigger emission and expulsion reflexes in conjunction with
intrathecal infusion of GRP

20-29

. This finding indicates the presence of combined effects of

endogenous neuropeptide release following sensory DPN stimulation and intrathecal infusions of
GRP 20-29 that cumulatively trigger activation of GRP receptors in the lumbosacral spinal cord to
induce ejaculatory reflexes in male rats. GRP receptor activation is pivotal for DPN stimulationinduced ejaculatory reflexes in anesthetized and spinalized male rats. Indeed, RC-2095 did not
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prevent activation of LSt cells induced by stimulation of the DPN. Instead, the GRP receptor
antagonist likely blocked GRP receptors in LSt target regions including autonomic and motor
areas of the lumbosacral spinal cord. Future studies will be necessary to elucidate the expression
and distribution of GRP receptors particularly in autonomic and motor nuclei of the lumbosacral
spinal cord that contain axonal projections from the LSt cells.

7.1.2

Chapter 3: Activation of Mu and Delta Opioid Receptors in the Lumbosacral Spinal
Cord is required for Ejaculatory Reflexes in Male Rats

The primary finding of Chapter 3 is that enkephalin is essential in the control of ejaculatory
reflexes in anesthetized and spinalized male rats and acts through the activation of MOR and
DOR in LSt cell target areas in the lumbosacral spinal cord. Enkephalin has been previously
shown to be expressed by LSt cells and axons (Nicholas et al., 1999). Pharmacological blockade
of MOR or DOR in the lumbosacral spinal cord prevented both the emission and expulsion
phases of ejaculation triggered by sensory stimulation in male rats. In contrast, the activation of
MOR or DOR following infusions of lower doses of the MOR agonist DAMGO and the DOR
agonist Deltorphin II significantly enhanced ejaculatory reflexes induced by sub-threshold levels
of DPN stimulation (5 – 10 Hz) in male rats. Interestingly, intrathecal infusions of the MOR
agonist but not the DOR agonist triggered both emission and expulsion reflexes in a large
percentage (75 %) of male rats without added sensory stimulation of the DPN. These findings
indicate that activation of MOR but not DOR is sufficient to trigger ejaculatory reflexes in
anesthetized and spinalized male rats. However, activation of MOR but not DOR with a higher
dose of agonist resulted in an inhibition of ejaculatory reflexes induced by DPN stimulation in
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male rats. This finding is consistent with a previous study which found that a high doses of
intravenous morphine inhibit rhythmic bursting of the BCM, associated with the expulsion phase
of ejaculation in male rats (Carro-Juarez and Rodriguez-Manzo, 2009). Taken together, the
current study provides insight into the role of opioid receptors specifically found in the
lumbosacral spinal cord, in nuclei comprising the spinal ejaculation generator, in the control of
ejaculatory reflexes in male rats.

7.1.3

Chapter 4: Activation of Galanin and CCK Receptors is Required for Ejaculatory
Reflexes in Male Rats

The main finding of Chapter 4 is that galanin and CCK receptor activation in LSt target regions
is required for ejaculatory reflexes in male rats by acting on galanin and CCK receptors in the
lumbosacral spinal cord. Moreover, intrathecal infusions of galanin or CCK receptor antagonists
galantide and proglumide respectively, abolished DPN stimulation-induced emission and
expulsion reflexes in male rats. Conversely, galanin and CCK agonists enhanced ejaculatory
reflexes triggered by DPN stimulation. In particular, galanin and CCK agonists were most
effective at facilitating ejaculatory reflexes triggered by subthreshold levels of DPN stimulation
(5 – 10 Hz) and all male rats demonstrated significantly greater numbers of SVP increases, BCM
events and bursts following infusions of either agonist followed by low levels of DPN
stimulation.

However, infusions of galanin or CCK alone were not sufficient to trigger

ejaculatory reflexes in male rats without added sensory stimulation of the DPN. This finding
suggests that the release of multiple neuropeptides, including galanin, CCK, enkephalin and
GRP, is necessary to trigger ejaculatory reflexes in male rats. However, the release of only one
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of these neuropeptides is not sufficient to induce ejaculatory reflexes in all male rats without
added sensory stimulation of the DPN. Since infusions of either the galanin antagonist galantide
or the CCK antagonist proglumide blocked ejaculatory reflexes but did not prevent the neural
activation of LSt cells induced by DPN stimulation in anesthetized and spinalized male rats
suggests that galanin and CCK likely act on receptors expressed on LSt target regions, including
autonomic preganglionic neurons in the IML, CAN and SPN and on motor neurons in the SNB
in the lumbosacral spinal cord to exert their effects on ejaculatory reflexes in male rats.
However, the expression of galanin and CCK receptors in the lumbosacral spinal cord remains to
be investigated in future experiments. Finally, both galanin and CCK may be used to
pharmacologically treat premature ejaculation by increasing the latencies for emission and
expulsion during sexual activity in men.

7.1.4

Chapter 5: Activation of Mu opioid and GRP receptors in the lumbosacral spinal
cord can improve ejaculatory reflexes in male rats with chronic contusion SCI

These studies utilized a model of chronic contusion SCI in male rats. The main finding of these
set of studies was that infusion of the GRP receptor agonist GRP

20-29

and the MOR agonist

DAMGO rescued ejaculatory reflexes in male rats with chronic SCI (4 – 5 weeks). Specifically,
intrathecal infusions of GRP

20-29

facilitated ejaculatory reflexes in all sham males and 66% of

SCI males following subthreshold levels of DPN stimulation (5 – 10 Hz) and triggered emission
and expulsion in 62% of sham males compared to 55% of SCI male rats. Similarly, intrathecal
administration of DAMGO rescued both emission and expulsion in a large subset of SCI males
(54 %). However, intrathecal infusions of DAMGO prevented ejaculatory reflexes triggered by

205

DPN stimulation in both sham and SCI males, a finding which is consistent with previous reports
of inhibitory effects of opioids on ejaculatory reflexes in male rats (Carro-Juarez and RodriguezManzo, 2009). In contrast to GRP and DAMGO, intrathecal infusions of galanin or the DOR
agonist deltorphin II did not restore ejaculatory reflexes in SCI male rats. This finding suggests
that galanin and DOR receptors may be substantially diminished in the lumbosacral spinal cord
following spinal cord trauma in SCI males. In addition, there may be insufficient amounts of
neuropeptides released following DPN stimulation in SCI males due to altered transmission of
sensory signals to the lumbosacral spinal cord following trauma. Overall, this set of experiments
demonstrated that administration of DAMGO and GRP can restore emission and expulsion
reflexes in a large subset of male rats with chronic SCI suggesting that the densities of MOR and
GRP receptors remain predominantly unchanged following chronic SCI although this hypothesis
remains to be investigated in future studies. Finally, GRP can be used to treat ejaculatory
dysfunction in men with SCI.

7.1.5

Chapter 6: Systemic Infusions of 7-OH-DPAT rescued ejaculatory reflexes in male
rats with chronic contusion SCI

The main finding of Chapter 6 was that systemic administration of the dopamine D3 receptor
agonist 7-OH-DPAT rescued ejaculatory reflexes in male rats with chronic contusion SCI.
Infusion of 7-OH-DPAT induced emission and expulsion reflexes in SCI males without added
sensory stimulation of the DPN. Furthermore, 7-OH-DPAT infusions enhanced ejaculatory
reflexes triggered by threshold levels of DPN stimulation (30 – 60 Hz) in SCI males.
Remarkably, there were no significant differences observed in emission and expulsion reflexes
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between sham and SCI males following infusions of 7-OH-DPAT indicating that the distribution
and densities of D3 receptors in the lumbosacral spinal cord and ejaculation generator are not
affected by chronic contusion SCI in male rats. However, diminished DPN stimulation-induced
ejaculatory reflexes persisted in SCI males compared to sham males even after infusion of 7-OHDPAT suggesting that the transmission of sensory signals following sensory stimulation of the
DPN is severely impaired in SCI males. This disruption of sensory transmission to the LSt cells
via the DPN may be attributed to several factors including neuroplasticity of the fibers of the
DPN resulting in diminished relay of sensory signals from the reproductive organs to the
lumbosacral spinal cord. In addition, the denervation of descending pathways to the lumbosacral
spinal cord that previously modulated the ejaculatory reflex may have resulted in impaired
emission and expulsion reflexes following sensory stimulation. Indeed, previous experiments
have found that the destruction of descending pathways innervating the lumbosacral spinal cord
leads to the denervation of spinal neurons. The release of neurotrophic factors as a result of the
trauma results in neuroplasticity and neurogenesis of afferent neurons, including those of the
DPN as well as changes in the connections of these neurons. All of these factors together may
contribute to the marked changes in the transmission of sensory information to the ejaculation
generator during sexual activity or stimulation of the DPN. Taken together, the results of Chapter
6 demonstrated that systemic infusions of 7-OH-DPAT restored ejaculatory reflexes and
enhanced ejaculatory reflexes following threshold levels of DPN stimulation in anesthetized and
spinalized SCI male rats by acting on D3 receptors in the lumbosacral spinal cord. In conclusion,
7-OH-DPAT may be incorporated in the treatment of ejaculatory dysfunction in men with
chronic SCI.
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7.2 Future Directions

The current set of studies have made significant progress in determining the functional role of
neuropeptides released from LSt cell axons onto autonomic and motor target areas in the
lumbosacral spinal cord in the control of ejaculatory reflexes in male rats. In addition, these
experiments have demonstrated that MOR, GRP and the D3 receptor agonist 7-OH-DPAT can
restore ejaculation in male rats with chronic SCI. However, many more questions remain
regarding the control of ejaculatory reflexes both in intact males and in males after chronic SCI.
First, it is imperative to elucidate the expression and densities of GRP, MOR, DOR, galanin,
CCK and D3 receptors in the lumbosacral spinal cord, particularly in LSt cell target areas
including autonomic preganglionic nuclei (IML, CAN and SPN) and motor neurons of the SNB
in order to determine precisely how the neuropeptides released onto LSt target areas exert their
effects on ejaculatory reflexes in normal, healthy male rats and in male rats with chronic SCI.
We confirmed that lower doses of DAMGO facilitate ejaculatory reflexes following subthreshold
levels of DPN stimulation in male rats. Thus, it will be useful to test in future experiments
whether intrathecal infusions of lower doses of DAMGO followed by DPN stimulation (5 – 60
Hz) can restore ejaculatory reflexes in male rats with chronic SCI. Finally, it is important to
investigate the nature of the altered transmission of sensory inputs to the LSt cells by the DPN
following chronic SCI. Specifically, synaptic alterations to the fibers of the DPN need to be
examined and tract tracing studies can elucidate changes to the sensory pathway from the DPN
to the lumbosacral spinal cord in male rats with chronic spinal injuries.
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Masters Research Summary
I completed my Master’s degree in Neuroscience at Queen’s University in Kingston, Ontario in
Canada under the supervision of Dr. Patrick W. Stroman. During this time, I conducted studies
on men and women to investigate the neural correlates of sexual responses in the intact and
injured human spinal cord during sexual arousal and orgasm using functional magnetic
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resonance imaging of the spinal cord (spinal fMRI). My thesis work focused on investigating
changes in neuronal activity in the human spinal cord in response to sexually salient stimuli.
Specifically, I mapped neuronal activity in the spinal cord of men and women in response to
viewing erotic films (mental sexual arousal), genital self-stimulation (physical sexual arousal)
and the combination of the former and latter component culminating in orgasm.
With recent advancements in fMRI, it is now possible to investigate changes in neuronal activity
not only in the human brain but also in the human spinal cord. Now it is possible to visualize and
map alterations in neural activity in individuals after injury or trauma to the spinal cord and
compare these maps to those obtained from able-bodied individuals. My work in humans
represents the very first glimpse into the neural circuitry of sexual arousal and orgasm in the
human spinal cord. A manuscript describing the neural correlates of sexual arousal in the spinal
cords of able-bodied men was accepted for publication in the Journal of Sex and Marital Therapy
(Kozyrev et al., 2011). Additional manuscripts describing the neural correlates of sexual arousal
and orgasm in the spinal cords of able-bodied women are in the final stages of preparation.
In August 2009 I went on to pursue a Ph.D in the laboratory of Dr. Lique M. Coolen at the
University of Western Ontario, in London, Canada. I was motivated to pursue a Ph.D. because I
wanted to continue my work in the spinal cord control of sexual function but in an animal model.
I was not satisfied to understand the physiology of sexual function in the spinal cord only at the
systems level. My goal was to elucidate the cellular mechanisms of sexual reflexes in the spinal
cord.
Ph.D Research Summary
Disorders of male sexual function have a severe negative impact on the quality of life of men of
all ages and world-wide. At present, ejaculatory dysfunction represents the biggest challenge, as
there are no satisfactory treatments available. Indeed, up to 30% of adult men in North America
alone suffer from premature ejaculation. In addition, ejaculatory function is considerably altered
following traumatic spinal cord injury and up to 85 % of men are not able to ejaculate after
spinal cord trauma. Spinal cord trauma can occur by means of direct damage to the spinal cord,
for instance as a result of a motor vehicle accident, sports injury or gunshot wound or by indirect
means due to damage of the surrounding blood vessels, tissues and bones. There are more than
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12,000 new cases of spinal cord trauma each year in the USA alone and the afflicted individuals
are usually young, healthy men between the ages of 15-35. It is well-known that sexual function
and ejaculation in particular is disrupted in men after spinal cord injury. Regaining the ability to
ejaculate is of the outmost importance to men after spinal cord trauma. However, few studies to
date have investigated the spinal cord control of ejaculation and no studies have directly
addressed what changes occur in the spinal cord after a chronic spinal cord injury to severely
disrupt ejaculation.
The overall goal of my Ph.D. thesis is to investigate the spinal cord control of ejaculation in male
rats. The thesis consists of two main parts. In the first, I tested the hypothesis that neuropeptides
expressed in the outputs of the spinal cord ejaculation generator are critical for ejaculatory
reflexes in a physiologically-relevant model of ejaculation in the absence of supraspinal inputs
using anesthetized and spinally transected male rats. Specifically, I tested whether these
neuropeptides are required for the emission and expulsion components of ejaculation using
specific receptor antagonists. In addition, I tested whether these neuropeptides are sufficient to
trigger ejaculatory reflexes in the absence of sensory stimuli using specific receptor agonists. A
manuscript describing the work on the role of gastrin-releasing peptide in the lumbosacral spinal
cord in the control of ejaculation has recently been published in the Journal of Sexual Medicine
(Kozyrev et al., 2012). Additional manuscripts describing the results of these studies are
currently in preparation for publication.
The second objective of my thesis is to investigate changes to the spinal cord ejaculation
generator following traumatic spinal cord injury. A chronic model of contusion spinal cord injury
was utilized for these experiments. Furthermore, I tested whether intrathecal infusions of
neuropeptide agonists identified in my first set of studies to facilitate ejaculation, can rescue
ejaculatory reflexes in male rats 4-5 weeks following a contusion spinal cord injury.
My studies used an interdisciplinary approach combining techniques in small animal surgery
(laminectomy, spinal cord transection, chronic spinal cord contusion injury) neuropharmacology
(intrathecal, intracranial and subcutaneous infusions of drugs), electromyography of striated
perineal muscle contractions and seminal vesicle pressure recordings, electrical nerve
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stimulation, neuroanatomy (immunohistochemistry and microscopy analysis and behavioral
neuroscience (recording and analysis of sexual behavior and locomotion).

